Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,24966,0.191173252576596,0.00460775800051238,0.182142046895591,0.2002044582576,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,29786,-0.196025594751394,0.00353116264341681,-0.202946673532491,-0.189104515970298,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,24951,0.0779796275430828,0.0016976069520036,0.0746523179171557,0.0813069371690098,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,29545,0.0842558790303565,0.00188771297742712,0.0805559615945993,0.0879557964661136,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,-0.093077979390344,0.0020157275755819,-0.0970288054384845,-0.0891271533422035,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C9,Complement component C9,24951,0.143336650016157,0.00364649608554395,0.136189517688491,0.150483782343823,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,29301,-0.209674118475027,0.0051556272374173,-0.219779147860365,-0.199569089089689,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,29383,-0.0802476435053939,0.00204445735646083,-0.0842547799240571,-0.0762405070867307,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.144713537836087,0.00214154400669678,0.140516111582962,0.148910964089213,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,28797,-0.511452752809991,0.00820713573145181,-0.527538738843636,-0.495366766776345,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,28916,-0.193205210019037,0.00450541606654469,-0.202035825509464,-0.184374594528609,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,0.326443350110006,0.00834423387355667,0.310088651717835,0.342798048502177,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,24922,-0.272243096060685,0.00558538584222927,-0.283190452311454,-0.261295739809915,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,29500,-0.196595376225149,0.00351811250044413,-0.20349087672602,-0.189699875724279,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,29478,0.134546953967496,0.0032060157231936,0.128263163150037,0.140830744784956,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,29443,-0.203892266615818,0.00283570152852916,-0.209450241611736,-0.198334291619901,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,29725,-0.236724177919798,0.00440747354796317,-0.245362826073806,-0.228085529765791,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.126910888470953,0.00210655655584243,0.122782037621501,0.131039739320404,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,0.10463586151162,0.00189510504314663,0.100921455627053,0.108350267396188,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,24938,-0.151163937397665,0.00271463642492465,-0.156484624790517,-0.145843250004812,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,29347,-0.144089467518692,0.00275422377924222,-0.149487746126007,-0.138691188911378,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PYY,Peptide YY,24111,-0.313806255727424,0.00655111156410581,-0.326646434393071,-0.300966077061776,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,29349,-0.277884862336199,0.00613133916765715,-0.289902287104807,-0.265867437567591,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,-0.0887185060199165,0.00224543337940636,-0.093119555443553,-0.0843174565962801,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,29489,-0.212524913016719,0.00553003682369837,-0.223363785191167,-0.20168604084227,1.11253705200145e-308
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,29454,-0.140819533704773,0.00374503689324836,-0.14815980601554,-0.133479261394007,2.88634121766693e-302
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,29725,-0.0862976720183416,0.00231864015545112,-0.0908422067230258,-0.0817531373136574,2.17314185976753e-296
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,29694,-0.351982712556957,0.00953192213954118,-0.370665279950458,-0.333300145163456,7.01551953217312e-292
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,-0.169239320563378,0.00467299164125743,-0.178398384180243,-0.160080256946514,5.22804310007795e-281
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,28931,-0.197463461835018,0.00546259330315364,-0.208170144709199,-0.186756778960836,6.77704318072038e-280
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,-0.138078300255674,0.0038192110121735,-0.145563953839534,-0.130592646671814,5.72261346064965e-279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,-0.116433655291038,0.00324614618317579,-0.122796101810063,-0.110071208772014,7.71172091840908e-276
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,-0.0802288581730995,0.00225503892858407,-0.0846487344731243,-0.0758089818730748,1.56940222899648e-271
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,29478,-0.150519734826123,0.00423843257481806,-0.158827062672767,-0.14221240697948,1.57811032845772e-270
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,24195,-0.198020946956359,0.00557403271036888,-0.208946051068682,-0.187095842844036,1.65779472960512e-269
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,-0.131352133637148,0.00370816413015596,-0.138620135332253,-0.124084131942042,3.60468320214425e-269
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,-0.128572184026243,0.00363123046191711,-0.1356893957316,-0.121454972320885,7.85716954339225e-269
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,-0.124880322418614,0.00355257149383753,-0.131843362546535,-0.117917282290692,4.16824124147943e-265
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FURIN,Furin,29566,-0.0804955514551983,0.00230233844920404,-0.0850081348156382,-0.0759829680947584,1.87797381960328e-262
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,29820,-0.104912855682046,0.00306248845291505,-0.110915333049759,-0.0989103783143321,2.67307701972823e-252
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,29400,-0.239650311117927,0.00699861064930972,-0.253367587990574,-0.22593303424528,5.09976767943018e-252
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,27442,-0.0956251605704949,0.00279872626072466,-0.101110664041515,-0.0901396570994746,1.32909274401586e-250
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,29786,-0.0612980547788173,0.00180683839692015,-0.0648394580367807,-0.0577566515208538,1.46049583481425e-247
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,29702,0.0838121024377754,0.00247136748928717,0.0789682221587726,0.0886559827167783,2.25238252790103e-247
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,-0.075288561659134,0.00221589606175442,-0.0796317179401727,-0.0709454053780953,3.90245280513361e-247
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,24922,-0.214120353196428,0.00630817532537322,-0.22648437683416,-0.201756329558697,6.4364594707998e-247
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,-0.192942400455088,0.00575910271020913,-0.204230241767098,-0.181654559143078,1.87581955997799e-241
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,29820,-0.12030604709127,0.00360332105694007,-0.127368556362872,-0.113243537819667,5.52654701877143e-240
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,29786,-0.0650543673414694,0.00195403750455666,-0.0688842808504004,-0.0612244538325383,1.1975493437608e-238
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,-0.108190396348804,0.00326283826161773,-0.114585559341574,-0.101795233356033,1.10249796678555e-236
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,29478,-0.139522692631023,0.00422534006391614,-0.147804359156298,-0.131241026105747,7.93721392006638e-235
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,-0.334381105909343,0.0101520163180454,-0.354279057892712,-0.314483153925974,1.29118493252357e-233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,28774,-0.116550242510925,0.00354876413821475,-0.123505820221826,-0.109594664800024,2.86509623689982e-232
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,29434,-0.120299299192529,0.00367475074163494,-0.127501810646133,-0.113096787738924,6.56859288996901e-231
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,-0.141728761831987,0.00437307209400989,-0.150299983136247,-0.133157540527728,2.38039270453929e-226
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,0.0686851102618249,0.00211790856461575,0.0645340094751781,0.0728362110484718,6.41927579445643e-226
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,-0.0978483098546788,0.00302614403443883,-0.103779552162179,-0.0919170675471787,2.36221355958313e-225
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,-0.175200629818171,0.00544429409854547,-0.18587144625132,-0.164529813385022,2.87349025324086e-223
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.077215546049768,0.00240678525826616,-0.0819328451559697,-0.0724982469435663,5.0227309352537e-222
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,-0.0700940025316257,0.0021939039959971,-0.0743940543637801,-0.0657939506994714,3.28927512935288e-220
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,-0.07880533672503,0.00247496714633404,-0.0836562723318447,-0.0739544011182152,8.7905429043298e-219
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,29435,0.0988562194815026,0.00311491659636766,0.092750982952622,0.104961456010383,2.27616662676932e-217
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,29443,-0.0903502021245043,0.00284751863816353,-0.0959313386553048,-0.0847690655937038,2.81086710522213e-217
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,29694,0.0473759984704213,0.00149496120693731,0.0444458745048242,0.0503061224360185,8.679717396167e-217
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,-0.12051984047671,0.0038067048903986,-0.127980982061891,-0.113058698891528,2.74516612788132e-216
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.150529252932973,0.00477374146245444,-0.159885786199384,-0.141172719666563,1.19059368570107e-214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,29674,-0.257362719177008,0.00817315048712123,-0.273382094131766,-0.24134334422225,4.16879533400893e-214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,29536,-0.0718411732335346,0.00229842396565483,-0.076346084206218,-0.0673362622608511,5.00571609497627e-211
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,-0.0656878544180109,0.00210440261299804,-0.069812483539487,-0.0615632252965347,1.8241006060578e-210
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,24240,-0.110281997336069,0.00354368267778743,-0.117227615384532,-0.103336379287605,1.60278935937772e-208
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,29786,-0.0736993953779723,0.00237566532418724,-0.0783556994133793,-0.0690430913425654,5.49653528271198e-208
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,29349,-0.120080682392488,0.00387704833523858,-0.127679697129556,-0.11248166765542,2.79644099805408e-207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,29584,-0.073034524708964,0.00236354305979714,-0.0776670691061664,-0.0684019803117616,2.26650541946225e-206
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,23787,0.0929245057303676,0.00301052464998671,0.0870238774163936,0.0988251340443415,3.74063090340961e-205
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,29426,-0.179065261011056,0.00581801198366317,-0.190468564499036,-0.167661957523076,9.25115330133415e-205
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,29725,0.0756165139873936,0.0024595664540594,0.0707957637374372,0.0804372642373501,2.36347547432124e-204
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,29683,-0.0426802990911149,0.00138916947616847,-0.0454030712644051,-0.0399575269178247,4.36474246664165e-204
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,-0.180691031512713,0.00589743600351426,-0.192250006079601,-0.169132056945825,2.20118054565e-202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,29694,-0.128384880270778,0.00419732211171708,-0.136611631609743,-0.120158128931812,2.50791014991311e-202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,-0.0814376546662692,0.0026848923874113,-0.0867000437455954,-0.0761752655869431,4.69100041231522e-199
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,-0.0490165837477935,0.00161721548274895,-0.0521863260939814,-0.0458468414016056,9.60687057319217e-199
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,-0.169001073255711,0.00561939473288768,-0.180015086932171,-0.157987059579251,9.79849570937172e-196
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,-0.0719758672665619,0.00239629183647023,-0.0766725992660436,-0.0672791352670803,2.76923251565729e-195
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,-0.116321750284441,0.00388448356417356,-0.123935338070221,-0.108708162498661,4.38293458137709e-194
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,-0.0704763798013323,0.00236468558521002,-0.0751111635483439,-0.0658415960543206,2.38412487720476e-192
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,29559,-0.067165261680628,0.00225493237454785,-0.0715849291347418,-0.0627455942265143,4.13427256053941e-192
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,-0.156907447996402,0.0052853276788415,-0.167266690246932,-0.146548205745873,2.36636550079468e-190
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,29820,-0.0897705768686554,0.00304886310553798,-0.0957463485555098,-0.0837948051818009,7.40525414032022e-188
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,29581,-0.0843812264034625,0.00287637438218538,-0.0900189201925458,-0.0787435326143792,1.70451211940418e-186
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,-0.147652255764767,0.00502859496441404,-0.157508301895018,-0.137796209634515,2.47186949753141e-186
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,-0.119911578925297,0.00409748718962931,-0.127942653816971,-0.111880504033624,1.53154904079056e-185
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MENT,Protein MENT,24381,0.0460049650764613,0.00157551624377457,0.0429169532386631,0.0490929769142595,2.89482428523919e-184
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,-0.0877395403980548,0.00303551599065236,-0.0936891517397334,-0.0817899290563762,3.98224911467705e-181
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MME,Neprilysin,29349,-0.160431846273718,0.00555628664227045,-0.171322168092568,-0.149541524454868,8.61568171398825e-181
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,29786,-0.0604806679401371,0.00210027901139184,-0.0645972148024651,-0.0563641210778091,6.97248418128425e-180
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,-0.0626085104960506,0.00217515897833256,-0.0668718220935824,-0.0583451988985188,1.03111789839822e-179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,29034,0.106447545335962,0.00371046108451326,0.0991750416103158,0.113720049061608,1.65391509688764e-178
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,0.0583462061353284,0.00204076095015115,0.0543463146730321,0.0623460975976246,2.31484946045941e-177
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,-0.0751880111997756,0.00263096660372015,-0.0803447057430671,-0.0700313166564841,3.12153425986711e-177
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,-0.0744234534957799,0.00260713914769799,-0.0795334462252679,-0.0693134607662918,2.50857424622688e-176
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,29426,-0.0913731015281607,0.00321444321399571,-0.0976734102275923,-0.0850727928287291,2.29052731682631e-175
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,29697,-0.0516636698269352,0.00184177521654902,-0.0552735492513712,-0.0480537904024991,6.60971988507937e-171
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,0.064675130037236,0.00230806911072185,0.0601513145802212,0.0691989454942508,1.51556140031411e-170
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,-0.0638026462080869,0.00228233491357683,-0.0682760226386975,-0.0593292697774763,2.3504311345255e-169
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,29349,-0.087774693330328,0.00316989560361773,-0.0939876887134188,-0.0815616979472373,1.28127087727655e-166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,29349,-0.0682395183721074,0.00247327456074948,-0.0730871365111764,-0.0633919002330384,1.86760092827811e-165
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,-0.174779040762782,0.00636085270482657,-0.187246312064242,-0.162311769461322,4.22876432060268e-164
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,29218,-0.0690144835132635,0.00251297581485408,-0.0739399161103775,-0.0640890509161496,5.86593166023719e-164
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,-0.15109843721321,0.00551237690903301,-0.161902695954915,-0.140294178471505,2.3431971810761e-163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,29443,0.0712561669113929,0.00259990571797129,0.0661603517041692,0.0763519821186166,2.53846094902552e-163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,-0.0699480946242845,0.00255982481206017,-0.0749653512559224,-0.0649308379926466,2.16645524653751e-162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,29577,-0.12352390011312,0.00452063845920345,-0.132384351493159,-0.114663448733081,2.27070934393771e-162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,29632,-0.091592805957478,0.00335538535911126,-0.0981693612613361,-0.0850162506536199,4.64933320269429e-162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,-0.064242869904659,0.00235427197928352,-0.0688572429840547,-0.0596284968252633,6.12789163763152e-162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,-0.0495906772863084,0.00181771564090281,-0.0531533999424779,-0.0460279546301389,1.77568662899278e-161
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,24329,-0.0710842749502466,0.00261724424470592,-0.0762140736698702,-0.065954476230623,4.72002865023288e-160
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,28797,-0.143849870810093,0.00531238262275687,-0.154262140750696,-0.133437600869489,1.77628424769471e-159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,29433,-0.0559628752331996,0.00206973120592445,-0.0600195483968115,-0.0519062020695877,4.57679174656544e-159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,24381,-0.0754578430281107,0.00280657882858759,-0.0809587375321424,-0.069956948524079,6.22704313856441e-157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,29545,-0.033704750362385,0.00126228022017919,-0.0361788195939362,-0.0312306811308338,3.16280750787421e-155
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,-0.160496361816833,0.00602526407896818,-0.17230587941161,-0.148686844222055,1.73676707512914e-154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,29443,0.0497807988666844,0.00187108013094288,0.0461134818100363,0.0534481159233324,3.92704336172853e-154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,29530,-0.0523463185206269,0.00196869190091524,-0.0562049546464208,-0.048487682394833,5.8803162365541e-154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,-0.0776546749299626,0.00292108616072362,-0.0833800038049809,-0.0719293460549443,6.60080676308097e-154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,29786,-0.0603880706468581,0.00227517398087257,-0.0648474116493684,-0.0559287296443479,1.93596958751301e-153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,-0.151377918776227,0.00570234224718867,-0.162554509580717,-0.140201327971737,1.98262513383139e-153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,24914,0.0692298114288559,0.00260644707884192,0.0641211751543257,0.074338447703386,2.6233165816435e-153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,-0.0534499162208586,0.00201645550670989,-0.05740216901401,-0.0494976634277072,4.97699040646617e-153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,-0.09356194051077,0.00355799097840161,-0.100535602828437,-0.0865882781931028,1.16898481021972e-150
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,29750,0.0981910124140271,0.00374736348815463,0.0908461799772441,0.10553584485081,1.24125884655795e-149
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,24805,-0.131523717912709,0.00501607214567645,-0.141355219318235,-0.121692216507183,1.69733771302283e-149
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,-0.0396904495629254,0.00153072262696437,-0.0426906659117756,-0.0366902332140753,1.36425840192602e-146
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OCLN,Occludin,24867,-0.079117481401252,0.00306091122778608,-0.0851168674077127,-0.0731180953947912,2.15591248602336e-145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,-0.0647315956403758,0.00250992017717225,-0.0696510391876334,-0.0598121520931182,4.86833761261486e-145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,-0.0642126055312486,0.00249279141792687,-0.0690984767103852,-0.0593267343521119,1.03326903311749e-144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,-0.0982055032597515,0.00381511640663192,-0.10568313141675,-0.0907278751027529,1.72517013131476e-144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,29604,-0.106463002058051,0.00414498403574197,-0.114587170768105,-0.0983388333479966,6.54957331782951e-144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,-0.0570538881654208,0.00222149504798541,-0.0614080184594722,-0.0526997578713694,1.42654809112795e-143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,29434,-0.0851170645270804,0.00331921052901739,-0.0916227171639545,-0.0786114118902063,1.87490108332048e-143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,-0.0883709696499708,0.00344849155373765,-0.0951300130952966,-0.081611926204645,6.12999136756577e-143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,-0.187782617911468,0.00734139567597131,-0.202171753436372,-0.173393482386565,9.7177084836326e-143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,29604,-0.105817553819748,0.00414701390099167,-0.113945701065692,-0.0976894065738048,4.45357453711641e-142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,24922,-0.0502536578829281,0.0019747670735316,-0.05412420134705,-0.0463831144188062,4.72795283604021e-141
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,-0.0527017329105093,0.00207330367248772,-0.0567654081085852,-0.0486380577124334,5.15530567851768e-141
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,29507,0.0349247004069786,0.00137599769619787,0.0322277449224308,0.0376216558915265,1.31255617050038e-140
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,29478,-0.0463612454758171,0.0018305748344813,-0.0499491721514005,-0.0427733188002338,5.20580872118468e-140
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELE,E-selectin,29820,-0.0883637205557114,0.00349809371953611,-0.0952199842460022,-0.0815074568654207,2.54248242873834e-139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,29169,-0.0539323147778437,0.00213541274759977,-0.0581177237631392,-0.0497469057925481,3.05241341387007e-139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,-0.0831059141585656,0.00329532881354342,-0.0895647586331107,-0.0766470696840205,1.4768509966022e-138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,29435,0.0553716540005538,0.00220158671110217,0.0510565440467935,0.059686763954314,3.9988754333972e-138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,-0.053322020185825,0.00212304240097066,-0.0574831832917275,-0.0491608570799225,9.3949270770222e-138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,-0.0676611239142732,0.00270305681075378,-0.0729591152633506,-0.0623631325651958,7.7429224144152e-137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,29443,-0.0408120598078214,0.00163203166303142,-0.044010841867363,-0.0376132777482798,1.37522772675106e-136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0471777760302669,0.0018868113272895,0.0434796258287795,0.0508759262317543,1.47212569768694e-136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,29683,-0.0596453009389946,0.00238840662549107,-0.0643265779249571,-0.0549640239530321,3.08763444049904e-136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,29725,-0.0495583634154387,0.00198576173445701,-0.0534504564149744,-0.0456662704159029,4.54701804868294e-136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,28762,-0.0548870035982687,0.00221017630545025,-0.0592189491569511,-0.0505550580395862,1.02057853094813e-134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,29725,-0.220508855807852,0.00888804923684051,-0.23792943231206,-0.203088279303645,1.65640858360294e-134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,-0.0650615475650418,0.00262608296896819,-0.0702086701842194,-0.0599144249458641,3.94968585486008e-134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELN,Elastin,24922,-0.0602308665354045,0.002448466897603,-0.0650298616547064,-0.0554318714161026,4.82700038819462e-132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,29453,-0.054358619725016,0.0022169167700734,-0.0587037765943599,-0.0500134628556721,1.89101607225572e-131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REN,Renin,29478,-0.12954184406616,0.00529240107367643,-0.139914950170566,-0.119168737961755,5.30107030300378e-131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGRN,Agrin,29581,-0.0585588081317599,0.00239292366049255,-0.0632489385063253,-0.0538686777571945,5.95809088853543e-131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,-0.0973255395520998,0.00397399783278089,-0.10511457530435,-0.0895365037998492,6.70232846739942e-131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,24381,-0.0490430643028837,0.00200525479539136,-0.0529733637018507,-0.0451127649039166,1.57866158359614e-130
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.0726232783510036,0.0029734719864221,-0.0784512834443909,-0.0667952732576163,1.90856356032151e-130
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,-0.0664209393324261,0.00271869417937498,-0.0717495799240011,-0.0610922987408512,3.01027616657408e-130
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,29544,-0.0519122117262988,0.00213079032282318,-0.0560885607590322,-0.0477358626935653,8.11291362579327e-130
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,24240,-0.0913225456593438,0.00376727850656683,-0.0987064115322148,-0.0839386797864729,2.77707013341311e-128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,-0.169940731786225,0.00701960893783685,-0.183699165304386,-0.156182298268065,3.48026597601624e-128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,28764,-0.1001176008987,0.00413782099385117,-0.108227730046648,-0.0920074717507516,4.71637832629274e-128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,29725,0.0278438898046627,0.00115468355700415,0.0255807100329346,0.0301070695763909,2.99454338271343e-127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,29693,-0.0950024848639988,0.0039502545007215,-0.102744983685413,-0.0872599860425847,1.37058815333227e-126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,29786,-0.0758165148712167,0.0031527983776516,-0.0819959996914138,-0.0696370300510196,1.4361162547309e-126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,-0.0451329919271577,0.00188003559236069,-0.0488178616881847,-0.0414481221661307,3.84548023409063e-126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,29434,-0.0668839454540706,0.00279081924016224,-0.0723539511647886,-0.0614139397433527,1.01862169014096e-125
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,-0.121071258996406,0.00505275216874847,-0.130974653247153,-0.111167864745659,1.15500349638257e-125
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,24867,-0.0736631707418164,0.00309034960053261,-0.0797202559588603,-0.0676060855247725,3.46261721056478e-124
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,29487,-0.0521513688096214,0.00219953575923391,-0.0564624588977198,-0.0478402787215229,4.03483834656884e-123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,-0.0906844236133502,0.00382898497495314,-0.0981892341642584,-0.0831796130624421,8.07873467685607e-123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,24240,-0.106048324467994,0.00447527848170003,-0.114819870292126,-0.0972767786438618,9.77137380918106e-123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,-0.0947539304119424,0.0040017971726241,-0.102597452870286,-0.0869104079535992,1.50524488383227e-122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,0.103654805587067,0.00438315449086233,0.0950638227849767,0.112245788389157,1.72084125389699e-122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,-0.135159422220024,0.00574531261561851,-0.146420234946636,-0.123898609493412,3.14773546184623e-121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,29820,0.0268377373408374,0.00114164345190992,0.024600116175094,0.0290753585065809,4.2829857721762e-121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,-0.0624529057662783,0.00266428526912666,-0.0676749048937666,-0.0572309066387901,2.03195257051047e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,29820,-0.096268223555502,0.00410806298381083,-0.104320027003771,-0.0882164201072328,2.36514655413689e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,29443,-0.0912834292593421,0.00390139098964821,-0.0989301555990526,-0.0836367029196316,5.633360467835e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,24951,0.084270865485113,0.00360743350057351,0.0772002958239889,0.0913414351462371,2.07447163892677e-119
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,0.0795000622920578,0.00341533647427059,0.0728060028024874,0.0861941217816281,1.39265565932947e-118
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,0.0549209079407319,0.00237344617409244,0.0502689534395107,0.059572862441953,2.00347909527536e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,-0.0461605702712497,0.0019958131569915,-0.050072364058953,-0.0422487764835463,2.65414537709552e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,-0.0444832927735421,0.0019227192156885,-0.0482518224362915,-0.0407147631107926,3.53945687279017e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,-0.0544805914116164,0.00236034381705126,-0.0591068652930369,-0.049854317530196,7.70570456169361e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,29566,-0.0425552384598687,0.00184599425707401,-0.0461733872037338,-0.0389370897160036,1.47645625225573e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,29545,-0.0529646250431988,0.00230022357402554,-0.0574730632482889,-0.0484561868381088,2.7209466392737e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,-0.0455302339509303,0.00197756417105025,-0.0494062597261888,-0.0416542081756718,2.96433891809935e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,24805,-0.17824154836389,0.00775345749180341,-0.193438325047825,-0.163044771679956,9.83232937939873e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,-0.109242096737833,0.00475584476440373,-0.118563552476064,-0.0999206409996012,1.61744310879114e-115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.06494092997553,0.00285630036918745,-0.0705392786991374,-0.0593425812519226,1.88312614349588e-113
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,29434,0.0540809946659106,0.00238530152341241,0.0494058036800223,0.058756185651799,7.75274997250269e-113
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,24381,-0.0432108312196178,0.00190569341158463,-0.0469459903063237,-0.0394756721329119,1.16974588460354e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,-0.104335686334019,0.0046029851051816,-0.113357537140175,-0.095313835527863,1.30891995999084e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,29433,-0.0472896352539312,0.00209091739055396,-0.051387833339417,-0.0431914371684455,2.69755122600014e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,28916,-0.084140987766985,0.00372977086242184,-0.0914513386573318,-0.0768306368766382,1.00535367592696e-111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.106154094829471,0.00472012411851337,-0.115405538101758,-0.0969026515571853,4.54965299887621e-111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,-0.054802796368824,0.00243848589532782,-0.0595822287236666,-0.0500233640139815,6.22351280624866e-111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,-0.0563822785409895,0.00251449178297328,-0.0613106824356171,-0.0514538746463619,1.97758288045413e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,24828,-0.0482483003639248,0.00215177454225638,-0.0524657784667473,-0.0440308222611023,2.95567231274277e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,29478,-0.0551539145584094,0.00246583644239897,-0.0599869539855114,-0.0503208751313074,6.76005531909911e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,29478,0.0580935796902719,0.00259977258429397,0.0529980254250557,0.063189133955488,1.08751146901753e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,29434,-0.084403437755033,0.00377853928684641,-0.091809374757252,-0.076997500752814,1.30254050954242e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,-0.0780461121664918,0.00349630554211952,-0.0848988710290461,-0.0711933533039376,1.82275056302701e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,29434,-0.0725752697770396,0.00325246876793652,-0.0789501085621952,-0.0662004309918841,2.19296997531325e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,24381,-0.0993858364377137,0.00445517873958212,-0.108117986767295,-0.0906536861081327,3.83404748250237e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,29786,-0.0640205149029706,0.00287607207985464,-0.0696576161794857,-0.0583834136264555,7.0374783163026e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,29725,-0.0858346850251551,0.00386176443996057,-0.0934037433274779,-0.0782656267228324,1.45365247987058e-108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,-0.0985863511967048,0.00443747224020554,-0.107283796787508,-0.089888905605902,1.84694584843658e-108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,-0.0621521246710937,0.00279692340043201,-0.0676340945359405,-0.056670154806247,2.41866673130462e-108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,-0.061095865397454,0.00275760340837674,-0.0665007680778724,-0.0556909627170356,7.10650308019753e-108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,0.0943017507196737,0.00425731461387077,0.085957414076487,0.10264608736286,1.20837995693483e-107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PXN,Paxillin,28774,-0.0793046339431635,0.00358502518817236,-0.0863312833119813,-0.0722779845743457,1.5647763854816e-107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,0.0409116752380243,0.00185205946361403,0.0372816386893408,0.0445417117867078,4.21843308565852e-107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,29594,-0.0822481401801056,0.00373189975302375,-0.0895626636960321,-0.0749336166641791,8.7848203418798e-107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0560483690770588,0.00254482722724526,-0.0610362304424595,-0.0510605077116581,1.2233588847814e-106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,29434,-0.0855068396850088,0.00389679447724882,-0.0931445568604164,-0.0778691225096011,7.17015696500112e-106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,29434,-0.115619218030512,0.00528571987569488,-0.125979228986874,-0.10525920707415,3.18189310160049e-105
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,-0.080142404130038,0.00366351343077667,-0.0873228904543602,-0.0729619178057157,4.36206758950878e-105
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,29351,-0.0485705668926713,0.00222493181029243,-0.0529314332408444,-0.0442097005444981,8.21094357054342e-105
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.0592631024432803,0.00271487660290987,-0.0645842605849837,-0.053941944301577,8.35458691153519e-105
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFM,Afamin,24966,-0.0296563961601494,0.00136152548140146,-0.0323249861036963,-0.0269878062166025,3.23581757831366e-104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,29725,-0.0698096856789968,0.00320851178073709,-0.0760983687692415,-0.0635210025887521,3.8078157622118e-104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,29349,-0.117647643229832,0.00541171322825119,-0.128254601157204,-0.10704068530246,5.76235374553437e-104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,29566,-0.0625214683124537,0.00289882905335912,-0.0682031732570376,-0.0568397633678698,2.22139977484524e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,29725,-0.0398624045620554,0.0018508234412625,-0.0434900185069299,-0.0362347906171809,4.17972193721475e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,29701,-0.0357863291255888,0.00166367105739939,-0.0390471243980916,-0.032525533853086,7.45864136890795e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,29786,-0.114530004378755,0.00535009352298266,-0.125016187683801,-0.104043821073709,6.62312320481962e-101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,-0.0760452446897013,0.00355447305964088,-0.0830120118865974,-0.0690784774928051,9.22360987014949e-101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,29786,-0.0514379836352177,0.00241493111346281,-0.0561712486176048,-0.0467047186528306,6.33356397580568e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,-0.040923512437244,0.00192355455050656,-0.0446936793562369,-0.0371533455182512,1.08454404456381e-99
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,29652,-0.0551359030587063,0.00259408917046528,-0.0602203178328183,-0.0500514882845944,1.66117516019732e-99
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,-0.083387474035657,0.0039323057951015,-0.091094793394056,-0.0756801546772581,6.77516216841732e-99
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,29786,-0.08019675005878,0.00379515503637038,-0.0876352539300659,-0.072758246187494,2.16580538884832e-98
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,-0.076625146921904,0.00363173451547245,-0.08374334657223,-0.069506947271578,4.29339461989039e-98
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,0.0290146654709558,0.00137823802438834,0.0263133189431547,0.0317160119987569,1.15847327982359e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_E,,29434,-0.0424706460011194,0.00202155375231196,-0.0464328913556509,-0.038508400646588,2.82090264444489e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,29581,0.063094987559518,0.00300946558868335,0.0571964350056987,0.0689935401133374,6.87892088286314e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POSTN,Periostin,24938,0.0555234779648199,0.00264926227033509,0.0503309239149631,0.0607160320146767,1.08146132657021e-96
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,-0.0295146363023856,0.00141042074644037,-0.0322790609654087,-0.0267502116393625,1.57176887675656e-96
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,-0.0864611326026658,0.00414811618300004,-0.0945914403213458,-0.0783308248839857,8.65487926144888e-96
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,29192,-0.0538258242272474,0.00258258166459356,-0.0588876842898508,-0.048763964164644,9.02164780150274e-96
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,-0.0651897346926666,0.00312864443343678,-0.0713218777822027,-0.0590575916031305,1.3974417708033e-95
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,-0.0520135324593064,0.00249849220155317,-0.0569105771743506,-0.0471164877442622,1.50746627643475e-95
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,-0.0872132992665684,0.0042225371306996,-0.0954894720427396,-0.0789371264903972,4.18448487483385e-94
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,29443,-0.0537832525082948,0.0026083168857109,-0.0588955536042882,-0.0486709514123015,8.38605979901346e-94
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,-0.0439018297669883,0.00212985171497286,-0.0480763391283351,-0.0397273204056415,9.80418587351487e-94
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,29683,-0.082616319774792,0.00402200166058339,-0.0904994430295354,-0.0747331965200485,4.11507579609136e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,28477,-0.0575428342765847,0.00280184607631522,-0.0630344525861625,-0.0520512159670069,4.71533811004689e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,-0.0630399421776891,0.00307205500004427,-0.0690611699777759,-0.0570187143776023,6.36238445107121e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,29694,-0.0616537477702285,0.00302543458489306,-0.0675835995566189,-0.0557238959838381,1.10253473897303e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAST,Gastrin,24845,-0.185879900272463,0.00911599397255094,-0.203747248458663,-0.168012552086263,1.14429535881647e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,24194,-0.039340530401557,0.0019294495956769,-0.0431222516090838,-0.0355588091940303,1.22290806600441e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,29581,-0.0948435329629456,0.00465813985780899,-0.103973487084251,-0.08571357884164,1.58198517074312e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,29478,-0.0901781782464775,0.00442951465571121,-0.0988600269716715,-0.0814963295212835,1.66655063883816e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,-0.0943594109621874,0.00464434150431401,-0.103462320310643,-0.085256501613732,3.79191895576646e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,-0.0394097994396059,0.00194020330776943,-0.043212597922834,-0.0356070009563778,4.22996129109191e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,29594,-0.0437569600340365,0.00215731055735191,-0.0479852887264463,-0.0395286313416268,7.53293780822536e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0633522262384071,0.00312401005904067,-0.0694752859541268,-0.0572291665226874,8.08328272520041e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,24922,-0.0375021949217317,0.00184962008176276,-0.0411274502819867,-0.0338769395614767,1.13957502359263e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,-0.0868314761580408,0.00428620847059385,-0.0952324447604048,-0.0784305075556769,1.24689905501644e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,-0.108809936009986,0.00537979343286246,-0.119354331138396,-0.0982655408815756,2.3925798613774e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.0388102531711216,0.0019199632168148,-0.0425733810760786,-0.0350471252661646,3.04666137395268e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,29595,-0.0957359610113582,0.00474191394068614,-0.105030112335103,-0.0864418096876133,4.9205100705228e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,24653,-0.0386165732583576,0.00191194624626012,-0.0423639879010275,-0.0348691586156878,5.51393707191806e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,-0.0951923153077526,0.00473049211089718,-0.104464079845111,-0.0859205507703942,1.91124071211315e-89
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,24240,-0.0449719328069651,0.00223896021257684,-0.0493602948236157,-0.0405835707903144,5.1864731641704e-89
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MLN,Promotilin,29434,-0.124362350746524,0.00620014644784434,-0.136514637784299,-0.112210063708749,6.76612730069973e-89
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,29163,-0.0867334465135706,0.00432833539208447,-0.0952169838820561,-0.078249909145085,1.00752496697386e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,24381,-0.0642539936273678,0.00320884458172844,-0.0705433290075556,-0.0579646582471801,1.75274099415859e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,24914,-0.0394073574991919,0.00197419199905039,-0.0432767738173307,-0.0355379411810531,5.83936013038407e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0511492154674556,0.00256664921353585,-0.0561798479259859,-0.0461185830089253,8.77116344239283e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,0.054321316934705,0.00272863267631504,0.0489731968891275,0.0596694369802825,1.31392925027796e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,-0.0830297380533622,0.00417342747416967,-0.0912096559027348,-0.0748498202039897,2.16975422729601e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,0.0484202255977477,0.0024377939417916,0.0436421494718362,0.0531983017236592,3.22052853715167e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,29434,-0.0837268578142893,0.00421621818444475,-0.091990645455801,-0.0754630701727776,3.48580471758029e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0353555233575951,0.00178194600919292,0.031862909179577,0.0388481375356132,4.90936468459141e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,29527,0.0538800427980826,0.00271649268651783,0.0485557171325076,0.0592043684636575,5.54692503350936e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,-0.129995525836902,0.00656317340942444,-0.142859345719374,-0.11713170595443,9.56173415662443e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,24229,-0.0620292289946726,0.00313073950494966,-0.068165478424374,-0.0558929795649713,1.1194857085557e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.0381890839676601,0.00193089717969343,-0.0419736424398592,-0.034404525495461,1.68513709967574e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSN,Gelsolin,24845,0.0264550629606089,0.0013379944944126,0.0238325937515602,0.0290775321696576,2.38883421991075e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,29581,-0.0558556540833206,0.00283469465921347,-0.061411655615379,-0.0502996525512622,7.05418943559237e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,29349,-0.0718064240860378,0.00364627081839017,-0.0789531148900825,-0.0646597332819931,8.85947499271443e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,29674,-0.0388279102018718,0.0019720454222123,-0.0426931192294079,-0.0349627011743357,9.43782344183148e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,29725,-0.0523816127085793,0.00266049903624154,-0.0575961908196127,-0.0471670345975459,9.51241427291891e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,29218,-0.0524019795521573,0.00266354522116425,-0.0576225281856392,-0.0471814309186754,1.29858711559534e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,-0.0382631831558009,0.00195042826178999,-0.0420860225489093,-0.0344403437626926,3.92730189240578e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,24938,-0.0511357137836172,0.00260690701781543,-0.0562452515385354,-0.0460261760286989,4.99863187426826e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,-0.0859989134383784,0.0043896186725322,-0.0946025660365415,-0.0773952608402153,6.30506759359702e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,-0.142952716111178,0.00730818251294036,-0.157276753836541,-0.128628678385815,1.16308610896447e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,24381,-0.0587582428266979,0.00300351209746523,-0.0646451265377297,-0.052871359115666,1.42069773962551e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,29497,-0.0677131967387378,0.00347152602567231,-0.0745173877490555,-0.0609090057284201,3.36287341213236e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,-0.0723309499727488,0.00370849729721219,-0.0795996046752847,-0.065062295270213,3.44927132858235e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,-0.149886277578018,0.00768656654259117,-0.164951948001496,-0.134820607154539,3.85448470131616e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,0.0843901193267844,0.00433974580196084,0.0758842175549412,0.0928960210986277,1.04680903024943e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,-0.102175258547501,0.0052551390731083,-0.112475331130794,-0.091875185964209,1.39452069657407e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,29566,-0.0443536723824652,0.00228606096711637,-0.0488343518780133,-0.0398729928869172,2.4621231399695e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,24938,-0.0342341086673067,0.00177219411553278,-0.0377076091337509,-0.0307606082008624,1.54144646651507e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,-0.0587608161407295,0.00304645507537429,-0.0647318680884632,-0.0527897641929959,2.18481646556567e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,29820,-0.0814930060433981,0.00424381213272114,-0.0898108778235316,-0.0731751342632647,1.09386450116822e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,-0.114881201715678,0.00598199246281545,-0.126605906942796,-0.103156496488559,1.37305796692921e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,29694,-0.04954099750562,0.00258178072481591,-0.0546012877262592,-0.0444807072849809,1.43676057515339e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.0414309065849716,0.00216301649364041,0.0371913942574364,0.0456704189125068,2.78049701841611e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,-0.0983049131401772,0.00513246351898079,-0.108364541637379,-0.0882452846429748,2.85163633074949e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,-0.0532034784232627,0.00279056147950411,-0.0586729789230907,-0.0477339779234346,1.58841113557001e-80
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,24966,0.0367238575758959,0.00192575401972911,0.0329493796972269,0.040498335454565,1.68191221960158e-80
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,-0.0368017203540116,0.00193586053857949,-0.0405960070096274,-0.0330074336983958,4.22177598071262e-80
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,-0.0895529069385836,0.00472346236654251,-0.0988108931770069,-0.0802949207001603,1.11256919341136e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EZR,Ezrin,29694,-0.0316524282655052,0.00167426788618941,-0.0349339933224365,-0.028370863208574,3.02118828409116e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.046402929713769,0.00245506326654917,-0.0512148537162054,-0.0415910057113326,3.30599506984726e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,0.035520340661201,0.00188089371313959,0.0318337889834474,0.0392068923389545,4.46782713793518e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,-0.0658254528918962,0.00348699926728104,-0.072659971455767,-0.0589909343280254,5.06505252891917e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,-0.0828278105612373,0.00438519076168303,-0.091422784454136,-0.0742328366683386,5.11782448022486e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,29349,-0.0952046234475879,0.00506067121125943,-0.105123539021656,-0.0852857078735194,1.72564738052911e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,-0.0558652424734144,0.00297584144325493,-0.0616978917021941,-0.0500325932446348,3.5993146035837e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,-0.0300985691758856,0.00160279842261844,-0.0332400540842177,-0.0269570842675534,4.01576484802309e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,29736,-0.065753340024363,0.00350552378612024,-0.0726241666451587,-0.0588825134035674,4.79031999268055e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,24240,-0.0792331106000431,0.00422163147210633,-0.0875075082853715,-0.0709587129147147,4.90629127160878e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,24922,-0.0589104787728898,0.00314263041816345,-0.0650700343924902,-0.0527509231532895,7.22976986611195e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEP,Leptin,29478,-0.0878600747356059,0.00469030039211052,-0.0970530635041425,-0.0786670859670693,7.65861553864609e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,29628,0.0362958141564603,0.00194175372195625,0.032489976861426,0.0401016514514945,1.59995230577034e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,29335,-0.0599060134564395,0.003208640938724,-0.0661949496963386,-0.0536170772165405,2.43219452190572e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,-0.0550171863915392,0.00295153731800132,-0.0608021995348218,-0.0492321732482566,4.22221360217791e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,-0.0741857642487282,0.00398354899693458,-0.0819935202827199,-0.0663780082147364,5.79689709685204e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,-0.0551260096391444,0.00297014861804448,-0.0609475009305116,-0.0493045183477772,1.84157311457606e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,-0.054553345932926,0.00294389811643406,-0.0603233862411368,-0.0487833056247153,3.14024320512622e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,-0.0614012222671873,0.00331330632818021,-0.0678953026704205,-0.054907141863954,3.74218189401652e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,24229,-0.108525463698399,0.00586197309527632,-0.120014930965141,-0.0970359964316578,5.38455631917563e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0335808324684175,0.00181556959936961,0.0300223160536531,0.0371393488831819,5.92763103664454e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,24793,-0.0576687518216909,0.00311854659509996,-0.0637811031480868,-0.051556400495295,7.73539895820379e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,-0.0726220333445628,0.00393086027264459,-0.0803265194789462,-0.0649175472101794,8.8423022744168e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,-0.159893963786512,0.00866154561727648,-0.176870593196374,-0.14291733437665,1.15918498736571e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,-0.089726988733252,0.00485941134573358,-0.0992514349708898,-0.0802025424956142,1.28135520090849e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,-0.0978815850058172,0.00530382554517932,-0.108277083074369,-0.0874860869372658,1.55922115917183e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.0843426018675691,0.00457524913283631,-0.0933100901679282,-0.0753751135672099,1.84864627872079e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,-0.0346617503632958,0.00188200638236656,-0.0383504828727342,-0.0309730178538573,2.51526885305233e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,24845,-0.0488717023046519,0.00265413220724916,-0.0540738014308603,-0.0436696031784435,3.24935249657624e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,-0.0899553464440456,0.00488824697263894,-0.099536310510418,-0.0803743823776733,4.09191136190824e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,-0.0741753421931098,0.00404007782696279,-0.0820938947339568,-0.0662567896522627,7.17658013544546e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,29786,-0.05371360149292,0.00292984493581289,-0.0594560975671132,-0.0479711054187267,1.15813676608018e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,29495,-0.0595828719642333,0.00324997381372884,-0.0659528206391419,-0.0532129232893248,1.16719907031067e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.065682034529595,0.00358546669801929,-0.0727095492577128,-0.0586545198014772,1.51338466949506e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,29581,-0.0850035445171309,0.00464417947183686,-0.0941061362819312,-0.0759009527523306,2.01090823074856e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,24922,-0.104384258302419,0.00572120124262106,-0.115597812737956,-0.0931707038668812,6.85274446033774e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,24240,-0.0771462100366801,0.00422824236284216,-0.0854335650678507,-0.0688588550055095,7.0309890232504e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,-0.0394599194105577,0.00216567815548866,-0.0437046485953155,-0.0352151902257999,1.10124795750343e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,-0.0585073043023523,0.00322664574355172,-0.0648315299597137,-0.052183078644991,4.41814049782942e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,-0.0326467234995828,0.00180438694373564,-0.0361833219093046,-0.0291101250898609,9.02574704405714e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,-0.0429010037737269,0.00237287254352214,-0.0475518339590303,-0.0382501735884235,1.13902163385601e-72
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,24966,-0.0393856864738951,0.0021815107628096,-0.0436614475690019,-0.0351099253787883,2.10972742655909e-72
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,-0.100605710085621,0.00558354958618841,-0.11154946727455,-0.0896619528966917,4.14831402120062e-72
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,-0.0348421099352908,0.00195177759349428,-0.0386675940185396,-0.031016625852042,6.68325216518615e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,29434,0.0575674773095377,0.00323345285431759,0.0512299097150752,0.0639050449040002,1.55193939922947e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,29192,0.0351883040594497,0.0019797305138036,0.0313080322523946,0.0390685758665048,2.6274297716451e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,23389,-0.0304466052263956,0.00171189798997175,-0.0338019252867402,-0.027091285166051,2.67146719457034e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFI,Complement factor I,24966,-0.0248168954115414,0.00139671352763231,-0.0275544539257007,-0.0220793368973821,3.3841760765313e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,-0.10539957852315,0.00593186123569342,-0.117026026545109,-0.0937731305011912,3.46640380519378e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,24938,0.0736137294031934,0.00414623141239574,0.0654871158348977,0.081740342971489,4.31090675888653e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,-0.0347354185609755,0.00196197333024266,-0.0385808862882511,-0.0308899508336999,8.93178657674065e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,-0.0371541534334054,0.00210279759068706,-0.041275636711152,-0.0330326701556588,1.94103828939528e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,24922,-0.069974879608238,0.00396043490177473,-0.0777373320157164,-0.0622124272007595,1.94685633056483e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,-0.0469731156407167,0.00266067807667442,-0.0521880446709985,-0.0417581866104348,2.12245368211833e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,29218,0.0418052767495951,0.00237542432219389,0.0371494450780951,0.0464611084210952,5.68873488558231e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,29081,-0.0444916845842902,0.00252820725048325,-0.0494469707952373,-0.039536398373343,5.80735120980525e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,29642,-0.0499909682875558,0.00284583850964594,-0.0555688117664618,-0.0444131248086497,9.95739526203533e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,29725,-0.0491347740602808,0.00279952135986467,-0.0546218359256156,-0.0436477121949461,1.29514360680348e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,24922,-0.112322307732191,0.00640022874174194,-0.124866756066005,-0.0997778593983764,1.54592898969484e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,24951,-0.0300688295424451,0.00171373072109307,-0.0334277417557875,-0.0267099173291026,1.65266610477367e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,29218,-0.04192644130494,0.00239107735502212,-0.0466129529207834,-0.0372399296890967,1.75308977100712e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,-0.111511319497717,0.00637156410839456,-0.123999585150171,-0.0990230538452639,3.09034663392594e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD248,Endosialin,24938,0.0493320030326342,0.00281921771479776,0.0438063363116306,0.0548576697536378,3.76316831491041e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,24922,-0.0839579068157458,0.00479868136638932,-0.0933633222938688,-0.0745524913376227,3.92783780233169e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,28765,-0.0483291770480467,0.0027642693363404,-0.0537471449472739,-0.0429112091488195,4.30882175930832e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,28347,-0.0385342740356738,0.00220502375425789,-0.0428561205940193,-0.0342124274773284,4.99690152322546e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,29468,0.0470941727204288,0.00269780341279714,0.0418064780313464,0.0523818674095112,6.75621421000092e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,-0.0418984724577889,0.00239912305882746,-0.0466007536530907,-0.037196191262487,6.83295541560289e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,29349,-0.138511106612383,0.00794298352080777,-0.154079354313166,-0.122942858911599,9.3088437740099e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,29536,-0.0700347247948324,0.00403413782565308,-0.0779416349331124,-0.0621278146565524,3.54380938438172e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,24805,-0.129958029784472,0.00749841452659967,-0.144654922256607,-0.115261137312336,6.76293694815865e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,29454,-0.03184030760051,0.00184376294780597,-0.0354540829782097,-0.0282265322228103,1.70777738860482e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,29218,-0.0803923523299548,0.00466374043257292,-0.0895332835777977,-0.0712514210821119,2.9455787510023e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTR,Transthyretin,24707,-0.0306640762327957,0.00177883654532354,-0.0341505958616298,-0.0271775566039615,3.3472458686811e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,-0.0600754793128767,0.00348752305655763,-0.0669110245037296,-0.0532399341220237,3.59017170959015e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,-0.069970871005478,0.00406339177988986,-0.0779351188940622,-0.0620066231168939,4.56189615903351e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,29434,-0.0408068604877882,0.00237492691201417,-0.045461717235336,-0.0361520037402404,7.54961320576867e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,28795,-0.0596825376137438,0.0034746769334796,-0.0664929044033638,-0.0528721708241238,8.49203250209512e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,-0.0366692564130901,0.00213750861743332,-0.0408587733032594,-0.0324797395229208,1.19461290097794e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,-0.101950931309587,0.00594277493713783,-0.113598770186377,-0.090303092432797,1.21024108005093e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,29218,-0.105943310764634,0.0061819305303058,-0.118059894604033,-0.0938267269252344,1.62873527074491e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,28774,-0.0733038696343828,0.0042906166597657,-0.0817134782875236,-0.064894260981242,4.04688810631418e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,29293,-0.0846838263260933,0.00496260810804857,-0.0944105382178685,-0.0749571144343181,5.63789276621132e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,29265,-0.027468438613769,0.0016098462252076,-0.0306237372151759,-0.0243131400123621,5.7976354914026e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,29694,-0.0411837268693807,0.00241484154885068,-0.045916816305128,-0.0364506374336334,6.60995506380814e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,-0.0473742497753286,0.00278017635170334,-0.0528233954246671,-0.04192510412599,8.47794668912849e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,29349,-0.0363687601083635,0.00213487799966212,-0.0405531209877013,-0.0321843992290258,9.17970106978422e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,-0.0381452335400523,0.00224089109273424,-0.0425373800818114,-0.0337530869982932,1.14356470410066e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,-0.0323216955352803,0.00189943872654656,-0.0360445954393116,-0.028598795631249,1.2576503416653e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,-0.0710902701360396,0.00417640824913203,-0.0792760303043384,-0.0629045099677408,1.31784590677665e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,24938,-0.134506922212606,0.00790753809509201,-0.150005696878986,-0.119008147546226,1.60330375909565e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,29372,0.0749835423844733,0.0044150802482083,0.0663299850979851,0.0836370996709616,2.20997392888139e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,24381,-0.0623245174206376,0.00367145616125311,-0.0695205714966937,-0.0551284633445815,2.92456334999728e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,-0.102505721825321,0.00604811876444998,-0.114360034603642,-0.0906514090469985,4.07316837701769e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,-0.105562341495001,0.00623763052139906,-0.117788097316943,-0.0933365856730588,6.10606280039595e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,29725,-0.0765797194834543,0.00452974270898817,-0.0854580151930711,-0.0677014237738374,8.08714136988293e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,-0.0541013820813568,0.00321094979269963,-0.0603948436750481,-0.0478079204876656,2.12363832478545e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,-0.0241140317038231,0.00143189681234418,-0.0269205494560177,-0.0213075139516285,2.41942219217426e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,-0.0479706004233206,0.00285236887675842,-0.0535612434217671,-0.0423799574248741,3.55595680747895e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,29694,0.0438299041975545,0.00261058866447671,0.0387131504151801,0.0489466579799288,5.71237578120434e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,0.0447476060354338,0.00266676850299703,0.0395207397695596,0.049974472301308,6.716280802781e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,29218,-0.0609931638281112,0.0036355406946518,-0.0681188235896288,-0.0538675040665937,7.0973259594425e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,-0.0309553979436533,0.00185024819347418,-0.0345818844028627,-0.0273289114844439,1.52734756206997e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,-0.0483309008361641,0.00288868904018136,-0.0539927313549196,-0.0426690703174087,1.53319718715007e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,29566,-0.0626001824316765,0.00374398438126909,-0.0699383918189639,-0.0552619730443891,1.81022230691126e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RETN,Resistin,29362,-0.0493144119968028,0.00295047787164487,-0.0550973486252267,-0.0435314753683788,2.01459101721559e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,28868,-0.0446397593586216,0.00267299487545071,-0.049878829314505,-0.0394006894027382,2.56073002390917e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,-0.0565966450674648,0.00340328032471246,-0.0632670745039013,-0.0499262156310284,8.1901346934703e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,-0.0336811264267797,0.0020248960287727,-0.0376499226431742,-0.0297123302103852,8.73886306499741e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,24820,-0.127389608327596,0.00765918436634105,-0.142401609685624,-0.112377606969567,8.79754811379237e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,24805,-0.114132455936942,0.00686338979419572,-0.127584699933566,-0.100680211940319,9.26387841667816e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,-0.0978116072083168,0.00590650519969743,-0.109388357399724,-0.0862348570169098,2.57644824821352e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDK,Midkine,29455,-0.0587541080615737,0.00355133938482792,-0.0657147332558364,-0.0517934828673109,3.33227318381684e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,29443,-0.0371898713583387,0.00225188242599625,-0.0416035609132913,-0.032776181803386,5.3860597635784e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,28797,-0.072734234228458,0.0044059980604698,-0.0813699904269788,-0.0640984780299372,6.1288742880327e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,29786,-0.0871892220852811,0.0052835741751594,-0.0975450274685935,-0.0768334167019687,6.62758039848893e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,-0.05810833338044,0.00352585348729566,-0.0650190062155395,-0.0511976605453405,1.08555736180146e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,29030,-0.0489434532399784,0.00297493741325899,-0.054774330569966,-0.0431125759099908,1.52836544537909e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,-0.0434672038636768,0.00264402718167756,-0.0486494971397648,-0.0382849105875888,1.86847813695123e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,-0.0820980855074888,0.00499618055151453,-0.0918905993884573,-0.0723055716265203,2.12186713149559e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,-0.0540682339334598,0.00329395821498464,-0.0605243920348297,-0.04761207583209,2.83785350910442e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,29082,-0.053886914907632,0.00328873240858664,-0.0603328304284618,-0.0474409993868022,4.52990764020841e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,29581,-0.0486682568672329,0.00297135231425463,-0.054492107403172,-0.0428444063312938,4.95583412566864e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,28797,-0.0848457367792976,0.00519753025637749,-0.0950328960817975,-0.0746585774767977,1.23065150720471e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,-0.0795070281713467,0.00487183853353642,-0.0890558316970781,-0.0699582246456154,1.48613489216482e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,-0.0465207217401036,0.0028554249059551,-0.0521173545557756,-0.0409240889244316,2.03148533714759e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.0384465525828417,0.00236020931668959,0.0338205423221301,0.0430725628435533,2.13197027741852e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,-0.0587333631656722,0.00361009849206328,-0.0658091562101162,-0.0516575701212281,3.00526861216027e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,-0.0562651983251751,0.0034594755868097,-0.0630457704753221,-0.049484626175028,3.26232262107417e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,29400,-0.104263185373847,0.00641353956107214,-0.116833722913548,-0.0916926478341455,3.62899736993677e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,29480,0.0595951507210736,0.00367067667335456,0.0524006244412987,0.0667896770008485,5.10908116667751e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,-0.0906337190293129,0.00558325839632336,-0.101576905486107,-0.0796905325725191,5.92820227906711e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,-0.0589642499430345,0.00363576423772487,-0.0660903478489752,-0.0518381520370937,6.78316944513146e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,-0.0676373174826312,0.0041731392806885,-0.0758166704727807,-0.0594579644924817,8.07638556740895e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,29694,-0.0255618835988477,0.00157746621506725,-0.0286537173803795,-0.0224700498173159,8.40018343377422e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,-0.1100755611027,0.00680370168911695,-0.123410816413369,-0.096740305792031,1.27781800614632e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,24905,0.0390744192770532,0.00241869794510026,0.0343337713046567,0.0438150672494497,2.07161363491087e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,28774,-0.0727553812645455,0.0045074118634527,-0.0815899085169128,-0.0639208540121782,2.36218810637388e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,-0.0436709627281034,0.00270630965242451,-0.0489753296468555,-0.0383665958093514,2.78681887224369e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,29218,-0.0595133206750466,0.00369671523474821,-0.0667588825351531,-0.0522677588149401,4.6142631125938e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,-0.0919344680635164,0.0057083467800382,-0.103122827752391,-0.0807461083746416,4.61938477422365e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,29820,0.030628035267269,0.00190797811521799,0.0268883981614417,0.0343676723730962,9.57627780066365e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,-0.0591338352570888,0.00368281283903113,-0.0663521484215899,-0.0519155220925878,1.01961152712343e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,-0.0589443628949637,0.00367347267375402,-0.0661443693355216,-0.0517443564544059,1.08493034593968e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,29443,-0.050152537321835,0.00312879314511518,-0.0562849718862607,-0.0440201027574092,1.39806188083072e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,-0.0336914608380247,0.00210321996293797,-0.0378137719653831,-0.0295691497106662,1.6508713979709e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,-0.0701650729736564,0.0043782366442384,-0.0787464167963637,-0.0615837291509491,1.67189608562797e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,-0.0716217304795127,0.00447169093489744,-0.0803862447119116,-0.0628572162471137,1.73220013996029e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,24381,-0.0347820980505896,0.00217267987435861,-0.0390405506043324,-0.0305236454968467,2.17576474133211e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,29566,-0.0448472843400415,0.00280323580327073,-0.0503416265144521,-0.0393529421656309,2.28446881070956e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,28931,-0.0528475881341339,0.00331467079994383,-0.0593443429020238,-0.046350833366244,5.52959607811637e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,24229,-0.104300627048514,0.00653919722582197,-0.117117453611125,-0.0914838004859032,5.55485154511624e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,29694,-0.0583861261413779,0.00366704178426239,-0.0655735280385322,-0.0511987242442236,7.68786889616952e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,-0.0464473908183433,0.0029216022550753,-0.0521737312382909,-0.0407210503983957,1.13313142955368e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,29820,-0.0627095999822475,0.00394515384659717,-0.070442101521578,-0.0549770984429171,1.16720233327436e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,0.0582055262806871,0.00366592624530166,0.0510203108398958,0.0653907417214783,1.55993773739674e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,29319,-0.0876147799601454,0.00551959530829694,-0.0984331867644073,-0.0767963731558834,1.66640700272071e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,29478,0.057151832042941,0.00360091109147775,0.0500940463036446,0.0642096177822374,1.7125848111738e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,-0.0569883941557675,0.00359086498692554,-0.0640264895301416,-0.0499502987813935,1.92816563472676e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,29434,-0.0650082408529659,0.0040997232814644,-0.0730436984846361,-0.0569727832212957,2.16362686196224e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,-0.0887035357774747,0.00559211871110174,-0.0996640884512341,-0.0777429831037153,2.1899855317177e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,-0.0409265852086693,0.00258970861497916,-0.0460024140940284,-0.0358507563233101,5.00808207875802e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,29478,-0.039882296797254,0.00252382121785184,-0.0448289863842437,-0.0349356072102644,5.09425535323974e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,29343,-0.034064678627423,0.00215738670675225,-0.0382931565726574,-0.0298362006821886,6.22156534956573e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,-0.0902401961438521,0.00571596671949452,-0.101443490914061,-0.0790369013736428,6.41920002378071e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,-0.0352584645501026,0.00223585298317783,-0.0396407363971312,-0.0308761927030741,9.44602338500839e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASPN,Asporin,24922,0.0304930139413337,0.00193416517098071,0.0267020502062115,0.0342839776764559,1.00054790499807e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,-0.0772464634308804,0.00490448371612699,-0.0868592515144893,-0.0676336753472715,1.16747387648793e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,-0.0471013120239406,0.00299807084377728,-0.0529775308777441,-0.0412250931701372,2.15218534011369e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,-0.0485653874053841,0.00309179973847668,-0.0546253148927984,-0.0425054599179698,2.49644547114245e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.0422057234184852,0.00268993736398815,-0.047478000651902,-0.0369334461850684,3.00203799159611e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0404681689286976,0.00258822750895325,0.0353952430111493,0.045541094846246,7.62494809150886e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,-0.0629018701229742,0.00402583774832528,-0.0707925121096918,-0.0550112281362567,8.22650475100753e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,29694,-0.0631065737031899,0.0040399611102122,-0.0710248974792058,-0.0551882499271739,8.71619700560361e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,24445,-0.141285791131549,0.00904362831092519,-0.159011302620963,-0.123560279642136,9.39242443379101e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,-0.119634779085949,0.00766192378090522,-0.134652149696523,-0.104617408475375,1.06392671059686e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,-0.0255294988558694,0.00163564219778486,-0.0287353575635277,-0.0223236401482111,1.16141797205274e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAYN,Layilin,29163,-0.0380759757352045,0.00244424554567833,-0.0428666970047341,-0.033285254465675,1.70969085538851e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,-0.0362058666407156,0.00232771904989674,-0.0407681959785132,-0.031643537302918,2.45619562046508e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,-0.134602585047146,0.00865078982631047,-0.151558133106714,-0.117647036987577,2.51177469222268e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,24240,-0.056020514907124,0.00360200442944488,-0.063080443588836,-0.048960586225412,2.79720088214455e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,-0.0791117487457717,0.00509735486869126,-0.0891025642884065,-0.0691209332031368,4.61660201914288e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,-0.0616563753113295,0.00397473971523975,-0.0694468651531994,-0.0538658854694596,4.76281737206283e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,-0.0477346105649255,0.00307909847538673,-0.0537696435766835,-0.0416995775531675,5.453781057863e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,-0.0349364238466854,0.00225406943736462,-0.0393543999439201,-0.0305184477494508,5.71021838985327e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,29511,0.0400955298419268,0.0025902290845812,0.0350186808361476,0.0451723788477059,7.76996196788958e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,-0.0253564669302808,0.00163846408252383,-0.0285678565320275,-0.0221450773285341,8.24499245376723e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,-0.069320242037142,0.00448076691908452,-0.0781025451985476,-0.0605379388757363,9.0216179566597e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,29694,-0.0850311383068249,0.00550186698737871,-0.0958147976020872,-0.0742474790115627,1.13115131856685e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,24229,-0.0499177571134742,0.00322877719465319,-0.0562461604149944,-0.0435893538119539,1.16154639699145e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,-0.0543242922398902,0.0035214439392546,-0.0612263223608292,-0.0474222621189512,1.75416092557935e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,29349,-0.0750786579425697,0.00487843891878409,-0.0846403982233865,-0.0655169176617528,3.0908317827252e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,-0.0394652253071785,0.0025639475374518,-0.044490562480584,-0.034439888133773,3.30067860908905e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,0.0325675658172044,0.00211728780404009,0.0284176817212858,0.036717449913123,3.48861577998581e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,29218,-0.0559941570221458,0.00364160208994946,-0.0631316971184468,-0.0488566169258449,3.81815055515302e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,-0.1510759317666,0.00982662761999357,-0.170336121901788,-0.131815741631413,4.29241820292751e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,24793,-0.107098259881686,0.00696803671711407,-0.12075561184723,-0.0934409079161425,4.57871475520119e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.0365304874623827,0.0023790641413452,-0.0411934531794193,-0.0318675217453461,5.26295656865691e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,-0.0653493877685791,0.0042563401436313,-0.0736918144500964,-0.0570069610870617,5.45201849167427e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,-0.0415594408033706,0.00270728347025956,-0.0468657164050793,-0.0362531652016619,5.58815488384157e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,28797,-0.050565069261978,0.00329577758346099,-0.0570247933255615,-0.0441053451983944,6.45469229492029e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,-0.0656926785871336,0.00428466339503376,-0.0740906188413998,-0.0572947383328675,7.48084822935638e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,29135,-0.0368238817707575,0.00240351282358816,-0.0415347669049903,-0.0321129966365247,8.91653716720744e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,29218,-0.0447792182235324,0.00292414515135328,-0.0505105427201848,-0.0390478937268799,9.94616507400639e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,-0.0341120322329365,0.00222867265865045,-0.0384802306438914,-0.0297438338219816,1.10673611087715e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,24752,-0.0466255510716386,0.00305244854400191,-0.0526083502178823,-0.0406427519253948,1.95379778183434e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.0451638076949528,0.00296526035982722,-0.0509757180002141,-0.0393518973896914,3.47254903731205e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,-0.0924407023781215,0.00606814205299802,-0.104334260801998,-0.0805471439542454,3.63435791990188e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,0.0262418203358625,0.00172435545839324,0.0228620836374118,0.0296215570343133,4.19721913191726e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,-0.0208213109345944,0.00137038185336714,-0.023507259367194,-0.0181353625019948,6.20476757670322e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,-0.07112066016195,0.00468547610417128,-0.0803041933261257,-0.0619371269977743,7.62024269412574e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,24919,-0.0598322342171584,0.00394257993835696,-0.067559690896338,-0.0521047775379787,8.70847677105592e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,-0.0901197351666022,0.00594293865347023,-0.101767894927404,-0.0784715754058006,9.68470781117824e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,24381,-0.0319746204529463,0.00211011517213285,-0.0361104461903267,-0.0278387947155659,1.24450507118913e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,0.0426103045894758,0.00281328384325906,0.037096268256688,0.0481243409222636,1.25898545868147e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,29434,-0.0778531249361881,0.00514498233934373,-0.0879372903213018,-0.0677689595510744,1.56127342722624e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,29786,-0.0520173311695446,0.00343879046060599,-0.0587573604723324,-0.0452773018667569,1.68023832204802e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,-0.0790064784024509,0.00522188127115668,-0.089241365693918,-0.0687715911109838,1.77402240323328e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,24892,0.0778567944638981,0.00514914722820797,0.0677644658966105,0.0879491230311857,2.01404597745389e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.0774992746988195,0.0051257479358513,-0.0875457406530881,-0.0674528087445509,2.07141748207695e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COCH,Cochlin,24922,-0.0491104191019965,0.00324878622061424,-0.0554780400944004,-0.0427427981095925,2.13070069810559e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,24922,-0.033187813516282,0.00219818735796716,-0.0374962607378977,-0.0288793662946664,2.82391557487223e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,-0.0438804936802531,0.00291098686733826,-0.0495860279402361,-0.0381749594202701,4.07814570251976e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,-0.102800039013937,0.00683487070104294,-0.116196385587981,-0.0894036924398924,6.76462583741904e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.0619789504538376,0.00412453181524159,-0.0700630328117111,-0.0538948680959641,7.58351086113152e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,29434,-0.041137655633707,0.00274634767360551,-0.0465204970739738,-0.0357548141934402,1.54648147117952e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,0.0458323632528993,0.00306644275736432,0.0398221354484652,0.0518425910573333,2.51509510740286e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,-0.0341125633061386,0.00228255790607605,-0.0385863768020477,-0.0296387498102296,2.56286975892855e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,29786,-0.0393462728980778,0.00263346593852638,-0.0445078661375895,-0.0341846796585661,2.71887876821562e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,29218,0.0268928774558162,0.0018007824247318,0.0233633439033419,0.0304224110082905,3.03650484074771e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,-0.0361534258355085,0.00242112409297232,-0.0408988290577343,-0.0314080226132828,3.09917830635682e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,29786,-0.0483758946057145,0.0032449880843408,-0.0547360712510225,-0.0420157179604065,4.44193193643036e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,-0.0806237431415589,0.00540768642790723,-0.091222808540257,-0.0700246777428607,4.72946601241394e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,29694,-0.0616359427530346,0.00414210710173008,-0.0697544726724255,-0.0535174128336436,6.69532809351806e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,28797,-0.0422787805679366,0.00284144913114026,-0.0478480208649715,-0.0367095402709017,6.8866797947639e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,29536,-0.0312047334475591,0.0020987033609496,-0.0353181920350203,-0.0270912748600979,7.98837505156149e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,29079,-0.0395024620617355,0.00265799001359304,-0.0447121224883778,-0.0342928016350931,8.89264972566548e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,29434,-0.0869632491109907,0.00585524454108666,-0.0984395284115206,-0.0754869698104609,1.01970862974489e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,24381,0.0541967794437508,0.00364810453732147,0.0470464945506008,0.0613470643369009,1.04779255554964e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANG,Angiogenin,29435,-0.0350493591389525,0.00236113191480286,-0.0396771776919661,-0.0304215405859389,1.14610088180511e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,29478,-0.0253008594360759,0.00170449741735497,-0.0286416743740917,-0.0219600444980602,1.15758777819804e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,-0.0464408510182907,0.00312979534322169,-0.0525752498910052,-0.0403064521455762,1.25403795002063e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,-0.0894066039698298,0.00603260388405283,-0.101230507582573,-0.0775827003570862,1.62582078907471e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,29725,-0.0398064389179237,0.00268841080281189,-0.045075724091435,-0.0345371537444124,1.99078543916207e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,24557,-0.024834947301508,0.00167795340325539,-0.0281237359718886,-0.0215461586311275,2.36584945328414e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,-0.0527119484163551,0.0035637073544884,-0.0596968148311524,-0.0457270820015578,2.5306014649379e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,-0.0326350349092708,0.00220717288769909,-0.036961093769161,-0.0283089760493806,2.92723846752506e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,-0.0277983622747981,0.00188610054111979,-0.0314951193353929,-0.0241016052142033,5.44291418487212e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,0.0435773964221993,0.00295895596475545,0.0377778427312786,0.04937695011312,6.42238042711407e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,-0.0630172650889741,0.00428150373018864,-0.0714090124001439,-0.0546255177778044,7.38836223000729e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,28990,0.0309317229795638,0.00210261881194835,0.0268105901081451,0.0350528558509826,8.21586153962532e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,28424,-0.0943756142776141,0.0064153025204661,-0.106949607217728,-0.0818016213375005,8.2859841634687e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,-0.0512576401390647,0.00348789687331016,-0.0580939180107526,-0.0444213622673768,1.12236158026436e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,29435,-0.0407312917128299,0.00277535781825962,-0.0461709930366188,-0.035291590389041,1.36367562738751e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,29639,-0.0592117039136915,0.00404073847629973,-0.067131551327239,-0.0512918565001441,1.88629159994771e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,28797,-0.0572972367064149,0.00391312409851473,-0.0649669599395037,-0.049627513473326,2.25217825164566e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,-0.10120550024478,0.00691539388137782,-0.114759672252281,-0.0876513282372799,2.48016147544199e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,-0.100320223485357,0.00685979869762096,-0.113765428932694,-0.0868750180380199,3.11639238249604e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,24938,-0.0289130109278211,0.00197710573848989,-0.0327881381752613,-0.0250378836803809,3.13329790634137e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,-0.124185690867406,0.00849681027629744,-0.140839439008949,-0.107531942725863,3.58798113431935e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,28705,-0.0711034267941173,0.0048683498190585,-0.080645392439472,-0.0615614611487626,3.87273551486119e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,29169,-0.0468116536567881,0.00320807677562393,-0.0530994841370111,-0.0405238231765652,4.67949796598983e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,24111,-0.06937413321223,0.00475296713045146,-0.0786899487879149,-0.0600583176365452,4.77956328019723e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,-0.05514922735667,0.00378563665696641,-0.0625690752043241,-0.0477293795090158,6.59832229498796e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,24805,-0.102644060227482,0.00704511825916551,-0.116452492015447,-0.0888356284395177,6.92522463518913e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,29581,-0.048303784901329,0.00331748146665244,-0.0548060485759677,-0.0418015212266902,7.35081857968883e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,-0.0645353909322563,0.00443235789349765,-0.0732228124035117,-0.0558479694610009,7.93953772366603e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,29786,-0.0477614729045824,0.00328329948733272,-0.0541967398997546,-0.0413262059094103,8.9303267214182e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NADK,NAD kinase,29478,-0.0550419045576821,0.00378561245880367,-0.0624617049769373,-0.0476221041384269,9.92800740874572e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,-0.0567362064731404,0.00390324467395374,-0.0643865660340897,-0.049085846912191,1.06325796351891e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,29349,-0.0332399895545293,0.00228690286539248,-0.0377223191706985,-0.02875765993836,1.06652735675304e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,28835,-0.0392830908169631,0.00270546167761121,-0.044585795705081,-0.0339803859288451,1.33477445601034e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,-0.038823616870384,0.00267592688269842,-0.0440684335604729,-0.033578800180295,1.56288825608704e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,-0.0293909603580351,0.00202850951553475,-0.0333668390084832,-0.025415081707587,2.06789727805807e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,-0.0340077884034278,0.00234806105689102,-0.0386099880749342,-0.0294055887319214,2.24412360522218e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,-0.0536782543411699,0.0037050445424088,-0.0609401416442911,-0.0464163670380486,2.25510500506957e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,29624,-0.0687426724689136,0.00474930139161452,-0.0780513031964781,-0.0594340417413492,2.55673252862735e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,29395,-0.083740345430275,0.00580502652190629,-0.0951181974132113,-0.0723624934473387,5.18024453094966e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,-0.0437170939849016,0.00303362066111074,-0.0496629904806787,-0.0377711974891246,6.84441106760509e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,29227,-0.0729580937487559,0.00506508941868835,-0.082885669009385,-0.0630305184881267,7.06009186700571e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,29786,-0.0948733010936221,0.00659046675110308,-0.107790615925784,-0.0819559862614601,7.93040060942247e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,29466,-0.0534639248161112,0.00371469347064225,-0.06074472401857,-0.0461831256136523,8.30996363002161e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,-0.0421600571111576,0.00293087705342713,-0.0479045761358748,-0.0364155380864404,9.93914189912631e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,29169,-0.0512512092802286,0.00358695987707891,-0.0582816506393032,-0.0442207679211539,3.71244172659411e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,24938,-0.0409000765986363,0.0028659100033098,-0.0465172602051235,-0.0352828929921491,5.02197426502548e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,-0.0268719803313839,0.00188494936397087,-0.0305664810847668,-0.023177479578001,5.84195133420362e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,-0.0509273446763863,0.00357662092847659,-0.0579375216962004,-0.0439171676565722,7.45868569557688e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,-0.0404538303559216,0.00284500169090774,-0.0460300336701008,-0.0348776270417424,1.06030000259869e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,29169,-0.0513275237404674,0.00361349246894916,-0.0584099689796078,-0.0442450785013271,1.22187910053455e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,29694,-0.0282799725627874,0.00199772715877573,-0.0321955177939878,-0.024364427331587,2.40693638009407e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,-0.0197128964762478,0.00139341311785307,-0.0224439861872398,-0.0169818067652557,2.73741159928031e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,29349,-0.0730739980046381,0.00516644677324465,-0.0832002336801976,-0.0629477623290786,2.86759493326943e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,-0.102844373187704,0.00726940546997074,-0.117092407908847,-0.0885963384665616,2.90121469083327e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BSG,Basigin,29760,-0.0203285882684715,0.00143775727011109,-0.0231465925178893,-0.0175105840190538,3.05679670280047e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,29443,-0.0550173154976673,0.00389176536604755,-0.0626451756151205,-0.0473894553802141,3.16654953013782e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,29383,-0.0285430972329811,0.00202090589700624,-0.0325040727911133,-0.0245821216748488,3.80328214035306e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,29786,-0.0556566709242084,0.00394078430268663,-0.0633806081574742,-0.0479327336909426,3.82152186731029e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,24966,-0.030148025894366,0.00213420496894882,-0.0343310676335057,-0.0259649841552263,3.91497238855068e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,24804,-0.0583579072766069,0.00413405173512924,-0.0664606486774602,-0.0502551658757536,4.50082169614994e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,-0.0567490853134651,0.00402434705699437,-0.064636805545174,-0.0488613650817561,5.22968205110095e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,-0.0453653160146298,0.003219489140734,-0.0516755147304685,-0.0390551172987912,6.05487033803728e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,-0.0476380573935779,0.0033809645828855,-0.0542647479760335,-0.0410113668111223,6.50958285301976e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,29434,0.0428591237780923,0.00304670302367685,0.0368875858516857,0.0488306617044989,8.42123703045506e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,-0.0451461382359679,0.00321035072503607,-0.0514384256570386,-0.0388538508148972,8.96919104574514e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,-0.0384861762414537,0.00273577408249332,-0.0438482934431406,-0.0331240590397668,8.97652708996827e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,-0.0283934211623862,0.00202109500113895,-0.0323547673646185,-0.0244320749601539,1.09759711600324e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,29736,-0.0271864989546722,0.00193635928011868,-0.0309817631437048,-0.0233912347656395,1.23222500907657e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,-0.068293279610652,0.00486738775796973,-0.0778333596162727,-0.0587531996050313,1.49521557994126e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,-0.09391818646652,0.00669984692453583,-0.10704988643861,-0.0807864864944298,1.67883003631327e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,-0.0368214302749774,0.0026372290329059,-0.041990399179473,-0.0316524613704819,3.69171955859148e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,-0.0660984957890894,0.00473745434619686,-0.0753839063076352,-0.0568130852705435,4.19813043974104e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,-0.0248114273307179,0.00177803472745955,-0.0282963753965386,-0.0213264792648972,4.33527986826342e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,-0.0501282505949199,0.00359457039083887,-0.057173608560964,-0.0430828926288757,4.61041540575e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,-0.0618309762700858,0.00443895443344919,-0.0705313269596462,-0.0531306255805254,5.80778465870067e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,29434,-0.0319020056676485,0.0022956381170509,-0.0364014563770683,-0.0274025549582287,9.11183387766246e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GH1,Somatotropin,29433,0.172569928994984,0.0124223941260992,0.148222036507829,0.196917821482138,9.7598150118254e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,24793,-0.0351959402249625,0.00253287353346616,-0.0401603723505562,-0.0302315080993688,9.82292162238175e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NBN,Nibrin,28931,-0.050933896981134,0.00367114885347206,-0.0581293487339393,-0.0437384452283288,1.25492978959489e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBIN,Erbin,29349,-0.09935633487707,0.0071650544153695,-0.113399841531194,-0.0853128282229458,1.38228918991032e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,-0.0744318422171573,0.00536889901114825,-0.0849548842790079,-0.0639088001553067,1.44638289196857e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,-0.0289906208126608,0.0020936244515657,-0.0330941247377295,-0.024887116887592,1.92166138459598e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,-0.0763730520934936,0.00552585658335821,-0.0872037309968757,-0.0655423731901115,2.61851144762519e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,-0.0807047036383251,0.00584044241256931,-0.092151970766961,-0.0692574365096893,2.88113484237277e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,24867,-0.101622901653958,0.00736362021748377,-0.116055597280227,-0.0871902060276901,3.64387592419839e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,-0.0836828913544668,0.00608278881396743,-0.095605157429843,-0.0717606252790907,6.24915377285184e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,29820,-0.0240491726607041,0.00174818114044612,-0.0274756076959785,-0.0206227376254297,6.28243131339029e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,-0.0922353019183447,0.00670508010125316,-0.105377258916801,-0.0790933449198885,6.39869896962905e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,24240,-0.0389771741923955,0.00283425001881865,-0.0445323042292801,-0.033422044155511,7.16001971484058e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,29443,-0.0374245115220715,0.00272261881718282,-0.0427608444037498,-0.0320881786403932,7.32574958895253e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,29786,0.00855271924956573,0.000622577219098046,0.00733246790013356,0.0097729705989979,8.16686581690569e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,24805,-0.0817454653568886,0.00595120889181735,-0.0934098347848506,-0.0700810959289266,8.87301695916463e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,24813,-0.0717850521442769,0.00523224872321815,-0.0820402596417845,-0.0615298446467693,1.10774955290528e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,29434,-0.0911209890856336,0.00664819060114495,-0.104151442663878,-0.0780905355073895,1.26165630040452e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,29725,0.0442389410954298,0.00322843982017401,0.0379111990478887,0.0505666831429708,1.31514963336988e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,29566,-0.0545766915110557,0.00398344613203727,-0.0623842459298487,-0.0467691370922626,1.35403404002393e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,-0.108623307690726,0.00793159557750388,-0.124169235022634,-0.0930773803588184,1.56162957060379e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,-0.0359625418127571,0.00262900937670164,-0.0411154001910924,-0.0308096834344219,1.82553738693425e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,23907,-0.0683936745532918,0.00499900567790077,-0.0781917256819773,-0.0585956234246063,1.89448540440731e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,-0.0283936539358113,0.00207562858466941,-0.0324618859617633,-0.0243254219098592,1.91570806006577e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,-0.0213115490634887,0.00155939427361536,-0.0243679618397748,-0.0182551362872026,2.15905087849302e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,-0.0693410983965902,0.00507235996845135,-0.0792829239347548,-0.0593992728584256,2.17480033343647e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFH,Complement factor H,23693,-0.0225292844046635,0.00164804281987114,-0.0257594483316109,-0.0192991204777161,2.2123613441786e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,-0.101349090056872,0.00741752955039249,-0.115887447975641,-0.0868107321381025,2.26105221895601e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGN,Mimecan,29443,-0.0402334308969385,0.002947768807228,-0.0460110577591054,-0.0344558040347717,2.76221473754686e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,24381,-0.110993749692726,0.00815244500018605,-0.126972541893091,-0.0950149574923614,4.66317641102324e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0375388657930113,0.00276461923321343,0.0321202120959129,0.0429575194901096,7.23889275319229e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,-0.0924139681457643,0.00681320996962497,-0.105767859686229,-0.0790600766052993,8.75238332209782e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,-0.0318759204977285,0.00235424141349574,-0.0364902336681801,-0.0272616073272768,1.2104706155531e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,29443,-0.0236793929975908,0.00175023267491731,-0.0271098490404288,-0.0202489369547529,1.398973591763e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,-0.0505699280632021,0.00373917988971663,-0.0578987206470467,-0.0432411354793575,1.49898100348819e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,-0.0354452092636184,0.0026207666236541,-0.0405819118459804,-0.0303085066812564,1.58119038934783e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,24801,-0.0305587277375362,0.00226116262323626,-0.0349906064790793,-0.0261268489959932,1.79890214941538e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,29328,-0.0405421013636717,0.00300304071570501,-0.0464280611664535,-0.0346561415608899,2.07002702405652e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,-0.0808683762141568,0.00600227875734804,-0.092632842578559,-0.0691039098497547,2.99175147669227e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,24867,-0.0500912807290889,0.00372390138829419,-0.0573901274501455,-0.0427924340080323,4.21396422803106e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,-0.0300595374815104,0.00223608545987315,-0.0344422649828617,-0.025676809980159,4.71590199357193e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,24845,-0.0596398206492028,0.00443662192649054,-0.0683355996251243,-0.0509440416732813,4.73550817339984e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,-0.0615397653911563,0.00457839050357087,-0.0705134107781552,-0.0525661200041574,4.84591380302194e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,29566,-0.0777608763122219,0.00578850161464231,-0.0891063394769209,-0.066415413147523,5.06583148317096e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,24888,-0.0419884457609825,0.00312515841390309,-0.0481137562522326,-0.0358631352697325,5.19865638524074e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,-0.0888420829367524,0.00661982831977427,-0.10181694644351,-0.0758672194299948,6.05741159106061e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,-0.079036969607426,0.00590442720972573,-0.0906096469384884,-0.0674642922763636,9.61037172402181e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,29694,-0.0338905582908283,0.00253353190268227,-0.0388562808200856,-0.0289248357615711,1.08411453522461e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,-0.0665737050145032,0.00497848755129068,-0.0763315406150329,-0.0568158694139735,1.15685113149751e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,-0.101478783806572,0.00758893233914053,-0.116353091191288,-0.0866044764218568,1.21948345660373e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,-0.0545366088656873,0.00408306349570996,-0.0625394133172788,-0.0465338044140957,1.4292387614706e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.0446345756288041,0.00334232719935819,-0.0511855369395461,-0.038083614318062,1.46700678595653e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,29594,-0.093882530712238,0.00703295239750039,-0.107667117411339,-0.0800979440131372,1.57411713377405e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,24101,-0.0373767813933272,0.00280178762567968,-0.0428682851396594,-0.031885277646995,1.87724949909147e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.028353456102522,0.00212553211913907,-0.0325194990560345,-0.0241874131490094,1.88148055735091e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.0269342342987489,0.00202327094093653,0.0229686232545133,0.0308998453429845,2.56267562078153e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,28870,-0.0465411375259326,0.00349773820620661,-0.0533967044100976,-0.0396855706417677,2.80567752450996e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,0.0223002674848959,0.00167627951636594,0.0190147596328187,0.0255857753369732,2.88721275529707e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,24793,-0.0198974527000282,0.00149547369999055,-0.0228285811520097,-0.0169663242480467,2.97145375850373e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,29581,0.0600937186272088,0.00451995063662633,0.0512346153794212,0.0689528218749964,3.21993520306358e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,29478,-0.06332434971071,0.00476380656640299,-0.0726614105808598,-0.0539872888405601,3.32785656371229e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,24845,-0.0261654678328688,0.00196913515023942,-0.030024972727338,-0.0223059629383995,3.7372014457909e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,29345,-0.0400775570661189,0.00301813662389721,-0.0459931048489574,-0.0341620092832803,4.00719616284821e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,28797,-0.0569487615677493,0.00429431875876096,-0.0653656263349207,-0.0485318968005778,5.07897376573252e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,-0.0744781895418919,0.00561739134619031,-0.0854882765804249,-0.0634681025033589,5.55558552481993e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,29566,-0.0277385967526728,0.0020936005400715,-0.031842053811213,-0.0236351396941327,5.92752693267011e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,-0.0310720423026062,0.00234693781521536,-0.0356720404204283,-0.0264720441847841,6.79898284359804e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,29489,0.0254969522582765,0.0019267640719052,0.0217204946773423,0.0292734098392107,7.34901651336568e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,-0.0365806886817614,0.0027644019093025,-0.0419989164239943,-0.0311624609395285,7.35449314208258e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,29434,-0.0846189328109463,0.00640605405808949,-0.0971747987648017,-0.0720630668570909,1.00746990377246e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,-0.0513208742686979,0.00388964868253034,-0.0589445856864574,-0.0436971628509384,1.2242051941441e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,-0.0711093060734552,0.00538964333725656,-0.0816730070144781,-0.0605456051324324,1.29754894539017e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,-0.0254317876307139,0.00192872570592745,-0.0292120900143317,-0.0216514852470961,1.36798508607947e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,0.0390007769227549,0.0029595272245295,0.0332001035626771,0.0448014502828328,1.52095288111824e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,24240,-0.0683864633864806,0.00519089273368649,-0.0785606131445062,-0.0582123136284551,1.68660468868982e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,-0.0790347414463921,0.00600102373692712,-0.0907967479707692,-0.0672727349220149,1.76763461150185e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,-0.0411095564118105,0.003121480675143,-0.0472276585350908,-0.0349914542885303,1.78305986048275e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,-0.0687337985888075,0.00522120891343629,-0.0789673680591426,-0.0585002291184723,1.82025349998025e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,-0.0376506006190511,0.00285981065924579,-0.0432558295111729,-0.0320453717269294,1.88170645590567e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,29498,-0.0601127333620483,0.00456780214722826,-0.0690656255706157,-0.0511598411534809,1.92376134492253e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,-0.126361748203452,0.00961524967935431,-0.145207637574986,-0.107515858831917,2.45007190563282e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,-0.0592378046668682,0.00450642706244859,-0.0680704017092674,-0.050405207624469,2.47333876214704e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,-0.0531565478704332,0.00404976259707287,-0.061094082560696,-0.0452190131801704,3.03685148365857e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,-0.0525334533549736,0.00400838487475229,-0.0603898877094881,-0.0446770190004591,3.94003309664881e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,29434,-0.0783133578525637,0.00597658214571088,-0.090027458858157,-0.0665992568469704,4.05409469828976e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,0.0481389425432578,0.00368361513128999,0.0409190568859294,0.0553588282005862,6.40671337568148e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,-0.0684462652226329,0.00524155851529415,-0.0787197199126094,-0.0581728105326563,7.70083016035288e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELP,P-selectin,29594,-0.0519205747919603,0.00397976010364951,-0.0597209045951134,-0.0441202449888073,8.55398194065205e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,29478,-0.0520880647734509,0.00399670767816677,-0.0599216118226577,-0.044254517724244,1.01988989403067e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,-0.066121860237037,0.0050786113018916,-0.0760759383887445,-0.0561677820853294,1.20765862647361e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,-0.0487761205175502,0.00376269358292392,-0.056150999940081,-0.0414012410950193,2.66782525248846e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,-0.0359612224653196,0.00277674018068297,-0.0414036332194583,-0.030518811711181,2.9715437167325e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,-0.0319720628725359,0.0024755792547541,-0.0368241982118539,-0.0271199275332178,4.94857604814128e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,-0.0603137396618137,0.00467243347522644,-0.0694717092732576,-0.0511557700503699,5.14530583093559e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,24381,-0.0460707870390994,0.00356835309652899,-0.0530647591082962,-0.0390768149699026,5.20425977328256e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,-0.0577800996835958,0.00447781761775975,-0.0665566222144049,-0.0490035771527867,5.68331170967016e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,-0.087880162321735,0.00682429799586115,-0.101255786393623,-0.0745045382498472,7.62313974917405e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,24966,-0.015460635813937,0.00120219575279148,-0.0178169394894083,-0.0131043321384657,9.91870205820011e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,24922,-0.0675183865163867,0.00525169821068864,-0.0778117150093365,-0.057225058023437,1.04261427602723e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,-0.0197913124657738,0.00153949496580309,-0.0228087225987479,-0.0167739023327998,1.05941246049193e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,28916,-0.0521154689511037,0.00405574731899726,-0.0600647336963384,-0.0441662042058691,1.09405145987912e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,29434,-0.0822302419870027,0.00640366999794943,-0.0947814351829836,-0.0696790487910218,1.2179053121664e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,-0.0621931957409934,0.00485606872886258,-0.0717110904495641,-0.0526753010324228,1.97481100935839e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,28774,-0.0311861425142388,0.00244097700560721,-0.0359704574452289,-0.0264018275832487,2.81667351448119e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,29760,-0.0469982257658504,0.00368430070871487,-0.0542194551549316,-0.0397769963767693,3.59667592373901e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,-0.0848310352069137,0.00665205179510209,-0.0978690567253138,-0.0717930136885136,3.77790508492267e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,-0.111645713247619,0.00875975174627158,-0.128814826670312,-0.0944765998249271,4.14647012511476e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,29694,-0.0539422764356179,0.00423920425771529,-0.0622511167807399,-0.045633436090496,5.39223183527548e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0215865790162796,0.00169771195392175,0.0182590635865929,0.0249140944459662,6.0916151258954e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREH,Trehalase,24938,-0.0668275027607331,0.00526385688469543,-0.0771446622547362,-0.0565103432667301,8.14009098810087e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,29581,-0.0937320124622261,0.0073890272047339,-0.108214505783505,-0.0792495191409477,8.89740017952217e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,29820,-0.0493691230450579,0.00390173737824789,-0.0570165283064238,-0.041721717783692,1.33573735124508e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,-0.0258267238583292,0.00204103504957497,-0.0298271525554962,-0.0218262951611623,1.38456006959746e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,29443,0.0228209827471492,0.00180815156020903,0.0192770056891395,0.0263649598051589,2.00623586747767e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,-0.041938720700255,0.00332521240061334,-0.0484561370054572,-0.0354213043950529,2.33514521049418e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,0.0189398132152897,0.00150322950833657,0.01599348337895,0.0218861430516294,2.65036322826252e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,29786,-0.0773822059964415,0.00614569691546342,-0.0894277719507498,-0.0653366400421332,2.9177795172784e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,-0.0737599631872714,0.00585678496352385,-0.0852392617157782,-0.0622806646587647,2.94481816444484e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,24816,-0.0572053911939889,0.00454348506772144,-0.0661106219267229,-0.0483001604612549,3.06911269807886e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,0.028739752699778,0.0022827411559503,0.0242655800341154,0.0332139253654406,3.11240864731335e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,-0.0498041070386982,0.00395858335855007,-0.0575629304214563,-0.0420452836559401,3.46547037229043e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGRN,Neugrin,24845,-0.0196154715687761,0.00155928310567892,-0.0226716664559068,-0.0165592766816454,3.51661098467685e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,-0.0641760168564887,0.00510519052083566,-0.0741821902773266,-0.0541698434356508,3.80328892387614e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,-0.0321341547115557,0.00256042405468537,-0.0371525858587391,-0.0271157235643724,4.92029314603987e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,29478,-0.0469864158960072,0.00374466918594256,-0.0543259675004547,-0.0396468642915598,5.06951913777717e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,-0.0588721182470237,0.00469428174537101,-0.0680729104679509,-0.0496713260260966,5.51572280175398e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,28654,-0.0619326514514512,0.0049418355185782,-0.0716186490678644,-0.0522466538350379,6.17475112721293e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,29434,-0.0710698504064926,0.00567933470447499,-0.0822013464272636,-0.0599383543857216,7.74700103996434e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,29163,-0.0701795441533875,0.00560907995383001,-0.0811733408628943,-0.0591857474438807,7.95787143413034e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,-0.0376454094250859,0.00301181211095806,-0.0435485611625637,-0.0317422576876081,9.27941517329347e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,-0.055559634781687,0.00445066948309031,-0.064282946968544,-0.04683632259483,1.17524240784983e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,-0.0604799503682044,0.00485661555091473,-0.0699989168479973,-0.0509609838884115,1.65911721751698e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,29820,0.026252978438485,0.0021088057478724,0.0221197191726551,0.0303862377043149,1.73073112049479e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,-0.0996943114150523,0.00802047151573771,-0.115414435585898,-0.0839741872442064,2.29087446572682e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,29478,0.0269846315220889,0.00217746141410438,0.0227168071504443,0.0312524558937334,3.50314659277895e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,29694,-0.106449755241326,0.00860051975674423,-0.123306773964545,-0.0895927365181075,4.24311627633595e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,-0.0767864798713843,0.00621700279577491,-0.0889718053511032,-0.0646011543916655,6.09051630869193e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,0.0229606438902339,0.00186043514494586,0.01931419100614,0.0266070967743278,6.84271454103167e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,-0.0894897518588029,0.00725867132182832,-0.103716747649586,-0.0752627560680194,7.74050294378471e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,24229,-0.0303881996312958,0.00246496414816957,-0.0352195293617082,-0.0255568699008834,8.137879706569e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,29674,-0.0494630469475949,0.004018068151274,-0.057338460524092,-0.0415876333710979,9.71082732934594e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,-0.0781914791509005,0.00635416547664366,-0.0906456434851221,-0.0657373148166789,1.06744908472691e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,-0.0503021023058422,0.00409110971340017,-0.0583206773441065,-0.0422835272675778,1.21375468186893e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,29218,-0.0525515949593009,0.00427530696200396,-0.0609311966048286,-0.0441719933137731,1.21983390602472e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,24111,-0.0412592600539279,0.00336009515153359,-0.0478450465509337,-0.034673473556922,1.4864023438024e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,29694,-0.0229339125621813,0.00186978904311365,-0.026598699086684,-0.0192691260376785,1.68193830265826e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASN,Vasorin,29065,0.0236945282403898,0.0019320724080521,0.0199076663206077,0.0274813901601719,1.72497786041615e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,29725,0.0291971603066545,0.00238653860491602,0.0245195446410191,0.0338747759722899,2.47200809260465e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,-0.0414798991485018,0.00339052458291776,-0.0481253273310206,-0.034834470965983,2.56828669926801e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,-0.0494561225982509,0.00404679554969422,-0.0573878418756516,-0.0415244033208502,2.90977657837158e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,-0.0511237588722026,0.00418533630374822,-0.0593270180275491,-0.0429204997168561,3.24018091307059e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,-0.0542982499402008,0.00444820319121402,-0.0630167281949803,-0.0455797716854213,3.5828759159291e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,-0.0374785120713016,0.00307329459087449,-0.0435021694694156,-0.0314548546731876,4.1668583346443e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,-0.0663238348209735,0.0054516124202871,-0.0770089951647362,-0.0556386744772108,5.89772883919689e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,-0.037955479742911,0.00312290715873469,-0.044076377774031,-0.031834581711791,6.62377036667244e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPSE,Heparanase,24688,-0.0802341717356778,0.00660129947465234,-0.0931727187059964,-0.0672956247653593,6.80374513652615e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORT1,Sortilin,29433,-0.031671116716326,0.00260791164254285,-0.03678262353571,-0.026559609896942,7.4183423066766e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,29331,-0.0244059501900983,0.00200983318119047,-0.0283452232252317,-0.020466677154965,7.51151907449575e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,29694,-0.0551645945313098,0.00454465512839931,-0.0640721185829724,-0.0462570704796471,7.95708763789026e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0342554035032791,0.00283505200983383,-0.0398121054425534,-0.0286987015640048,1.56536581131032e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,-0.0420583953299448,0.00348623117982013,-0.0488914084423922,-0.0352253822174973,2.03713896668482e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,-0.0569512827040906,0.00473805131536035,-0.0662378632821969,-0.0476647021259843,3.46409084827527e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,-0.0594762426505723,0.00496421919639092,-0.0692061122754985,-0.0497463730256461,5.3317014676338e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,29446,-0.0363925318812073,0.0030395457495206,-0.0423500415502676,-0.0304350222121469,5.86998301380518e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,0.068741014439213,0.0057424370893476,0.0574858377440917,0.0799961911343343,6.03187987889314e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,29349,-0.0462237750846726,0.00386281475539897,-0.0537948920052546,-0.0386526581640907,6.36265992007047e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,-0.0244565782822129,0.00204678964339332,-0.0284682859832638,-0.020444870581162,7.87101962452841e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,-0.0448013204788848,0.00375279037909962,-0.0521567896219201,-0.0374458513358496,9.23759439470937e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,29353,-0.0411193630694731,0.00345564505650154,-0.0478924273802161,-0.0343462987587301,1.42032809721104e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0319895509042846,0.00268995720033787,-0.0372618670169468,-0.0267172347916223,1.54007664917378e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,28797,-0.0318617215794645,0.0026830025879398,-0.0371204066518265,-0.0266030365071025,1.89189358747159e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,24867,-0.0651970131050457,0.00548988876444409,-0.0759571950833561,-0.0544368311267353,1.93456256964616e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,28916,0.019506559776795,0.00164296082999078,0.0162863565500131,0.022726763003577,1.94967390728954e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,-0.0608960219444489,0.00512876812545776,-0.0709484074703461,-0.0508436364185517,1.99001593133199e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,24867,-0.0457609691181657,0.00386555225802247,-0.0533374515438897,-0.0381844866924416,3.02639309975108e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,-0.0535861247963412,0.00453003319524326,-0.062464989859018,-0.0447072597336644,3.26831395561739e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,-0.0473655917427753,0.00401217587223688,-0.0552294564523596,-0.039501727033191,4.33802279951805e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,29333,-0.0282871227953149,0.00239898810390383,-0.0329891394789665,-0.0235851061116634,5.11468768055096e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,24195,-0.0404595543267524,0.00343441511767833,-0.047191007957402,-0.0337281006961029,6.00783553421367e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,-0.064758601962916,0.00549811988223465,-0.0755349169320959,-0.0539822869937361,6.16411818106734e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,24229,-0.0274736456413522,0.00233335149370486,-0.0320470145690137,-0.0229002767136907,6.46912433620451e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,24177,-0.0362252272562903,0.00307689622186664,-0.0422559438511489,-0.0301945106614317,6.55069213715247e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KAZN,Kazrin,24805,-0.0863243810940932,0.00733437187754853,-0.100699749974088,-0.0719490122140981,6.7890788993981e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,29474,0.0179284640949083,0.00152454570960176,0.0149403545040888,0.0209165736857277,7.40350301899861e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,-0.0641527474495845,0.00545572026692327,-0.0748459591727541,-0.0534595357264149,7.52625729864284e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,-0.0595349178230997,0.00506388796700328,-0.0694601382384262,-0.0496096974077733,7.68187639767882e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,24381,-0.0579864922673196,0.00493273764779731,-0.0676546580570023,-0.0483183264776369,8.07158307065569e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,24845,-0.0549346544440381,0.00467651440310316,-0.0641006226741203,-0.0457686862139559,8.88961400642684e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,29786,-0.0286128538211905,0.00243835760340339,-0.0333920347238611,-0.0238336729185198,9.96724060866444e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,-0.0427780033803844,0.00364633337529145,-0.0499248167959556,-0.0356311899648131,1.03065218475123e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,28797,-0.0440751353795508,0.00376075900736174,-0.0514462230339798,-0.0367040477251218,1.19175296249619e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,24732,-0.0384148973250116,0.00327878337675204,-0.0448413127434456,-0.0319884819065776,1.2765047808549e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,24195,-0.0374051640382561,0.00319362687923149,-0.0436646727215498,-0.0311456553549623,1.33984247828271e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,-0.0368211248613653,0.0031442816314331,-0.0429839168589742,-0.0306583328637565,1.3702311401528e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,24845,-0.0314115705051537,0.00268667815820224,-0.0366774596952301,-0.0261456813150773,1.70180050143735e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,29725,-0.0903054449412591,0.00773105758481697,-0.1054583178075,-0.0751525720750178,1.87074401077266e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNST,Consortin,29478,-0.0886220359252406,0.00758753067404621,-0.103493596046371,-0.07375047580411,1.89325049079795e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,29443,-0.0620179477670695,0.00530997524786102,-0.0724254992528771,-0.0516103962812619,1.90339559177218e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,29478,-0.0347867807513561,0.00298548170672002,-0.0406383248965273,-0.0289352366061849,2.62610760292059e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,-0.0530362387245734,0.00455152278177549,-0.0619572233768534,-0.0441152540722934,2.69164745189789e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,28774,-0.0583454700667417,0.00500973771177186,-0.0681645559818145,-0.0485263841516688,2.8134706066712e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,24381,0.0175584279052016,0.00150862575937097,0.0146015214168345,0.0205153343935687,3.16936529066053e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,-0.0591796298395888,0.00509334254987111,-0.0691625812373362,-0.0491966784418414,3.97104521499139e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,28719,-0.0374282683569097,0.00322255332339028,-0.0437444728707547,-0.0311120638430647,4.08413728488273e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,-0.0212507625457903,0.00183555933047223,-0.0248484588335159,-0.0176530662580648,6.27586417740193e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,29581,-0.0625013706135431,0.00539886161752873,-0.0730831393838994,-0.0519196018431868,6.30223964149253e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,-0.0901013380762607,0.00781003954235121,-0.105409015579269,-0.0747936605732524,1.00598765635164e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,29478,-0.0983047575968451,0.00852375710403668,-0.115011321520757,-0.0815981936729332,1.0467256948226e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,29390,-0.0227389845739508,0.00197951325588731,-0.0266188305554899,-0.0188591385924116,1.77828269798471e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,-0.0283716284736801,0.00246990766560243,-0.0332126474982608,-0.0235306094490993,1.78242823296035e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,-0.0627293870789979,0.00546102746095883,-0.0734330009024772,-0.0520257732555186,1.84477749946537e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,24793,-0.0319842724358985,0.00278557082051941,-0.0374439912441165,-0.0265245536276804,1.93734066681878e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,-0.0187293989500351,0.0016329350070761,-0.0219299515639043,-0.0155288463361659,2.17418319237374e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOST,Sclerostin,29433,-0.0311028979604521,0.00271188125778717,-0.0364181852257149,-0.0257876106951892,2.18820433031704e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,-0.0323337977665278,0.00282092892102595,-0.0378628184517387,-0.026804777081317,2.43840003257226e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,24793,-0.0668133769085,0.00583362876228234,-0.0782472892825734,-0.0553794645344267,2.7031254014754e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,-0.0307207373946768,0.00268516305914148,-0.0359836569905941,-0.0254578177987596,3.03581531040435e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,-0.0522252833783447,0.00457514860362791,-0.0611925746414554,-0.043257992115234,4.07396254333049e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,-0.0604727282016337,0.00529948143291011,-0.0708597118101375,-0.0500857445931299,4.2629098050134e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,-0.0240285839663371,0.00210671769603942,-0.0281577506505744,-0.0198994172820998,4.52981042286976e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,28931,-0.0908931584551264,0.00797163481878287,-0.106517562699941,-0.0752687542103119,4.73371505032052e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,24761,-0.0227948539939821,0.00200046076267251,-0.0267157570888203,-0.018873950899144,5.2730882122921e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,-0.0183619222867729,0.00161235206896244,-0.0215221323419393,-0.0152017122316065,5.52913230584939e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,-0.0537003915725693,0.00471687080307233,-0.0629454583465911,-0.0444553247985475,5.74586095134408e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,24890,-0.0374010845667266,0.00328778355646835,-0.0438451403374046,-0.0309570287960486,6.54611297686505e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,24845,-0.0603133707658239,0.00530285458028158,-0.0707069657431758,-0.049919775788472,6.70063156710485e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,29498,-0.0741350213228174,0.00651994062651727,-0.0869141049507913,-0.0613559376948436,6.7696530443515e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,-0.0613635437861346,0.00539549948206778,-0.0719387227709874,-0.0507883648012817,6.77974278318407e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,24922,-0.079896098031762,0.00702763454122876,-0.0936702617325703,-0.0661219343309536,7.08253622282587e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,29640,-0.057616401913674,0.00507238148001526,-0.0675582696145039,-0.0476745342128441,7.72682748397473e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,24229,-0.0437222220517293,0.00385540408581346,-0.0512788140599237,-0.0361656300435349,9.82609280480657e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,-0.019773335738107,0.00174405818466651,-0.0231916897800533,-0.0163549816961606,9.87014810360413e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,24805,-0.0564425844793058,0.004977665341927,-0.0661988085494827,-0.0466863604091289,9.93650661135491e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,29434,-0.031802161818953,0.00280853533053652,-0.0373068910668046,-0.0262974325711014,1.15771929828628e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,-0.0719022397767,0.00635061586825604,-0.0843494468784819,-0.0594550326749182,1.21118668048856e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,29218,-0.0281784894177848,0.00249282832211826,-0.0330644329291366,-0.023292545906433,1.44728066230484e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,-0.063702836764002,0.00563449827079398,-0.0747464533747582,-0.0526592201532458,1.4496386199369e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,-0.0500594028047975,0.00443239984755276,-0.0587469065060009,-0.0413718991035941,1.65882003303561e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,29820,-0.0335176295266286,0.00296999845736922,-0.0393388265030723,-0.027696432550185,1.77818295694888e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,24229,-0.0448587523726437,0.0039772177763526,-0.0526540992142948,-0.0370634055309926,1.9749233504322e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,24845,-0.0652610628577458,0.00578982575070655,-0.0766091213291306,-0.0539130043863609,2.13461102219649e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-0.0224998099556945,0.00199700123272871,-0.0264139323718428,-0.0185856875395462,2.25625492654042e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,-0.0380264211190215,0.00337532125266446,-0.0446420507742439,-0.0314107914637992,2.27629581016073e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,24845,-0.0489366506022384,0.00434551501119263,-0.057453860024176,-0.0404194411803009,2.3970349866925e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,29661,-0.033817443345524,0.00300815732063085,-0.0397134316939604,-0.0279214549970875,2.90921267755918e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,29349,-0.0707322777551382,0.00629290273050361,-0.0830663671069252,-0.0583981884033511,2.97670825053026e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,24966,0.0240709274103332,0.00214130665612647,0.0198739663643253,0.0282678884563411,3.00756498588197e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,-0.0425959345080081,0.00379202743681833,-0.050028308284172,-0.0351635607318442,3.22722766884007e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,29674,-0.0408015005775237,0.00363282608925287,-0.0479218397124593,-0.0336811614425881,3.27743811013492e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,-0.0812589310001063,0.00723579638298552,-0.0954410919107579,-0.0670767700894546,3.42480849808482e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,29434,-0.0640815235377861,0.00570973347519797,-0.0752726011491742,-0.0528904459263981,3.59584880107289e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,29349,-0.0233137308741605,0.00207788205836843,-0.0273863797085626,-0.0192410820397584,3.73171424990619e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,-0.0672302382787639,0.00599881081254628,-0.0789879074713546,-0.0554725690861732,4.29986452816764e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,24922,-0.0647486790812832,0.00577897465873009,-0.0760754694123942,-0.0534218887501722,4.56483337483294e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,-0.0399575786003419,0.00356695034983039,-0.0469488012860095,-0.0329663559146744,4.66922961125262e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,29434,-0.0521545826436533,0.00466419944647911,-0.0612964135587524,-0.0430127517285542,5.72160399779978e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,29443,-0.0359342429233184,0.00321581578755822,-0.0422372418669325,-0.0296312439797043,6.23551919036839e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,-0.0510063251293456,0.00457706473930046,-0.0599773720183745,-0.0420352782403167,8.74797668024087e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,29786,-0.0210552442484664,0.00189574786508167,-0.0247709100640264,-0.0173395784329063,1.32672428735514e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,24793,-0.0490996064507968,0.00442260459959783,-0.0577679114660085,-0.0404313014355851,1.43321858663816e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,-0.0486247581708681,0.00438140343255189,-0.0572123088986699,-0.0400372074430664,1.50470415187438e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,-0.0593171484844269,0.00535365037628096,-0.0698103032219376,-0.0488239937469162,1.83404102403803e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,-0.0464135252804211,0.00418996086784516,-0.0546258485813977,-0.0382012019794446,1.84437576624519e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,29163,-0.049513353973171,0.0044710987015851,-0.0582767074282778,-0.0407500005180642,1.90972841074845e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,24951,-0.0214897482749922,0.00194100512692153,-0.0252941183237585,-0.017685378226226,2.01025543991701e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,24867,-0.0430755046309433,0.00389263035127087,-0.0507050601194342,-0.0354459491424523,2.13892791185834e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,-0.0593114558790224,0.00537941510706576,-0.0698551094888713,-0.0487678022691735,3.34341089415809e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,0.0241214639482878,0.00219106185420925,0.0198269827140376,0.0284159451825379,3.98985764474448e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,24565,-0.0850218501330176,0.00772372460273059,-0.10016035035437,-0.0698833499116656,4.07403346562936e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,-0.0468795249978925,0.00427447651138712,-0.0552574989602113,-0.0385015510355738,6.35987539814748e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,-0.0467127554113985,0.00426106565237073,-0.0550644440900451,-0.0383610667327519,6.69893429338129e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,28277,-0.0177132697928135,0.00161796744691397,-0.0208844859887648,-0.0145420535968621,7.73957543439495e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,0.0191573931138792,0.00175433070863138,0.0157189049249617,0.0225958813027967,1.04320437961885e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,28797,-0.074989003416981,0.00687167256566487,-0.0884574816456842,-0.0615205251882779,1.13477580860532e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,-0.0483711978736752,0.00443682260567674,-0.0570673701808016,-0.0396750255665487,1.27387316261621e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,0.018304019632581,0.0016825324533845,0.0150062560239474,0.0216017832412146,1.64092803326101e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PI3,Elafin,29014,-0.0419993294408047,0.00386164920259902,-0.0495681618778987,-0.0344304970037106,1.69503745576483e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,24240,-0.0468578225886161,0.00431762813463338,-0.0553203737324975,-0.0383952714447347,2.23913199047841e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,-0.0375216129547633,0.00346124828611413,-0.044305659595547,-0.0307375663139796,2.49004955740569e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,-0.03508846378557,0.00323698736714517,-0.0414329590251745,-0.0287439685459655,2.57455080926546e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,29434,-0.0515833450195762,0.00476076555527523,-0.0609144455079156,-0.0422522445312368,2.64329634613413e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,24793,-0.0367262764851113,0.00338966212348391,-0.0433700142471397,-0.0300825387230828,2.71155088707977e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,29443,0.0217367391057662,0.00200812237774598,0.0178008192453841,0.0256726589661483,2.9689654038554e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.0451006588386108,0.00417303411213976,-0.0532798056984047,-0.0369215119788168,3.56958216328321e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,29786,-0.037547872347062,0.00347583625227136,-0.0443605114015139,-0.0307352332926101,3.75977264863873e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,-0.0572325252421008,0.00530238549456673,-0.0676252008114516,-0.04683984967275,4.15125821573331e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,-0.020698112033027,0.00191868427318644,-0.0244587332084725,-0.0169374908575816,4.42247513213034e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,29411,-0.0457435180881,0.0042405369599257,-0.0540549705295544,-0.0374320656466457,4.44691049573459e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,29395,-0.05010008616992,0.00465876390805108,-0.0592312634297002,-0.0409689089101399,6.37299379772541e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWC2,Brorin,29114,-0.030006800119374,0.00279358106127807,-0.0354822189994791,-0.024531381239269,7.31021425260619e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,-0.0411426268995076,0.00382965136093253,-0.0486487435669354,-0.0336365102320799,7.33176811027181e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,28797,-0.0726354573864431,0.00676347538421038,-0.0858918691394955,-0.0593790456333908,7.47674366930307e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,-0.0500391610119273,0.00466862455495814,-0.0591896651396452,-0.0408886568842093,9.56973353186978e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,24240,-0.0403256531678,0.00376233554335649,-0.0476998308327787,-0.0329514755028213,9.5947167645292e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,29632,-0.0445637885483917,0.00416273141907718,-0.052722742129783,-0.0364048349670005,1.07424973705345e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,28916,-0.037509474350216,0.00350756021107603,-0.044384292363925,-0.030634656336507,1.2193333158288e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,24845,-0.0419181056235305,0.00392053306864395,-0.0496023504380726,-0.0342338608089883,1.26874998911285e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,28797,-0.021670942571474,0.00202865075498785,-0.0256470980512501,-0.0176947870916978,1.37953041587312e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,-0.0234426002283642,0.00219540171584801,-0.0277455875914263,-0.0191396128653021,1.44304314517899e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,-0.0585479994351557,0.00548640041043188,-0.0693013442396022,-0.0477946546307092,1.54914218071806e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,29674,-0.0230813084565163,0.00216752779496175,-0.0273296629346413,-0.0188329539783912,1.97421780658439e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,29313,-0.0288525458027917,0.00271169957592587,-0.0341674769716064,-0.0235376146339769,2.16865459070206e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,24240,-0.0576446601104552,0.00541828997813104,-0.068264508467592,-0.0470248117533184,2.24621148818067e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,-0.0537415886469012,0.00505176151675718,-0.0636430412197453,-0.0438401360740572,2.26167560483413e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,-0.0492714549115024,0.00463660913183459,-0.0583592088098982,-0.0401837010131066,2.5525058135414e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.0197940658199227,0.0018638133887922,0.01614099157789,0.0234471400619554,2.67978989024549e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.022622053421579,0.00213440500571817,-0.0268054872327866,-0.0184386196103714,3.36376483715598e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,-0.0832798257214001,0.00785810691695441,-0.0986817152786307,-0.0678779361641694,3.39599113434149e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,-0.0598401568778071,0.00565078187138597,-0.0709156893457236,-0.0487646244098906,3.79515055985975e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,24805,-0.0512147790751549,0.00484197920409001,-0.0607050583151714,-0.0417244998351385,4.31909440656129e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,24240,0.0317213096102811,0.00300350802895699,0.0258344338735254,0.0376081853470368,5.12399523048106e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,24381,-0.040207922278257,0.00381231005893616,-0.0476800499937718,-0.0327357945627421,5.97414040285251e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,24922,-0.0220884597366204,0.00209709178772574,-0.0261987596405628,-0.0179781598326779,6.9066294615568e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,28774,-0.0498468115051107,0.00473370673174652,-0.0591248766993339,-0.0405687463108875,6.98990223304741e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,28931,-0.0325308160649471,0.00309278252161049,-0.0385926698073036,-0.0264689623225905,7.92157988659921e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,29169,-0.0386159871359562,0.00367544205920488,-0.0458198535719978,-0.0314121206999147,8.96678317987513e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,-0.0421121594941827,0.00400899887770204,-0.0499697972944787,-0.0342545216938868,9.36666856776527e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,28797,-0.0433738450222664,0.00413013731288416,-0.0514689141555193,-0.0352787758890134,9.43535824069822e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,29174,-0.0429541512436591,0.00409164527325825,-0.0509737759792453,-0.034934526508073,9.80558742339795e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,-0.018993713391134,0.00181024649872048,-0.0225417965286261,-0.0154456302536418,1.03959019389501e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,-0.0416523039862042,0.0039769548312975,-0.0494471354555473,-0.0338574725168611,1.26955181280083e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,29566,-0.0406494866066412,0.00389496405149538,-0.0482836161475721,-0.0330153570657102,1.8720859253713e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,24240,-0.034748234648948,0.00333485949413211,-0.0412845592574469,-0.0282119100404491,2.28088468135475e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,-0.0445862377599227,0.00428027046704477,-0.0529755678753305,-0.036196907644515,2.30335629343927e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,24229,-0.0298822111513064,0.00286887630872792,-0.0355052087164131,-0.0242592135861997,2.37110110805186e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,24229,-0.0325472398305144,0.00312554731077701,-0.0386733125596374,-0.0264211671013915,2.43917375861861e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,24381,0.0209497208934866,0.00201345227869106,0.0170033544272521,0.0248960873597211,2.66155524418537e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,29544,-0.0216988830530042,0.00208769124070916,-0.0257907578847942,-0.0176070082212143,2.92773460134656e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,29443,0.0207768246799483,0.00200197282608172,0.0168529579408281,0.0247006914190685,3.44498571323483e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,29725,-0.0206164865702183,0.00198820003789297,-0.0245133586444885,-0.016719614495948,3.77072105502149e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,-0.0752857985609452,0.00726282631641831,-0.0895209381411251,-0.0610506589807653,3.91632919560108e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,-0.0678551310855167,0.00654678234883796,-0.0806868244892391,-0.0550234376817943,3.9738475279521e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,-0.0747979355436027,0.00722201237012253,-0.0889530797890428,-0.0606427912981625,4.37902724854391e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,-0.041347951128097,0.00399363182423182,-0.0491754695035914,-0.0335204327526027,4.46656842792325e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,0.0248702916144518,0.00240281924299121,0.020160765898189,0.0295798173307146,4.59823612052791e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,-0.0320718929466708,0.00309863377331864,-0.0381452151423753,-0.0259985707509662,4.6064077333961e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRN,Progranulin,29313,-0.0178695417488931,0.00172835498949806,-0.0212571175283093,-0.0144819659694769,5.18051309011876e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,-0.0283543103486638,0.00274275880707126,-0.0337301176105235,-0.0229785030868041,5.23653159138292e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,-0.0396023733545238,0.00383149338206286,-0.047112100383367,-0.0320926463256806,5.35330206367601e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,24922,-0.0400899457869633,0.00388106038206949,-0.0476968241358195,-0.0324830674381071,5.81260861885891e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,29443,-0.0415760334532213,0.00403126012681595,-0.0494773033017805,-0.033674763604662,6.75766305045598e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,24805,-0.0429827998571012,0.00416770692615092,-0.051151505432357,-0.0348140942818453,6.88989459743349e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,-0.0430825030617379,0.00417971371684848,-0.051274741946761,-0.0348902641767149,7.3342305153717e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,29443,-0.019327888042698,0.00187579093137273,-0.0230044382681886,-0.0156513378172075,7.46077158133398e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,0.0316008833703917,0.00306846885556634,0.0255866844134816,0.0376150823273017,7.87605598312693e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,-0.0608797590747633,0.00592912715585024,-0.0725008483002298,-0.0492586698492969,1.10136204744654e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,24793,-0.0294282732101167,0.00287057561403036,-0.0350546014136162,-0.0238019450066172,1.30224425007207e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,24951,-0.0341127446389768,0.00333316869643879,-0.0406457552839968,-0.0275797339939568,1.55611809881819e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,-0.0514570423780001,0.00503234648929064,-0.0613204414970098,-0.0415936432589905,1.67751392952132e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,-0.105629199761438,0.0103327071231426,-0.125881305722797,-0.0853770938000782,1.75308904393784e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,28774,-0.0588941950881648,0.00576225334379936,-0.0701882116420115,-0.047600178534318,1.76417303088996e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,-0.0253166181241772,0.00248081476497677,-0.0301790150635317,-0.0204542211848227,2.10556272681195e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,0.0254863671218862,0.00250020730948969,0.0205859607952864,0.030386773448486,2.32177367570243e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,24381,-0.0483030527901468,0.00473775289504977,-0.0575890484644444,-0.0390170571158493,2.32795007993017e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,24845,-0.0331614194386002,0.00325437246933875,-0.0395399894785042,-0.0267828493986962,2.45890370542498e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,-0.0262184510846584,0.00257325768066267,-0.0312620361387572,-0.0211748660305595,2.49224176072552e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,0.0796390936097528,0.00781658015939271,0.0643185964973431,0.0949595907221626,2.50934225420975e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,-0.0466945923630549,0.00458452303779423,-0.0556802575171316,-0.0377089272089782,2.53729345725159e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,24240,-0.0491837619627011,0.00483746527401766,-0.0586651938997757,-0.0397023300256265,3.10536709421267e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,-0.0925413077666668,0.00910467487649609,-0.110386470524599,-0.0746961450087345,3.14148594230009e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,-0.0257140156437455,0.00253081257841739,-0.0306744082974435,-0.0207536229900474,3.33166023919331e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,29218,-0.0482388892357141,0.00475462495432734,-0.0575579541461957,-0.0389198243252326,3.79837785979665e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,24805,-0.0482890406082148,0.004758884982926,-0.0576164551747497,-0.0389616260416798,3.80415212092788e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,29795,-0.0240924558013234,0.00237500724887654,-0.0287474700091214,-0.0194374415935254,3.85073783170134e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,29434,-0.0594267557604214,0.00586237931775814,-0.0709170192232273,-0.0479364922976154,4.14849015410548e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,-0.0774462438088906,0.00764313310649544,-0.0924267846976217,-0.0624657029201596,4.40324273134454e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,-0.0515272016820786,0.00509550612038071,-0.0615143936780248,-0.0415400096861325,5.43966610204976e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,-0.0177029521864568,0.00175179487578763,-0.0211364701430005,-0.014269434229913,5.80314135561423e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,-0.0236554256044174,0.00234094887672343,-0.0282436854027953,-0.0190671658060395,5.86336083248106e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,23498,-0.0877780454474302,0.00869730812567689,-0.104824769373757,-0.0707313215211035,6.66811655077866e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.0201550310522918,0.0019979168304748,-0.0240709480400225,-0.0162391140645612,6.82815735352772e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,-0.0564801694296811,0.00559895779120638,-0.0674541267004456,-0.0455062121589166,6.85284414764907e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,29322,-0.0595323402800035,0.00590602978138285,-0.0711081586515139,-0.0479565219084931,7.41292678111447e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,29478,-0.0242176954753981,0.00240319039162454,-0.0289279486429822,-0.019507442307814,7.60854709079721e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,-0.0554188399468669,0.00550225466460658,-0.0662032590894958,-0.044634420804238,8.04452161724286e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,-0.0626220364273381,0.006219385201065,-0.0748120314214255,-0.0504320414332507,8.45057414418718e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,29434,-0.0340669430132651,0.00338573120302112,-0.0407029761711865,-0.0274309098553438,8.89405161866669e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,24922,-0.0456131318487929,0.00453410627116127,-0.054499980140269,-0.0367262835573168,9.21401165823936e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,24867,-0.0472164953013163,0.0046976515629692,-0.056423892364736,-0.0380090982378967,1.00860644596855e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,24816,-0.0598203489509136,0.0059553722593044,-0.0714928785791502,-0.048147819322677,1.07528543662412e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BGN,Biglycan,28750,0.0844283728649657,0.00840878249628733,0.0679471591722426,0.100909586557689,1.10682652081841e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,-0.0283543549411262,0.00282795932001497,-0.0338971552083555,-0.0228115546738968,1.29312427288055e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,29645,-0.0346589624009873,0.00345808101992936,-0.0414368012000488,-0.0278811236019257,1.32244116358949e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,29163,0.0340925498203672,0.00340334221887,0.027421999071382,0.0407631005693524,1.3959957332284e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,24195,-0.0923331377458872,0.00921577465887536,-0.110396056077283,-0.0742702194144915,1.39781073620479e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,-0.0335397678653058,0.00334869589579752,-0.040103211821069,-0.0269763239095427,1.44005764470623e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,-0.0378135143847805,0.00377830549232728,-0.045218993149742,-0.030408035619819,1.55981751540438e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,24016,-0.0359669903742262,0.00359484301312459,-0.0430128826799504,-0.028921098068502,1.60853626687749e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,-0.0163366813802297,0.00163341316704333,-0.0195381711876346,-0.0131351915728247,1.63448076353821e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,-0.0434015210436411,0.00434268461288279,-0.0519131828848913,-0.0348898592023908,1.78970591313393e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,29329,-0.0547898687939506,0.0054896356738715,-0.0655495547147388,-0.0440301828731625,2.02007252041604e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,28534,-0.0535249253351167,0.00536682970290468,-0.0640439115528099,-0.0430059391174235,2.17926291512623e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,24805,-0.0238000037880025,0.00238624739918058,-0.0284770486903965,-0.0191229588856086,2.19648510454954e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,29218,-0.0673664261659171,0.00676058534586508,-0.0806171734438126,-0.0541156788880215,2.37315554202457e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,29349,-0.0414529690664232,0.00416022340271396,-0.0496070069357425,-0.0332989311971038,2.38330977901592e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,-0.033358633989903,0.00334884178411863,-0.0399223638867756,-0.0267949040930305,2.4910060877078e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,-0.0360832652308721,0.00362519693281029,-0.0431886512191802,-0.0289778792425639,2.65632348323628e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,-0.0469032337351381,0.00471496372947034,-0.0561445626448999,-0.0376619048253762,2.81322070609736e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,-0.0425844163476095,0.00428484531278485,-0.0509827131606678,-0.0341861195345512,3.08237908796076e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,-0.0398701767594362,0.00401357238130315,-0.0477367786267903,-0.032003574892082,3.22673137578211e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,-0.0360419802416746,0.00363130209609227,-0.0431593323500154,-0.0289246281333337,3.51867202021911e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,-0.0352739602535086,0.00355530037085149,-0.0422423489803775,-0.0283055715266397,3.64963277946955e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,-0.0291958742106767,0.00294329198402722,-0.03496472649937,-0.0234270219219833,3.78180421084741e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,29478,-0.0279848589865477,0.00282225514694487,-0.0335164790745597,-0.0224532388985358,3.8642903469504e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,-0.0155348663584234,0.00156721905176765,-0.018606615699888,-0.0124631170169588,4.05856079664652e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,-0.0356084307072915,0.00359901395161691,-0.0426624980524607,-0.0285543633621224,4.8140754043011e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,24867,-0.0335352736767189,0.00339269498035473,-0.0401849558382142,-0.0268855915152236,5.35612005270664e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,24610,0.0753193258404485,0.00762269490716583,0.0603788438224035,0.0902598078584935,5.5581560899007e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,24195,-0.0292061924150978,0.00295755494055694,-0.0350030000985894,-0.0234093847316062,5.89887963077762e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,-0.0352633474352328,0.00357347489319392,-0.0422673582258929,-0.0282593366445727,6.31000790855921e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,24229,-0.0303385100826934,0.00307466908559256,-0.0363648614904548,-0.0243121586749319,6.37750134295987e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,29443,-0.0233859515864603,0.00237685129847648,-0.0280445801314742,-0.0187273230414464,8.2885923321337e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,-0.0192414072927001,0.00195627687928672,-0.023075709976102,-0.0154071046092981,8.7176257168744e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,-0.0301839017401885,0.00307240031951595,-0.0362058063664397,-0.0241619971139372,9.76715003079121e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,-0.0587199540154734,0.00597891204548432,-0.0704386216246226,-0.0470012864063241,1.00670554565231e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,29023,-0.0517107120109795,0.00526726579139337,-0.0620345529621105,-0.0413868710598485,1.02832576031155e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,0.0228068894772497,0.00232472843336783,0.0182504217478488,0.0273633572066507,1.11464306293617e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,0.0199074390169159,0.00203018906167959,0.0159282684560239,0.0238866095778079,1.15221617420104e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,-0.0478349851491808,0.00488005475204358,-0.0573998924631862,-0.0382700778351753,1.21381789042426e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,24845,-0.0468709090577331,0.00478575816980047,-0.056250995070542,-0.0374908230449241,1.31509005793673e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,24111,-0.0458576087399509,0.00468342637466902,-0.0550371244343022,-0.0366780930455997,1.34996896742833e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,24326,-0.0784473274471354,0.00801354720031986,-0.0941538799597623,-0.0627407749345085,1.37737595955037e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,-0.0502413202388479,0.00513664143886987,-0.0603091374590329,-0.040173503018663,1.47092796230698e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,24037,-0.037987692406142,0.00388429826661634,-0.0456009170087101,-0.030374467803574,1.51462070088299e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,0.0313377060899513,0.00320926210796367,0.0250475523583425,0.0376278598215601,1.72412890512748e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,24229,-0.0311847997409969,0.0031933773058994,-0.0374438192605597,-0.0249257802214341,1.74280731784949e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,24793,-0.0223225935947807,0.00228677890228734,-0.0268046802432639,-0.0178405069462975,1.80647462686499e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,-0.0217570135912166,0.00223150021524978,-0.0261307540131061,-0.017383273169327,2.02945599226533e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,29566,-0.0383126061619626,0.00393165927801081,-0.0460186583468638,-0.0306065539770614,2.10181509690313e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,-0.0289604180898566,0.0029723865046714,-0.0347862956390125,-0.0231345405407006,2.16815523103718e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,24966,-0.0366217202872954,0.00375891359323056,-0.0439891909300273,-0.0292542496445635,2.1744312862369e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,29491,-0.0722773597872122,0.00743152928594361,-0.0868431571876616,-0.0577115623867627,2.52942269276737e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGMN,Legumain,29581,-0.0244286982794204,0.00251393370169439,-0.0293560083347414,-0.0195013882240994,2.74700267944053e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,-0.0221411024388482,0.00228504863684971,-0.0266197977670736,-0.0176624071106227,3.60554782789903e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,28774,-0.0353738455057562,0.00365202263335699,-0.0425318098671359,-0.0282158811443765,3.73494227781122e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,24240,-0.0617929959269743,0.00637925111647015,-0.0742963281152558,-0.0492896637386928,3.77264939529204e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,29349,-0.0371129605343859,0.00383262913728496,-0.0446249136434645,-0.0296010074253074,3.82788881747697e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPARC,SPARC,29566,-0.047651592196758,0.00492556881028602,-0.0573057070649186,-0.0379974773285974,4.18017649395068e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,29384,-0.0770752570665223,0.00797258627554137,-0.0927015261665834,-0.0614489879664612,4.46844103688591e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,24111,-0.0539405360090997,0.00558906933355079,-0.0648951119028592,-0.0429859601153401,5.33135602100097e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.0178451554804404,0.00184911808655262,0.0142208840307973,0.0214694269300835,5.339631732556e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,-0.0469218573932917,0.00486490898627955,-0.0564570790063996,-0.0373866357801838,5.56614290407823e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,0.0257394403050044,0.00267188463251363,0.0205025464252777,0.0309763341847311,6.22930846835191e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,-0.0243567456679943,0.0025296244947091,-0.0293148096776241,-0.0193986816583644,6.62870863357763e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,24240,-0.0205908652131519,0.00214548797508733,-0.0247960216443231,-0.0163857087819808,8.97348621781398e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,-0.0567416432146346,0.00591701411382497,-0.0683389908777315,-0.0451442955515377,9.51812180653087e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,-0.0515946463033384,0.00538136124522763,-0.0621421143439846,-0.0410471782626923,9.69518061187054e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,-0.0233155584546111,0.00243246002985355,-0.028083180113124,-0.0185479367960981,9.94327506136016e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,-0.0231306752239,0.00241358461736537,-0.0278613010739361,-0.0184000493738639,1.00909547249937e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,-0.0697343306289377,0.00730128393931342,-0.084044847149992,-0.0554238141078834,1.38047396361888e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALB2,Calretinin,28774,-0.0204659721522744,0.00214296066533954,-0.0246661750563399,-0.0162657692482089,1.39182947712913e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,28797,-0.0292600918883155,0.00306436526725408,-0.0352662478121335,-0.0232539359644975,1.41640928880941e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,-0.0285037572033504,0.002987023888575,-0.0343583240249574,-0.0226491903817434,1.49964503575461e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,24240,0.043471166664953,0.00456452070126143,0.0345247060904806,0.0524176272394254,1.82212110444819e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,-0.0452996793176835,0.00475931965322776,-0.0546279458380099,-0.0359714127973571,1.91862395161458e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,24822,-0.0651253900819371,0.00684557423698223,-0.0785427155864223,-0.051708064577452,2.0053447388496e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,29296,-0.0205743383388167,0.00216306275027317,-0.0248139413293521,-0.0163347353482812,2.01487319807304e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,-0.0355655799760167,0.00374186968551333,-0.0428996445596228,-0.0282315153924106,2.1547554332326e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,-0.0671357702975683,0.00707431483602018,-0.0810014273761678,-0.0532701132189687,2.47686160096797e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,0.0125522538568156,0.00132402053123069,0.00995717361560344,0.0151473340980277,2.75131180689293e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,29414,-0.0604109755473787,0.0063734028932331,-0.0729028452181155,-0.0479191058766418,2.76392646498512e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,28916,-0.0376519678233078,0.00398259190983097,-0.0454578479665765,-0.0298460876800391,3.49488378308028e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,-0.0648540941013117,0.0068595168931526,-0.0782987472118908,-0.0514094409907326,3.52666364831464e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,-0.0585210808444018,0.00619165060190493,-0.0706567160241355,-0.0463854456646682,3.57623859798641e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,24240,-0.0601160928970849,0.00636126339479455,-0.0725841691508822,-0.0476480166432876,3.67309045291722e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C3,Complement C3,23779,-0.0309874546368641,0.00328648727034273,-0.0374289696867358,-0.0245459395869923,4.51745090557985e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,-0.0601095577895094,0.00637676549184529,-0.0726080181535262,-0.0476110974254926,4.60398555511215e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,-0.0442624034577326,0.00469752594987064,-0.0534695543194791,-0.0350552525959862,4.78821542590236e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,-0.068785779777217,0.00730905671944309,-0.0831115309473254,-0.0544600286071085,5.25859849177333e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,29320,-0.0276780665950554,0.00294203825106785,-0.0334444615671484,-0.0219116716229625,5.42453433230379e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,-0.025127211618139,0.00267352834071276,-0.030367327165936,-0.019887096070342,5.99625444084625e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,-0.0265617188170774,0.00282739241945557,-0.0321034079592103,-0.0210200296749445,6.2322861856684e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,29349,-0.0621328840232096,0.00661595447377899,-0.0751001547918164,-0.0491656132546027,6.3369574680659e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,29443,0.0158397648547989,0.00168777044214232,0.0125317347882,0.0191477949213979,6.7278798517495e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,24111,-0.0260426072018226,0.00277451915510842,-0.0314806647458351,-0.0206045496578101,6.74339815846299e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,29214,0.0221890934840726,0.00236483303029931,0.0175540207446859,0.0268241662234592,6.86520103218373e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,-0.061890056235555,0.00659660827796466,-0.0748194084603657,-0.0489607040107442,6.91991741937545e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,-0.0160575238822181,0.00171207392382241,-0.01941318877291,-0.0127018589915261,7.12369817672072e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,24805,-0.0229928527788676,0.00245518994333279,-0.0278050250677999,-0.0181806804899354,8.23138934026109e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,-0.0686357436046943,0.00733311236768786,-0.0830086438453625,-0.0542628433640261,8.55079781320116e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,24845,-0.0708294182748664,0.00756748178215845,-0.085661682567897,-0.0559971539818359,8.65163076407302e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,-0.0214966169693537,0.00229885169493484,-0.026002366291426,-0.0169908676472815,9.27201471721917e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,-0.0237580379566442,0.00254304182672649,-0.0287423999370282,-0.0187736759762603,1.00655556845454e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,29786,-0.015432081838978,0.00165206060833552,-0.0186701206313156,-0.0121940430466403,1.01757354524513e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,-0.0231332153494334,0.00248450339088419,-0.0280028419955664,-0.0182635887033004,1.35172486852584e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,-0.0335759854746414,0.00361392246594184,-0.0406592735078874,-0.0264926974413954,1.65739814467324e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.0296084358202699,0.00319062770255704,-0.0358620661172817,-0.0233548055232582,1.8095432624489e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,-0.0623683325026662,0.00672984797022109,-0.0755588345242995,-0.0491778304810328,2.03428010457316e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,24951,-0.046509263592625,0.00502128569877328,-0.0563509835622206,-0.0366675436230294,2.15483700689551e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,29497,-0.0156612599603122,0.0016911283312589,-0.0189758714895797,-0.0123466484310448,2.16179995795936e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,24240,-0.0190682335975858,0.00205966799212785,-0.0231051828621564,-0.0150312843330152,2.25233148818959e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,-0.0559670272951905,0.00604634145781659,-0.067817856552511,-0.04411619803787,2.28492845436253e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,24381,-0.0482521676733349,0.00521334187836125,-0.058470317754923,-0.0380340175917469,2.30231298106493e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,28774,-0.0302836824715167,0.00327367098558836,-0.0367000776032698,-0.0238672873397635,2.38052246131018e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,29434,-0.0455887531659652,0.00492847720715049,-0.0552485684919802,-0.0359289378399503,2.3906510199316e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,24951,-0.0150848198020468,0.00163066903898718,-0.0182809311184617,-0.011888708485632,2.40400280869334e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,0.0509465681353179,0.00550820500774902,0.0401504863201298,0.0617426499505059,2.40955609589628e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,-0.031951137804501,0.00345581498522119,-0.0387245351755345,-0.0251777404334674,2.52164100394456e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,-0.0302506930485535,0.00327509302893365,-0.0366698753852634,-0.0238315107118435,2.70921468507105e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,-0.0438823616721949,0.00475679019490458,-0.0532056704542079,-0.0345590528901819,3.05588214305273e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,-0.0375965820868963,0.00407709649792711,-0.0455876912228334,-0.0296054729509591,3.16439486490798e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,-0.0620018304637658,0.0067266238645206,-0.0751860132382262,-0.0488176476893055,3.24141092937548e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,-0.0311714480505328,0.0033860855428215,-0.0378081757144629,-0.0245347203866026,3.65975743451769e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,24111,-0.0382858955562942,0.00415980068085706,-0.0464391048907741,-0.0301326862218144,3.72863872767758e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,24867,-0.0490369125800973,0.00532922216047167,-0.0594821880146218,-0.0385916371455728,3.79912049532318e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,-0.0415818194928407,0.00452659521685339,-0.0504539461178733,-0.0327096928678081,4.38280844499676e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,-0.0404680853222234,0.00440691181781331,-0.0491056324851375,-0.0318305381593093,4.52490831090993e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,29732,-0.0443973359299544,0.00483620288216588,-0.0538762935789995,-0.0349183782809093,4.57353654287107e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,24111,-0.0278412605949868,0.00303364791147599,-0.0337872105014798,-0.0218953106884939,4.75719478272747e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,-0.0184157595914359,0.0020070522862664,-0.0223495820725181,-0.0144819371103538,4.83244087678259e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,-0.0385751138349545,0.00420717491445054,-0.0468211766672776,-0.0303290510026314,5.08859374193234e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,28931,-0.0593270312673085,0.00647222797005812,-0.0720125980886224,-0.0466414644459946,5.20549053957011e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,-0.0661200040203752,0.00721373747489043,-0.0802589294711605,-0.05198107856959,5.2248040680612e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,-0.0343799433936188,0.00375125398883861,-0.0417324012117425,-0.0270274855754951,5.3314791243106e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,-0.0187182074768039,0.00204354609660721,-0.022723557826154,-0.0147128571274537,5.52934995583699e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,-0.0401245946073908,0.00438285241472009,-0.0487149853402422,-0.0315342038745394,5.84779861390467e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,28931,-0.0452035664876967,0.0049405354296051,-0.0548870159297227,-0.0355201170456707,6.08348863476327e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,-0.0189144435314933,0.00206730108370228,-0.0229663536555498,-0.0148625334074368,6.09156933440378e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,-0.0556782369564712,0.00608660137017276,-0.0676079756420098,-0.0437484982709326,6.25265630099264e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,24845,-0.0375621274421464,0.00410710438432926,-0.0456120520354318,-0.0295122028488611,6.36959505001428e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,-0.0217640934659934,0.00238170785064678,-0.0264322408532611,-0.0170959460787257,6.75283716230608e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,-0.0781292610396403,0.00855477540394842,-0.0948966208313792,-0.0613619012479014,7.1025504063845e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.0420767634853429,0.00461211128419172,0.0330370253683271,0.0511165016023587,7.75441809765258e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,-0.0730222398013936,0.00800885237323533,-0.0887195904529349,-0.0573248891498524,8.14892061316123e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,24805,-0.0498319825982624,0.00546706604668838,-0.0605474320497717,-0.0391165331467532,8.45152528758469e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,-0.0430928075349216,0.00473030859380206,-0.0523642123787736,-0.0338214026910695,8.84771789824127e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,-0.0216671587784269,0.00238000868261001,-0.0263319757963426,-0.0170023417605113,9.37667953734335e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,24381,-0.0358277824054214,0.00393859206434656,-0.0435474228515406,-0.0281081419593021,1.00143148883398e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,-0.0228938291041207,0.00252063141434384,-0.0278342666762346,-0.0179533915320068,1.13716642099484e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.0134613297379403,0.00148211033973021,0.0105563934720691,0.0163662660038115,1.13958611984896e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,29434,-0.0235592039535877,0.00259620035355797,-0.0286477566465613,-0.0184706512606141,1.21136519774166e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,-0.0425965214925928,0.00469513819748546,-0.0517989923596643,-0.0333940506255213,1.24885496570453e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,-0.0288324603506046,0.00317947148442644,-0.0350642244600805,-0.0226006962411288,1.2834737870649e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,-0.0374433334077801,0.0041332534575095,-0.0455445101844987,-0.0293421566310615,1.39429386173876e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,-0.059669736104194,0.00658635736045429,-0.0725789965306844,-0.0467604756777036,1.40323868247788e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,-0.0348915186809931,0.00385169059621637,-0.0424408322495772,-0.027342205112409,1.41660095735366e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,29218,-0.0512532756882859,0.00566045926744201,-0.0623477758524723,-0.0401587755240996,1.45355460169707e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,29694,-0.0402105567688783,0.00444285813867909,-0.0489185587206893,-0.0315025548170672,1.50635274676692e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,29291,-0.0355480959539145,0.00393766333396514,-0.0432659160884862,-0.0278302758193428,1.85763261049849e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,-0.0275257175770472,0.00305402444994934,-0.033511605498948,-0.0215398296551465,2.15108016952109e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,24867,-0.0420829297024277,0.0046716052755717,-0.0512392760425482,-0.0329265833623072,2.24065229229872e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,-0.0346096778986929,0.00384307855105516,-0.042142111858761,-0.0270772439386248,2.26902754700597e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,28628,-0.0708284556016305,0.00786695688019368,-0.0862476910868101,-0.0554092201164509,2.3230768216107e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,-0.0221925539793512,0.00246794660639988,-0.0270297293278949,-0.0173553786308074,2.56483587316067e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,24381,-0.0437309760972054,0.00486588278450528,-0.0532681063548358,-0.0341938458395751,2.71411875499166e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,-0.0453306737721498,0.00504948445755449,-0.0552276633089566,-0.035433684235343,2.93929259865373e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,24805,-0.0226568531265771,0.00252616120938387,-0.0276081290969695,-0.0177055771561848,3.20194131878133e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,-0.0293592248562362,0.0032752791437736,-0.0357787719780324,-0.0229396777344399,3.34978270333505e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,28774,-0.0388645047916158,0.00434097952375546,-0.0473728246581765,-0.0303561849250551,3.66506903782112e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,24922,-0.0173363873611548,0.00193770311242419,-0.0211342854615062,-0.0135384892608034,3.90547728432444e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,-0.0199887253884438,0.00223534904286186,-0.0243700095124531,-0.0156074412644346,4.03361421581337e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,24845,-0.0584086698879893,0.00653535977845895,-0.0712179750537689,-0.0455993647222098,4.25755887596421e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,29694,-0.0187872996717862,0.00210768417150833,-0.0229183606479425,-0.0146562386956299,5.21093088322712e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,29566,-0.0445619233656124,0.00500146281229864,-0.0543647904777177,-0.034759056253507,5.40017269928095e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,-0.0240067397573708,0.00269731831336462,-0.0292934836515654,-0.0187199958631761,5.89326856071495e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,-0.0334740734145081,0.0037756355965253,-0.0408743191836977,-0.0260738276453185,8.00995037131075e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,24951,-0.0399210861101832,0.00450237866996123,-0.0487457483033072,-0.0310964239170592,8.0301803771894e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,29311,-0.0216906415779614,0.00244667102412326,-0.026486116785243,-0.0168951663706798,8.04777453331327e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,28916,-0.0225874865709133,0.00255238689715547,-0.027590164889338,-0.0175848082524886,9.27727870001478e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,-0.0349425852641364,0.00395001125698343,-0.0426846073278239,-0.0272005632004489,9.6515536135442e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,29566,-0.0424540845929402,0.00481139767869152,-0.0518844240431756,-0.0330237451427048,1.16760608960566e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,-0.0175526458682569,0.00198964209794842,-0.0214523443802358,-0.013652947356278,1.18495021134891e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,29566,0.0247864649842816,0.00281136487624991,0.0192761898268318,0.0302967401417315,1.2441135522543e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,24951,-0.0176291281269375,0.00199979830128405,-0.0215487327974542,-0.0137095234564207,1.26822076103694e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,-0.0563131566177597,0.0063907519202483,-0.0688390303814463,-0.043787282854073,1.31218171312339e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,-0.0183365331382994,0.00208689268111825,-0.0224268427932912,-0.0142462234833077,1.62531967408933e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,24381,-0.0356219371965845,0.00405675217113409,-0.0435731714520073,-0.0276707029411617,1.72619206173103e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,24229,-0.0260899593197519,0.00297159033112175,-0.0319142763687505,-0.0202656422707532,1.7438429247918e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,-0.0539088131313217,0.00614102643773762,-0.0659452249492875,-0.041872401313356,1.76442656596036e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,24240,-0.0141513441937328,0.00161227162461555,-0.0173113965779792,-0.0109912918094863,1.78327134955205e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,-0.0729151151035072,0.00831147731680601,-0.089205610644447,-0.0566246195625674,1.85229847837748e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,29478,-0.0239218765184385,0.00272819905454991,-0.0292691466653563,-0.0185746063715207,1.908144511823e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,-0.0166401958147497,0.00189768422174092,-0.0203596568893619,-0.0129207347401375,1.9207255933194e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,-0.0339112816567032,0.00386738641606786,-0.0414913590321961,-0.0263312042812102,1.92410821503621e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,29536,-0.0352464101205349,0.00402216617822121,-0.0431298558298485,-0.0273629644112213,2.00023434551963e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,24101,-0.0338066766841302,0.0038583199264149,-0.0413689837399034,-0.026244369628357,2.04176925685733e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,24867,0.028700224251041,0.00327872944335647,0.0222739145420623,0.0351265339600197,2.19808101091778e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,28931,-0.0298158632661241,0.00340824245047928,-0.0364960184690635,-0.0231357080631847,2.28394986114768e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,-0.0526454953891856,0.00601908156150105,-0.0644428952497277,-0.0408480955286435,2.34164163634424e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,-0.0547969875753501,0.00627236551981026,-0.0670908239941782,-0.042503151156522,2.55903337108572e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,-0.0217771990899769,0.00249347879962874,-0.0266644175372492,-0.0168899806427045,2.5946371901749e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,-0.0484813246199451,0.0055569419626159,-0.0593729308666722,-0.0375897183732179,2.81389688253415e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,24195,-0.0302056221832423,0.0034626757377114,-0.0369924666291566,-0.023418777737328,2.87538613532906e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,29725,-0.0368800623414771,0.004231016455976,-0.04517285459519,-0.0285872700877641,3.01317192681316e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,-0.0658654639014149,0.00755586134510195,-0.0806749521378147,-0.0510559756650151,3.02777248322832e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0201094753040548,0.00230689436573851,0.0155879623472073,0.0246309882609023,3.02817073178078e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,24966,-0.0113780466634143,0.00130548186985542,-0.013936791128331,-0.00881930219849772,3.06886731719154e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,-0.0315099554639422,0.00361542118166462,-0.0385961809800048,-0.0244237299478795,3.07446045577861e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,-0.0147559958902651,0.00169497101544616,-0.0180781390805395,-0.0114338526999906,3.35222889631527e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,23862,-0.0495837151865082,0.00569796465299855,-0.0607517259063854,-0.0384157044666311,3.46776245661115e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,29443,-0.0317987111412813,0.0036572423280256,-0.0389669061042115,-0.0246305161783511,3.654064911827e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,-0.0360490408459891,0.00414626568657553,-0.0441757215916771,-0.0279223601003011,3.70007904389159e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,29581,-0.0563377163624237,0.00648250342843952,-0.0690434230821652,-0.0436320096426823,3.78347241317334e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,24297,-0.0402371598358782,0.00463287294497514,-0.0493175908080295,-0.0311567288637269,4.01660048809079e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,29218,0.0256883773109985,0.00296012446814068,0.0198865333534427,0.0314902212685542,4.22809820168126e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,-0.0468273400660523,0.00540321857548349,-0.057417648474,-0.0362370316581047,4.67773163228563e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLGN,Calmegin,24195,-0.0274773314716889,0.0031710504292945,-0.0336925903131061,-0.0212620726302717,4.79053354058841e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,-0.0244518489162072,0.00282217139185486,-0.0299833048442427,-0.0189203929881716,4.81831761053819e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,-0.0696290285858628,0.00803946545479815,-0.0853863808772672,-0.0538716762944585,4.95983770798069e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,-0.0341893534070686,0.00395057266585873,-0.0419324758321518,-0.0264462309819855,5.26362704835794e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,0.0145190075965975,0.0016783569828467,0.011229427910218,0.0178085872829771,5.37245222497311e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,24951,0.0159947202176864,0.00184888189581726,0.0123709117018845,0.0196185287334882,5.40620945148501e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,-0.0322876855493648,0.00373521268061127,-0.0396087024033629,-0.0249666686953667,5.74334069756053e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,-0.0293012692442165,0.00339037154429736,-0.0359463974710394,-0.0226561410173937,5.77959432133215e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,29368,-0.0414904756044095,0.00481136234897303,-0.0509207458083966,-0.0320602054004224,6.81880495740358e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,24867,-0.0352115412069198,0.00408353420463267,-0.0432152682479998,-0.0272078141658398,6.91615104165834e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,-0.0301140380176574,0.00349442221641008,-0.0369631055618212,-0.0232649704734937,7.23513744268503e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEXN,Nexilin,24951,-0.0418837312172956,0.00486123754512595,-0.0514117568057425,-0.0323557056288487,7.34632966801549e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,24111,-0.0403924436754133,0.00468912473791006,-0.049583128161717,-0.0312017591891095,7.47628086671708e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,-0.0414598509813551,0.00482034769017548,-0.0509077324540991,-0.0320119695086112,8.3619008479542e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,29732,0.0215869866033321,0.00251174694963847,0.0166639625820407,0.0265100106246235,8.7724943699053e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,28591,-0.050814868234579,0.00591364509237012,-0.0624056126156244,-0.0392241238535336,8.9115312747485e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,-0.0341406520732023,0.00397394049606757,-0.0419295754454947,-0.0263517287009099,9.02637814655814e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,24845,-0.0429251605561135,0.00499740403714358,-0.0527200724689149,-0.0331302486433121,9.24020967378673e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,-0.0359807347576784,0.00419556414205334,-0.0442040404761029,-0.0277574290392538,1.03167421152317e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,28797,-0.0315692290665105,0.00368402943343285,-0.0387899267560389,-0.0243485313769821,1.09321296523837e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0194794086967158,0.00227388602038844,-0.0239362252966771,-0.0150225920967544,1.12823597708904e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,24951,0.0291557783339488,0.00341334137806771,0.0224656292329361,0.0358459274349615,1.39685517201672e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,-0.0697358523198811,0.00817403975041102,-0.0857569702306867,-0.0537147344090755,1.51526282815207e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,-0.0136873629569587,0.00160469623095307,-0.0168325675696267,-0.0105421583442906,1.55115708392481e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,28722,-0.0539962060280665,0.00634128215429292,-0.0664251190504806,-0.0415672930056523,1.74554690398181e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,-0.0176666012980704,0.00207499320000681,-0.0217335879700837,-0.013599614626057,1.75823928293547e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,29566,-0.0190895358492388,0.00224229073405093,-0.0234844256879786,-0.014694646010499,1.767715618619e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,-0.0135509908511645,0.00159249139313848,-0.0166722739817159,-0.010429707720613,1.83105582593243e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,28931,-0.0487957514729938,0.0057427646978289,-0.0600515702807385,-0.0375399326652492,2.03917425010289e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,-0.0222219442887285,0.0026155157383634,-0.0273483551359208,-0.0170955334415362,2.0672728913228e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,28774,-0.0270411688789198,0.00318319819135199,-0.0332802373339697,-0.0208021004238699,2.07397307475246e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,24805,-0.0339900343909318,0.00400454029451089,-0.0418389333681732,-0.0261411354136905,2.22057226119116e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,24951,-0.0435033848678019,0.0051343045451473,-0.0535666217762907,-0.0334401479593132,2.51991995420129e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,28753,0.0275036651391371,0.0032484775855698,0.0211366490714203,0.0338706812068539,2.64444513918389e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,24938,-0.0499289933520944,0.00589964722357501,-0.0614923019103014,-0.0383656847938874,2.74598192295855e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,29683,-0.0358336443743924,0.00423988913587877,-0.0441438270807148,-0.02752346166807,3.00420920720287e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,29443,-0.0385142886685971,0.00456452204889084,-0.0474607518844232,-0.0295678254527711,3.38125773474629e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAX,Protein max,28774,-0.0621636535816128,0.00737769383174938,-0.0766239334918416,-0.047703373671384,3.74477599603386e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,28671,-0.0280137486495859,0.00333160072881663,-0.0345436860780665,-0.0214838112211053,4.3431681751562e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,29443,0.0186454481606244,0.00221879771320118,0.0142966046427501,0.0229942916784987,4.53005587258944e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TF,Serotransferrin,24966,-0.0127883400615922,0.00152325246282133,-0.015773914888722,-0.00980276523446237,4.88573077532565e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,-0.0288395606400212,0.00343770118563165,-0.0355774549638593,-0.0221016663161832,5.15143997332978e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,0.0187357741240502,0.00223373288873143,0.0143576576621366,0.0231138905859638,5.17542128368799e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,0.00875967062587598,0.0010449039606328,0.00671165886303568,0.0108076823887163,5.41866997496766e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,24966,-0.0245336738595106,0.00292871289158178,-0.0302739511270109,-0.0187933965920103,5.71396383789577e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.0127105915372375,0.00151773311687747,0.00973583462815768,0.0156853484463174,5.82304122449087e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,29453,-0.0452472174814996,0.00540344437052161,-0.0558379684477219,-0.0346564665152772,5.82463802197953e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,0.0338111747081757,0.00404048745201552,0.0258918193022253,0.0417305301141261,6.10922783094238e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,-0.0177277077147196,0.00212207467009353,-0.0218869740681029,-0.0135684413613363,6.94142263889422e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,29344,-0.0513328819196396,0.00615314705929451,-0.0633930501558568,-0.0392727136834223,7.58601494262683e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,29386,-0.0396357117835251,0.00476407949623129,-0.0489733075961384,-0.0302981159709118,9.19583677283702e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,29478,-0.0746096922736372,0.0089687792976036,-0.0921884996969403,-0.0570308848503342,9.26270674266375e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,-0.0226967289341521,0.00273097352579124,-0.0280494370447029,-0.0173440208236013,9.90657677663538e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,-0.0210066438819152,0.00252825850454714,-0.0259620305508276,-0.0160512572130028,1.01760729025937e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,28931,-0.0462704105624137,0.00557509875353692,-0.0571976041193461,-0.0353432170054814,1.09069980603683e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,24845,-0.0414189065468098,0.00499511897615103,-0.0512093397400658,-0.0316284733535538,1.17060597073568e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,24111,-0.0445951613737986,0.0053922628314825,-0.0551639965235043,-0.0340263262240929,1.40554952079592e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,24845,-0.0157251969113065,0.00190585639578721,-0.0194606754470494,-0.0119897183755635,1.64805230694338e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,-0.0285481288755794,0.00346357034409289,-0.0353367267500014,-0.0217595310011573,1.75896141318815e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,-0.0530548707556344,0.00643728111200517,-0.0656719417351645,-0.0404377997761042,1.76751352640217e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,-0.0221730906545685,0.00269014725854443,-0.0274457792813156,-0.0169004020278214,1.77280444480615e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,-0.0357945268712647,0.00435516359114168,-0.0443306475099023,-0.027258406232627,2.15667619520562e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,28774,-0.0296443172202021,0.00360951698842282,-0.0367189705175108,-0.0225696639228934,2.25014661584589e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,0.0260191839975272,0.00316814654128317,0.0198096167766122,0.0322287512184422,2.26595197415667e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,24951,0.0346919150080988,0.00423089754574888,0.026399355818431,0.0429844741977666,2.52564304019011e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,29478,0.0403353090370482,0.00491974136483325,0.0306926159619751,0.0499780021121214,2.52843160582205e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,-0.0683607377455051,0.00834799656269097,-0.0847228110083794,-0.0519986644826308,2.76216931865579e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,-0.0178080853119225,0.0021748949481101,-0.0220708794102183,-0.0135452912136267,2.78528889164359e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,24528,-0.0162121390034203,0.00198016978724665,-0.0200932717864237,-0.0123310062204169,2.80157675590771e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,-0.0161681773963381,0.0019750368378653,-0.0200392495985541,-0.0122971051941221,2.82672368662568e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.0162139136507223,0.00198156217740868,-0.0200977755184433,-0.0123300517830013,2.89327286535357e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,24381,-0.0494791479773059,0.00604676963346718,-0.0613308164589016,-0.0376274794957102,2.90892036856821e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,-0.0111643718731747,0.00136666221125202,-0.0138430298072287,-0.00848571393912077,3.23110025806478e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,-0.0172138188554448,0.00210815231032529,-0.0213457973836824,-0.0130818403272072,3.33461780803801e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,-0.0358210797431549,0.00439107687746535,-0.044427590422987,-0.0272145690633228,3.54808605077536e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,24381,0.0185986485250796,0.0022823259195442,0.0141252897227729,0.0230720073273862,3.84452134758591e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,29434,-0.0334649173839107,0.00410978401066206,-0.0415200940448083,-0.025409740723013,4.01555075226759e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,24445,-0.0312040187291877,0.0038318514890222,-0.0387144476476712,-0.0236935898107042,4.02772121104373e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,24445,-0.0194855100407554,0.00239569503381043,-0.0241810723070239,-0.014789947774487,4.36536241337222e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,-0.0247202073336524,0.00304003158718073,-0.0306786692445266,-0.0187617454227782,4.40298804555465e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,-0.0297711045820612,0.00366148180198233,-0.0369476089139466,-0.0225946002501758,4.45918324057482e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,-0.0225941855400205,0.00277926795345814,-0.0280415507287985,-0.0171468203512426,4.50816311313512e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,24381,-0.0621069779145162,0.00764215011712334,-0.0770855921440779,-0.0471283636849544,4.61154640680455e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,24229,-0.0228621598343962,0.00281408647497056,-0.0283777693253385,-0.0173465503434539,4.71694527563199e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,-0.0182819870068928,0.00225275571132885,-0.0226973882010974,-0.0138665858126883,5.02946820253663e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.019601113103834,0.00241549197340704,-0.0243354773717118,-0.0148667488359562,5.09175359009635e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,-0.027958564046788,0.00344834466770445,-0.0347173195954887,-0.0211998084980873,5.39547537143258e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,29443,-0.0416473191850427,0.00513842092735933,-0.0517186242026669,-0.0315760141674184,5.47360949152349e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,0.0100346674350786,0.00123872620351087,0.00760676407619729,0.0124625707939599,5.66975496770079e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTD,Biotinidase,24966,-0.011815092592339,0.00145858511940424,-0.0146739194263713,-0.0089562657583067,5.72736095189892e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,29163,-0.0180848184842549,0.00223688652294094,-0.0224691160692191,-0.0137005208992906,6.4649528436233e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,24421,-0.0218870390500237,0.0027089406467612,-0.0271965627176756,-0.0165775153823717,6.79877244230918e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPART,Spartin,24381,-0.0441008171250811,0.00546124343615915,-0.0548048542599531,-0.0333967799902092,7.04387065659966e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,-0.0382691501865028,0.00474214163908347,-0.0475637477991063,-0.0289745525738992,7.29416776673935e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,28916,-0.0432796717081783,0.00536565587369775,-0.0537963572206259,-0.0327629861957307,7.53942669589327e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,29478,0.0201725039982037,0.00250256525207442,0.0152674761041379,0.0250775318922696,7.8687727007377e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,-0.0515604944188561,0.00639689956777608,-0.0640984175716972,-0.039022571266015,7.96411592841052e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,-0.0121927106467772,0.00151339924100672,-0.0151589731591504,-0.00922644813440405,8.20134188005922e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,-0.0507869322655384,0.00631275762154788,-0.0631599372037723,-0.0384139273273046,8.99657011272633e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,29518,-0.0213753588889277,0.00266550943629043,-0.026599757384057,-0.0161509603937985,1.10310002592624e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,-0.0469226657518877,0.00585359834261292,-0.058395718503409,-0.0354496130003663,1.13994761056207e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DMD,Dystrophin,24240,-0.0291631394139692,0.00364674978541907,-0.0363107689933905,-0.0220155098345478,1.3312329324779e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,29786,-0.0354319633140729,0.00444004276874841,-0.0441344471408198,-0.026729479487326,1.51438997295879e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,29443,0.0448215577295775,0.005624851360487,0.033796849063023,0.055846266396132,1.66394816440901e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,-0.0208377557812787,0.00261586916856107,-0.0259648593516584,-0.0157106522108989,1.71150449300486e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,29218,-0.0735980507170319,0.00924113781697452,-0.091710680838302,-0.0554854205957619,1.72333041610728e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0143911000075016,0.0018077313057779,0.0108479466481769,0.0179342533668263,1.76947045323862e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,-0.0612666476288188,0.00771193992560586,-0.0763820498830063,-0.0461512453746313,2.02039694596175e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0372361625542798,0.00468883561924119,-0.0464262803679926,-0.0280460447405671,2.06924311382006e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,29396,-0.0144333320391548,0.00182073498670432,-0.0180019726130953,-0.0108646914652143,2.32034463423524e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,-0.0426344103569096,0.00538132601747957,-0.0531818093511696,-0.0320870113626496,2.42195218125402e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,24606,0.0173275540762849,0.00218734380396753,0.0130403602205085,0.0216147479320612,2.44081534898192e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,-0.0597904309688335,0.00755003133789922,-0.074588492391116,-0.0449923695465511,2.4892625066965e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,24329,-0.0575225195423242,0.00726469658215522,-0.0717613248433484,-0.0432837142413,2.51438441328566e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,-0.0371737096070015,0.00469574114977602,-0.0463773622605625,-0.0279700569534405,2.54814567818508e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,-0.0206418619782049,0.00260804363848573,-0.0257536275096369,-0.0155300964467729,2.58160298613499e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,-0.0108709379428267,0.00137468661053483,-0.0135653236994749,-0.00817655218617842,2.72480395427966e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,29618,0.0229737699511391,0.00290618328871325,0.0172776507052611,0.0286698891970171,2.76894805412511e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,-0.0580190532080494,0.00734948636022199,-0.0724240464740845,-0.0436140599420143,3.0418111434617e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.0155473772171812,0.00197791184272084,-0.0194240844289141,-0.0116706700054484,3.98000287529317e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,29694,-0.0161196927506796,0.00205309281748494,-0.0201437546729501,-0.0120956308284091,4.25153704792736e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,29349,-0.0179581302056936,0.0022897168646101,-0.0224459752603293,-0.0134702851510578,4.54965073266594e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,-0.0233766380596051,0.00298252568919126,-0.0292223884104199,-0.0175308877087902,4.76551189094361e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,-0.0541068169639986,0.00690804176654208,-0.0676465788264211,-0.0405670551015762,4.97491258564845e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,-0.0613171989992023,0.00783813159569357,-0.0766799369267617,-0.0459544610716429,5.3318695768331e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,24966,0.0124838784454198,0.00159590014537317,0.00935591416048839,0.0156118427303512,5.3839703992884e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,29349,-0.0491730539405344,0.00629644298825143,-0.0615140821975072,-0.0368320256835616,5.9249752432843e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,29218,-0.05499824419044,0.00704381987488344,-0.0688041311452115,-0.0411923572356685,6.0033761681077e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,29381,-0.0224813899882589,0.00288188727089388,-0.0281298890392109,-0.0168328909373069,6.34851321692825e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,-0.0251255757489504,0.00322803207801999,-0.0314525186218696,-0.0187986328760312,7.28245596277017e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,24229,-0.0315172580066646,0.00405347201453074,-0.0394620631551448,-0.0235724528581843,7.82099243915338e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,-0.021036745969394,0.00270985460931369,-0.0263480610036488,-0.0157254309351391,8.61936693009856e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,28884,-0.0224529322439177,0.0028939615343607,-0.0281250968512647,-0.0167807676365708,8.87350672236323e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,29820,-0.0106544420624937,0.00137388746466096,-0.0133472614932291,-0.00796162263175818,9.11808166236927e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,24966,-0.0195193874911283,0.00252136652945804,-0.0244612658888661,-0.0145775090933905,1.0189372591609e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,-0.0363536132444095,0.00469662533972181,-0.0455589989102643,-0.0271482275785548,1.02293216149069e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,-0.0197139905271888,0.00255032131752355,-0.024712620309535,-0.0147153607448427,1.11712383801656e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,24793,-0.0229513393081582,0.00297100621526365,-0.028774511490075,-0.0171281671262415,1.15980314332371e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-0.0315543387657966,0.00409813952007512,-0.0395866922251438,-0.0235219853064494,1.40716542944556e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,-0.0322100178455922,0.00418380147946041,-0.0404102687453346,-0.0240097669458498,1.42528282379096e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,29434,-0.0363868974618173,0.00472970743542611,-0.0456571240352524,-0.0271166708883821,1.47901023728495e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,24240,-0.0282666757441012,0.00367492277009092,-0.0354695243734794,-0.021063827114723,1.50619397717539e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,29192,-0.0257380984184901,0.00334920862211576,-0.032302547317837,-0.0191736495191432,1.57999717246345e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,-0.0130885752293841,0.00170519160342186,-0.0164307507720909,-0.00974639968667722,1.69576442236762e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,-0.0345009495229987,0.00449756271799921,-0.0433161724502771,-0.0256857265957202,1.76002262738982e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,29478,-0.0154295888158413,0.00201250950050335,-0.0193741074368279,-0.0114850701948548,1.81702270184269e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,29694,-0.0144701070937783,0.00188800047885453,-0.0181705880323332,-0.0107696261552234,1.85359061586385e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,-0.0145062000989325,0.00189625373228651,-0.0182228574142141,-0.010789542783651,2.07245586281163e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,24025,0.0338764788287549,0.004428940629006,0.0251957551959032,0.0425572024616067,2.10318617956742e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,0.0323387036736477,0.00422999793484833,0.0240479077213449,0.0406294996259504,2.16350561319626e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,29166,-0.0377227156784399,0.00493648882071639,-0.0473982337670441,-0.0280471975898358,2.21101016273689e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,24845,-0.0245380150256579,0.00321109613200155,-0.0308317634443809,-0.0182442666069348,2.22223815293748e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,-0.049551234669397,0.00649488445425885,-0.0622812081997443,-0.0368212611390496,2.44762078002777e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,28879,-0.0228527727772013,0.00299912438509523,-0.028731056571988,-0.0169744889824147,2.61817059047833e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,-0.0475639934627046,0.00624896629569023,-0.0598119674022574,-0.0353160195231518,2.79060552493693e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,-0.0485835148448913,0.00638485925610515,-0.0610978389868574,-0.0360691907029252,2.85887155174327e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.0162117045449651,0.00213189774648028,-0.0203902241280665,-0.0120331849618638,2.94748202156174e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.0633631122426584,0.0083331091160446,-0.0796960061101058,-0.047030218375211,2.96170112605185e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,28916,-0.0250807796294658,0.00330232945658316,-0.0315533453643688,-0.0186082138945628,3.17386985883572e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,-0.027180769800347,0.00358144336460831,-0.0342003987949793,-0.0201611408057147,3.31023643783339e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2,Complement C2,29545,-0.0124506963813012,0.00164068911015324,-0.0156664470372016,-0.00923494572540089,3.32642571671537e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,24445,-0.028323564629004,0.00373362295795495,-0.0356414656265957,-0.0210056636314123,3.4147358107522e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,29379,-0.0549312600115031,0.00724606218890022,-0.0691335419017476,-0.0407289781212587,3.53436826912317e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,24229,-0.0265748830036657,0.00350528204609216,-0.0334452358140064,-0.0197045301933251,3.54152249089554e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,29383,-0.0251706219335791,0.00332183022468095,-0.0316814091739537,-0.0186598346932044,3.63100677846341e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0168732733285649,0.00222703819291507,-0.0212382681866784,-0.0125082784704514,3.6526986931766e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,28722,-0.0377972981089339,0.00499058680031816,-0.0475788482375575,-0.0280157479803104,3.73588877668238e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,24867,-0.0408426414618755,0.00539475315297893,-0.0514163576417142,-0.0302689252820368,3.83790449081816e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,-0.0220354699962636,0.0029141905078649,-0.0277472833916788,-0.0163236566008484,4.12854383244992e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,24755,-0.046971527398994,0.00621277264659595,-0.059148561786322,-0.0347944930116659,4.15527122676654e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,24805,-0.0548214973243517,0.00725327265270627,-0.069037911723656,-0.0406050829250474,4.22903984949563e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,24195,-0.0430780643634331,0.00570274337361013,-0.054255441375709,-0.0319006873511572,4.37298991005705e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPTC,Opticin,29349,0.0239171837420817,0.0031717443385074,0.0177005648386072,0.0301338026455562,4.80947001730151e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,29443,0.0153724396069845,0.00204076486169243,0.0113725404780673,0.0193723387359016,5.11326130903443e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,-0.033372861917988,0.00443230742777295,-0.042060184476423,-0.024685539359553,5.27386654301082e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,-0.0439761263755403,0.00584182577632304,-0.0554261048971335,-0.0325261478539472,5.30743146057201e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,-0.0586049080918997,0.00778902812268443,-0.0738714032123612,-0.0433384129714382,5.46557405279791e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,28916,-0.0445449810477544,0.00592401648134733,-0.0561560533511951,-0.0329339087443136,5.66289644235071e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",28774,-0.0285946486099011,0.00380378027803838,-0.0360500579548564,-0.0211392392649459,5.74902436732503e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,29279,-0.0317695926859606,0.0042301677412251,-0.0400607214587617,-0.0234784639131594,6.06989426029842e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,24229,-0.0153379199226667,0.00204219405403741,-0.01934062026858,-0.0113352195767534,6.09313119687155e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,-0.0447296600482707,0.00595944921509433,-0.0564101805098556,-0.0330491395866858,6.2881934136068e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,-0.0314938628418803,0.00419734174245188,-0.039720652657086,-0.0232670730266746,6.39994323796633e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0150672689135985,0.00200870305035209,0.0111302109349084,0.0190043268922886,6.51008607310634e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0238102853679589,0.00317536455570437,0.0175865708387784,0.0300339998971395,6.63918964811831e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,28452,-0.0316733428532186,0.00422942335151788,-0.0399630126221936,-0.0233836730842435,7.1517284399997e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,28916,-0.0234639023971039,0.00313503780664903,-0.029608576498136,-0.0173192282960718,7.39160962562102e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,24111,-0.0208564736014949,0.00279618174672892,-0.0263369898250836,-0.0153759573779063,9.01855001940164e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,24636,-0.0522122937008524,0.00700509824802719,-0.0659422862669857,-0.0384823011347191,9.39109080874079e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,-0.0178676391504417,0.00240247862768195,-0.0225764972606983,-0.0131587810401851,1.06203211425173e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,-0.0122736672713997,0.00165452949922404,-0.0155165450898789,-0.00903078945292063,1.21936403484818e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,-0.027609102716947,0.00373648512461311,-0.0349326135611887,-0.0202855918727053,1.52656322679391e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,28890,-0.0287648502295093,0.00389603696201296,-0.0364010826750547,-0.0211286177839639,1.58813014245637e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,29725,-0.0236835671413328,0.00320908706837024,-0.0299733777953385,-0.0173937564873271,1.62241369511341e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,28931,-0.0341809300781401,0.00463207635358371,-0.0432597997311642,-0.025102060425116,1.63548845481308e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,29623,-0.0305729973007556,0.00414480852821524,-0.0386968220160574,-0.0224491725854537,1.67122202850981e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,-0.0219578055936502,0.00298010463286046,-0.0277988106740567,-0.0161168005132437,1.7856861845142e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,-0.0459286032751129,0.00624133322672965,-0.0581616163995031,-0.0336955901507228,1.91351940885249e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,-0.0314679925001584,0.00427770172329988,-0.0398522878778261,-0.0230836971224906,1.94937443899237e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPL,Periplakin,24229,-0.0169777466392584,0.00230855079385967,-0.0215025061952233,-0.0124529870832934,1.9804349638529e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,29420,-0.0490982083731699,0.00668145247524659,-0.0621938552246532,-0.0360025615216866,2.05757970830044e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,29478,-0.0351810871157508,0.00479450126906561,-0.0445783096031194,-0.0257838646283822,2.22737154753723e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,-0.0612793707891874,0.00835114870188604,-0.077647622244884,-0.0449111193334908,2.23938800517663e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,28669,0.0463859268529627,0.00632604209664667,0.0339868843435353,0.0587849693623902,2.31815352283446e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,-0.0179337332371386,0.00244676129709596,-0.0227293853794466,-0.0131380810948305,2.36833169572194e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,29208,-0.0234255792876951,0.00319603557364946,-0.029689809012048,-0.0171613495633421,2.36871600778375e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,29786,-0.0313464077100814,0.00428710181615726,-0.0397491272697496,-0.0229436881504131,2.70233647851486e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,-0.0476285995513858,0.00651520214681269,-0.0603983957591387,-0.034858803343633,2.73294018257662e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,-0.0166712017661848,0.00228147863722283,-0.0211428998951416,-0.0121995036372281,2.81222853829638e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0317563442945249,0.0043491706413268,-0.0402807187515254,-0.0232319698375243,2.91257604395424e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,-0.0240372387568873,0.00329666935514105,-0.0304987106929637,-0.0175757668208108,3.14742479175359e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,-0.0246289762678563,0.00337853272160082,-0.0312509004021939,-0.0180070521335187,3.19567424723733e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,-0.0242036540095013,0.00332499098763162,-0.0307206363452592,-0.0176866716737433,3.45509096250018e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,29566,-0.03196319780091,0.00439141658477072,-0.0405703743070606,-0.0233560212947594,3.4580110016177e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,29478,-0.0336361093700873,0.00462910083749173,-0.0427091470115711,-0.0245630717286035,3.78833434633476e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,28797,-0.0246359133186908,0.00339750927225529,-0.0312950314923112,-0.0179767951450704,4.23602876978136e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,29786,-0.0212784417962398,0.00293458653596402,-0.0270302314067292,-0.0155266521857503,4.2404130615018e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,29725,-0.0219007349757654,0.0030228078946065,-0.0278254384491941,-0.0159760315023367,4.42426722858368e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0123429124933561,0.00170409300578583,0.00900289020201583,0.0156829347846963,4.49308770473898e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,24101,-0.03272748051083,0.00452147843017978,-0.0415895782339824,-0.0238653827876776,4.68215422507598e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,24720,0.0143585734643213,0.00198490342987518,0.0104681627417659,0.0182489841868766,4.83026197497717e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,-0.01437533757457,0.00198814924631739,-0.0182721100973521,-0.0104785650517879,4.95440153261077e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,-0.0589639407021547,0.00815939868541378,-0.0749563621255658,-0.0429715192787437,5.0766657281917e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,-0.0434638233165305,0.00601604152240797,-0.0552552647004501,-0.0316723819326108,5.16851884250565e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,29536,-0.0438946091654945,0.0060855200930114,-0.0558222285477968,-0.0319669897831921,5.60656068312726e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,29395,-0.0203871889511116,0.0028271955232583,-0.0259284921766979,-0.0148458857255253,5.6841839833499e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,-0.0352022586530846,0.00488256586799597,-0.0447720877543567,-0.0256324295518124,5.76920335259416e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,-0.017847106454098,0.00247912239275008,-0.0227061863438881,-0.0129880265643078,6.21524465535433e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,-0.0322489846140966,0.00448390224719235,-0.0410374330185936,-0.0234605362095996,6.53267958317783e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,24793,-0.0342976408633808,0.00477282343438012,-0.0436523747947658,-0.0249429069319957,6.85907067024634e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,-0.0428467085095512,0.0059640772308722,-0.0545362998820608,-0.0311571171370417,6.9243063861629e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,-0.0295882523986424,0.00411980255090316,-0.0376630653984126,-0.0215134393988722,7.06584503186525e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,24016,-0.0284344283480062,0.00396127774912429,-0.0361985327362898,-0.0206703239597226,7.2745815178951e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,29349,0.0386639282619321,0.00539647674573963,0.0280868338402824,0.0492410226835818,7.98170816822466e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,-0.0127381044708078,0.00177855201511373,-0.0162240664204307,-0.00925214252118486,8.13275249234559e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,-0.015855429134073,0.00222002432454743,-0.0202066768101859,-0.01150418145796,9.41500967371228e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,24805,-0.0155233488805683,0.00217417661699491,-0.0197847350498783,-0.0112619627112583,9.59906804230084e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,29478,-0.022757933196097,0.00319044511767372,-0.0290112056267375,-0.0165046607654565,1.00357400437868e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,-0.0166220933879725,0.00233421905409992,-0.0211971627340083,-0.0120470240419366,1.0959121119456e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,28774,-0.0185059073293718,0.00260069448579779,-0.0236032685215355,-0.0134085461372081,1.13905698646674e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,24195,-0.0342606888639256,0.00482431130999461,-0.0437163390315151,-0.0248050386963362,1.26664572992987e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0188212146086454,0.00265382588243981,0.0136197158790634,0.0240227133382275,1.35134235702983e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,28931,-0.0250650193306479,0.00354128272835909,-0.0320059334782317,-0.0181241051830641,1.49637061634911e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,29640,-0.0345389331455498,0.00488363079349951,-0.0441108495008088,-0.0249670167902908,1.55665343223851e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,-0.0484238805037059,0.0068785743534696,-0.0619058862365063,-0.0349418747709055,1.97505368987059e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,29349,-0.0667216557372197,0.00948105299574538,-0.0853045196088807,-0.0481387918655588,2.00206045185817e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,-0.0590115700092588,0.00839400646778532,-0.075463822686118,-0.0425593173323996,2.11672340694498e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0144270065750677,0.00205254155244656,-0.018449988017863,-0.0104040251322725,2.12785125906758e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,24229,-0.0316869353354499,0.00450945991348479,-0.0405254767658801,-0.0228483939050197,2.1696931051444e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,-0.0335295876813138,0.00477925446449262,-0.0428969264317193,-0.0241622489309083,2.34849645357723e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,-0.0260519256384506,0.00371412464891268,-0.0333316099503194,-0.0187722413265817,2.36234440513019e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELL,L-selectin,24966,0.0114769030059545,0.00163687663208113,0.00826862480707546,0.0146851812048335,2.41844112474338e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,-0.0201090281432661,0.00287006014923856,-0.0257343460357736,-0.0144837102507585,2.49678895626653e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,24793,-0.0349155372036725,0.00498596175432487,-0.0446880222421493,-0.0251430521651958,2.57359897585811e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,-0.0390906059085179,0.00558556463693845,-0.0500383125969173,-0.0281428992201186,2.65276075699002e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,-0.0214978826795157,0.00307795991227626,-0.0275306841075772,-0.0154650812514542,2.92167601245099e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,28774,-0.0333007408329437,0.00477082142612122,-0.0426515508281413,-0.0239499308377461,3.01396898134821e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,-0.0361388196804199,0.0051855391521923,-0.0463024764187168,-0.025975162942123,3.26797848220716e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALB1,Calbindin,29349,-0.021363975818462,0.00306752771999943,-0.0273763301496609,-0.0153516214872632,3.36375498428552e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,24845,-0.0411679458890283,0.00592063474750673,-0.0527723899941415,-0.0295635017839151,3.65679239963677e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,-0.0283925362628253,0.00408474775842836,-0.0363986418693449,-0.0203864306563057,3.70672398623524e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,-0.013693494170411,0.00197449924665487,-0.0175635126938545,-0.00982347564696745,4.14042298444219e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,-0.0157991548549558,0.00227876464387652,-0.0202655335569538,-0.0113327761529578,4.21437964319447e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,-0.0332476749026699,0.00480269573315841,-0.0426609585396604,-0.0238343912656794,4.53856110643897e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAT,Catalase,24587,-0.0261469449178349,0.00378051437012869,-0.0335567530832872,-0.0187371367523827,4.75154699712623e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,28774,-0.0238332437642597,0.00344998437061673,-0.0305952131306685,-0.0170712743978509,5.00993389807974e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.023814931246886,0.00344722920033421,0.0170583620142309,0.030571500479541,5.02145395157567e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,-0.0369207006563445,0.00535668473356663,-0.0474198027341351,-0.0264215985785539,5.59397162951208e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,24229,0.0147188268931884,0.00213669912096449,0.010530896616098,0.0189067571702788,5.77308809198883e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,-0.0272073547840915,0.00395911670251047,-0.0349672235210121,-0.019447486047171,6.45380163012974e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.0166008518328254,0.00241699285347537,-0.0213381578256371,-0.0118635458400137,6.62121726338874e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,-0.0347993689335654,0.00507079690299814,-0.0447381308634418,-0.0248606070036891,6.89028567565534e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,0.0552421387532054,0.00805093011477324,0.0394623157282498,0.0710219617781609,6.94594072060449e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0190702357211536,0.00278256510736187,0.0136164081107243,0.0245240633315828,7.34977525383787e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,24845,-0.0659715690615948,0.00962607677810702,-0.0848386795466846,-0.0471044585765051,7.37902733480619e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,-0.0319272704015951,0.00467386178359087,-0.0410880394974332,-0.022766501305757,8.62543420417404e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,-0.038484359201273,0.00565015672057777,-0.0495586663736055,-0.0274100520289406,9.90523370634008e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,29039,-0.0328303514269031,0.00482584221660484,-0.0422890021714486,-0.0233717006823576,1.04428846474939e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,28916,-0.0639601129545274,0.00940520750060128,-0.082394319655706,-0.0455259062533489,1.06285496534824e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,24793,-0.0185925070166525,0.0027338383427546,-0.0239508301684515,-0.0132341838648535,1.06345886507073e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,-0.0158246450023052,0.00233123353689272,-0.0203938627346149,-0.0112554272699955,1.15776467200012e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,-0.0238062451249149,0.00351090842228137,-0.0306876256325864,-0.0169248646172434,1.22330160328801e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,28674,-0.0213534266312952,0.00315017571734,-0.0275277710372817,-0.0151790822253088,1.23793436883855e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,-0.0385531845043389,0.00569939220966192,-0.0497239932352762,-0.0273823757734015,1.36874956197703e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,29566,-0.0103637229257027,0.00153270097031649,-0.013367816827523,-0.00735962902388236,1.38882182596979e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSPN,Persephin,29434,-0.0445171864704247,0.00659345928090159,-0.0574403666609918,-0.0315940062798576,1.4881757192785e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,-0.0709971397964702,0.0105250299357756,-0.0916261984705904,-0.05036808112235,1.55267907318889e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,29725,-0.0099878748198446,0.00148646109152192,-0.0129013385592276,-0.00707441108046164,1.85983589840146e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,-0.041850189681115,0.00623899833937058,-0.0540786264262813,-0.0296217529359486,2.0175940817796e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,24845,-0.0471056194164215,0.00702255715440516,-0.0608698314390556,-0.0333414073937874,2.01881885751043e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,24229,-0.0124417026588979,0.00186432930313343,-0.0160957880930394,-0.00878761722475634,2.55072572266218e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,-0.0412587320100352,0.00618410975129307,-0.0533795871225696,-0.0291378768975008,2.58124229336375e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,24922,-0.030711186272143,0.00460427708048446,-0.0397355693498926,-0.0216868031943935,2.60906705756207e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,-0.0359429863848878,0.00539380649574425,-0.0465148471165466,-0.0253711256532291,2.72685491501598e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",24966,-0.00780389134695676,0.00117170053770094,-0.0101004244008506,-0.00550735829306292,2.78926037078709e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,24381,-0.0155333971666094,0.00233448316478235,-0.0201089841695828,-0.010957810163636,2.91497180570656e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,28797,-0.0271432182106117,0.00408026510087555,-0.0351405378083277,-0.0191458986128956,2.93681549047177e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,28774,-0.0332912300184286,0.00500832688588894,-0.043107550714771,-0.0234749093220863,3.04109235686085e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,-0.0353908983146073,0.00533139340896409,-0.0458404293961769,-0.0249413672330377,3.24173330312704e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,0.0164763452123196,0.0024840683231604,0.0116075712989253,0.021345119125714,3.36301312373285e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,24101,-0.0205154275441413,0.0030961648386982,-0.0265839106279898,-0.0144469444602928,3.51999837742372e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,-0.0329532490816564,0.00498831289847748,-0.0427303423626723,-0.0231761558006406,4.02712275202551e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,-0.0138746674787714,0.00210303568504874,-0.0179966174214669,-0.00975271753607589,4.25330060855782e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,24240,-0.0198750551001224,0.0030146964650263,-0.0257838601715739,-0.0139662500286708,4.40717170599633e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,-0.0438533636998489,0.006655470389146,-0.0568980856625751,-0.0308086417371228,4.51467170226516e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,-0.0117739261370342,0.00178719092984938,-0.015276820359539,-0.00827103191452942,4.5336754564974e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,28706,-0.0349202745001285,0.00531201445179435,-0.0453318228256454,-0.0245087261746115,4.98783852759884e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,28931,-0.0133878006982716,0.00203664988698059,-0.0173796344767535,-0.0093959669197896,5.00013159376484e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0223069620588487,0.00339450666101683,-0.0289601951144417,-0.0156537290032557,5.06464012038579e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,-0.014069801855972,0.0021423080073738,-0.0182687255504247,-0.0098708781615194,5.21523931731993e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,-0.0225477663055819,0.00343496868243398,-0.0292803049231525,-0.0158152276880113,5.33525575287242e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,-0.0159095402215377,0.00242698991391165,-0.0206664404528046,-0.0111526399902709,5.64574369029692e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNC,Tenascin,29594,0.0219569103311484,0.00335414793474994,0.0153827803790385,0.0285310402832582,5.99862919870819e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,-0.0172459608814891,0.00263990389943643,-0.0224201725243845,-0.0120717492385937,6.56044792656344e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,-0.0382461891095608,0.00586173318404714,-0.0497351861502932,-0.0267571920688284,6.92279064368197e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.0478221011625384,0.00733305137411307,-0.0621948818558,-0.0334493204692768,7.07589865996095e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOC,Myocilin,29443,0.0208748283093346,0.00320506687068154,0.0145928972427988,0.0271567593758704,7.48160695822336e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,24381,-0.0178169636794197,0.00273813316435482,-0.0231837046815551,-0.0124502226772842,7.81681432136826e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0194183837478944,0.00299177268152057,0.0135545092921141,0.0252822582036747,8.68508678518697e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,24805,-0.0275505117060592,0.00424967606045706,-0.035879876784555,-0.0192211466275633,9.16272404159465e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,-0.0166047346436976,0.00256295635879043,-0.0216281291069269,-0.0115813401804684,9.42754127080058e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,29349,-0.0340407252263016,0.00525829752343072,-0.0443469883722258,-0.0237344620803774,9.71307802637169e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,-0.0254954734484512,0.00393869626503736,-0.0332153181279245,-0.017775628768978,9.7844634128279e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,29373,-0.0302762493661645,0.00468102752541506,-0.039451063315978,-0.021101435416351,1.00959914914783e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,-0.0174916850844724,0.00270672541341364,-0.0227968668947632,-0.0121865032741817,1.05031927825989e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,-0.0235867415728881,0.00365105768004897,-0.0307428146257841,-0.0164306685199921,1.0619197548192e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,-0.0342020364084593,0.00529924873449543,-0.0445885639280703,-0.0238155088888482,1.10883988749444e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,29218,0.0152900757691209,0.00237052663209704,0.0106438435702107,0.0199363079680311,1.13541596006047e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,0.0204620033429581,0.00317289658950114,0.0142431260275359,0.0266808806583804,1.14331543592468e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,29820,0.0137286932612071,0.00213315160011581,0.00954771612498011,0.0179096703974341,1.24628834951962e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,-0.0479790167926766,0.00746974693189163,-0.0626197207791842,-0.033338312806169,1.35973401081502e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,29343,-0.0489642590962648,0.00763020227084276,-0.0639194555471166,-0.0340090626454129,1.40953748385019e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.0117454212387168,0.0018332870595503,-0.0153386638754354,-0.00815217860199822,1.51301709854863e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,24195,-0.0308635890952092,0.00482015876532724,-0.0403111002752506,-0.0214160779151678,1.55127215885993e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,28797,-0.030262082848932,0.00472693919527701,-0.0395268836716749,-0.020997282026189,1.55669037880534e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,24922,-0.0241475339080697,0.00377306893333534,-0.0315427490174069,-0.0167523187987324,1.5817055422041e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,24381,-0.0129379557325351,0.00202258924194306,-0.0169022306467435,-0.00897368081832674,1.61621875822378e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,24805,-0.0193011293272024,0.00302330666165633,-0.0252268103840488,-0.013375448270356,1.75446021150924e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,-0.0241384071670649,0.00378907950376071,-0.0315650029944359,-0.0167118113396939,1.91694958806212e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,24381,0.00968378214811697,0.00152250438600315,0.0066996735515508,0.0126678907446831,2.04761069924066e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,-0.0299842182474212,0.00471484248767518,-0.0392253095232645,-0.0207431269715778,2.06006756506225e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,29349,-0.0366555449209981,0.00578208197197795,-0.0479884255860749,-0.0253226642559214,2.33852868028612e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,24711,-0.021625481852023,0.00341141940285517,-0.0283118638816192,-0.0149390998224269,2.35036478279022e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,29536,-0.0140143267630464,0.00221345981692869,-0.0183527080042266,-0.00967594552186617,2.46417928388513e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,-0.0213171622182396,0.00336672659905917,-0.0279159463523956,-0.0147183780840836,2.46594526006301e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,-0.0269949673838578,0.00426344944473721,-0.0353513282955428,-0.0186386064721729,2.46670622526538e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,-0.0188053162925712,0.00297639050316568,-0.0246390416787759,-0.0129715909063664,2.68573424983242e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,29434,0.011763205601568,0.00186191043713919,0.00811386114477518,0.0154125500583608,2.69080523162127e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,-0.00993336894753463,0.00157310907276533,-0.0130166627301547,-0.00685007516491459,2.75655636671175e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,24805,-0.0306418155028906,0.00485415191401493,-0.0401559532543599,-0.0211276777514214,2.79219072877045e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,-0.0435332968288333,0.00689838096593642,-0.0570541235220687,-0.0300124701355979,2.81901684437301e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,-0.00889403735210194,0.00141078853587789,-0.0116591828824226,-0.00612889182178128,2.94363510158379e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,29688,-0.0412452568093809,0.00655787892151436,-0.0540986994955491,-0.0283918141232128,3.23091294468061e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,24951,0.0108765772958333,0.00173450080144114,0.00747695572500868,0.014276198866658,3.65263925670163e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,24240,-0.0131768054229983,0.0021078297605871,-0.017308151753749,-0.00904545909224758,4.13676438225538e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,-0.0189200181696611,0.00302894990148379,-0.0248567599765693,-0.0129832763627529,4.25877321812148e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,29820,-0.038551097478777,0.0061734798644476,-0.0506511180130943,-0.0264510769444597,4.30530979817357e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,-0.00953787090230363,0.00152826491752007,-0.012533270140643,-0.0065424716639643,4.40780343612657e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,-0.0160840479707292,0.00257741574106981,-0.021135782823226,-0.0110323131182324,4.43684205304674e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,-0.0360889319263707,0.0057836148469026,-0.0474248170262998,-0.0247530468264416,4.43933863792176e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,29466,-0.0174601980918192,0.0028044063913379,-0.0229568346188415,-0.0119635615647969,4.84985840487854e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,29694,-0.0130587474258626,0.00209939268078008,-0.0171735570801916,-0.00894393777153369,5.02980384090717e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,24776,-0.0413956756800605,0.00666127199468913,-0.0544517687896512,-0.0283395825704698,5.23489376126168e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,-0.0241130611853893,0.00388720335865321,-0.0317319797683496,-0.0164941426024291,5.62049784561052e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,-0.0233341505909295,0.00376385703349429,-0.0307113103765783,-0.0159569908052807,5.75203213141497e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,29594,-0.0203010828053345,0.00327505191412731,-0.026720184557024,-0.013881981053645,5.76806040516427e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,29443,-0.0527060901070379,0.0085040813132525,-0.0693740894810128,-0.036038090733063,5.80387091332286e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,29434,-0.02948165117685,0.00475849890488001,-0.0388083090304148,-0.0201549933232851,5.88404768729667e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,0.0220180868516439,0.00355631543844591,0.0150477085922899,0.0289884651109979,6.06200498446067e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,29786,0.0172066288894225,0.00277961012040547,0.0117585930534278,0.0226546647254173,6.08317284578636e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.0210166055244777,0.00339700128151324,-0.0276747280362437,-0.0143584830127118,6.23763872413548e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0304566985539713,0.00492722186941975,-0.040114053418034,-0.0207993436899086,6.45571123420682e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,0.0296725013476743,0.0048022518412552,0.0202600877388141,0.0390849149565345,6.55642951434452e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,-0.0307642416470221,0.00499642306563891,-0.0405572308556744,-0.0209712524383698,7.51484151941169e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,24938,-0.0235824353380683,0.00383692541987811,-0.0311028091610294,-0.0160620615151072,8.05744742591988e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,24445,-0.0321206433291134,0.00523648054612403,-0.0423841451995165,-0.0218571414587103,8.70044508502045e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,-0.0262089717395729,0.0042781875763773,-0.0345942193892725,-0.0178237240898734,9.11595350053303e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,-0.0108258867595918,0.00177132211763273,-0.0142976781101519,-0.00735409540903161,1.00036487065838e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,-0.0317672474199327,0.0051988495715252,-0.0419569925801221,-0.0215775022597433,1.00860366402316e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,-0.0463974931276289,0.00760175299249984,-0.0612969289929286,-0.0314980572623292,1.0529367385442e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,-0.0428126410706882,0.00701518007806588,-0.0565623940236973,-0.029062888117679,1.05729850849188e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,-0.0354966816402566,0.00583156081292127,-0.0469265408335823,-0.0240668224469309,1.16767485623381e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,28931,-0.0213356582358356,0.00352113396528896,-0.028237080807802,-0.0144342356638693,1.38390746835073e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,-0.0287249018355728,0.00474098941067242,-0.0380172410804907,-0.0194325625906548,1.38805968658086e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,-0.0190747697209669,0.00315609747423175,-0.0252607207704611,-0.0128888186714726,1.5235533336066e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,24922,-0.030562014586175,0.00505896874126389,-0.0404775933190522,-0.0206464358532977,1.55184414959744e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,-0.0400929029667352,0.00665333875549787,-0.053133446927511,-0.0270523590059594,1.70079207430507e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,28774,-0.0258920550103631,0.00431092004211246,-0.0343414582929036,-0.0174426517278227,1.9225276006168e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,24951,-0.0386749902453265,0.00644792330223811,-0.0513129199177132,-0.0260370605729398,2.02446307442355e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,-0.0346453859437508,0.00577861659432367,-0.0459714744686252,-0.0233192974188764,2.05274452382314e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,28774,-0.0141127291369469,0.00235579716177103,-0.0187300915740181,-0.00949536669987565,2.11500391977947e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0206562785918027,0.00345348605690505,-0.0274251112633365,-0.0138874459202688,2.23931533957707e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,-0.0220751704066729,0.00370029164123389,-0.0293277420234913,-0.0148225987898544,2.46829265711966e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,29456,0.0267544304537214,0.0044891126951774,0.0179557695711737,0.0355530913362691,2.55341484369758e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,-0.0260198880493383,0.00437317629190459,-0.0345913135814713,-0.0174484625172054,2.7202651090853e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,-0.0108677028325914,0.00183038415065584,-0.0144552557678768,-0.00728014989730593,2.92853368058412e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,-0.0340085780178454,0.00573191546112266,-0.0452431323216458,-0.022774023714045,3.00413862489136e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,-0.0415402727516123,0.00701453428751378,-0.0552887599551393,-0.0277917855480853,3.22307347506128e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,-0.0441905770451128,0.00747998128175689,-0.0588513403573563,-0.0295298137328693,3.51126839854306e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,28774,0.0306930595739807,0.00520354605105449,0.0204941093139139,0.0408920098340475,3.70944112557657e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,28931,-0.03404276711348,0.00577317743176139,-0.0453581948797323,-0.0227273393472277,3.74931063834586e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,29218,-0.0177478421438885,0.00301173078147987,-0.023650834475589,-0.0118448498121879,3.83625210353262e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,28774,-0.0148580491948346,0.00252232193780611,-0.0198018001929346,-0.00991429819673461,3.8901736761093e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,-0.0102333247340863,0.00173847932476301,-0.0136407442106218,-0.00682590525755081,3.99038558186307e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,-0.0166075286075317,0.00282122378982755,-0.0221371272355937,-0.0110779299794697,3.99201067761447e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,28931,-0.0233202584165157,0.00396219636953986,-0.0310861633008139,-0.0155543535322176,4.00765016604573e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,-0.0282748450312161,0.00480665047629226,-0.0376958799647489,-0.0188538100976832,4.09575798947025e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,24240,-0.0487271422928695,0.00828973974969607,-0.0649750322022738,-0.0324792523834652,4.20675381830233e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,29443,-0.0370077978691286,0.0063087950010729,-0.0493730360712315,-0.0246425596670258,4.51028862546926e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,-0.0252981477175227,0.00431468540372128,-0.0337549311088164,-0.0168413643262289,4.59747374513098e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,-0.0137695799435637,0.00235271190109775,-0.0183808952697153,-0.00915826461741213,4.89043025837008e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,29293,-0.0230075672648257,0.00393512948920075,-0.0307204210636592,-0.0152947134659922,5.06701465153067e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,-0.0360825448748128,0.00618697777036767,-0.0482090213047334,-0.0239560684448921,5.54416603354782e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,-0.0271277272729229,0.00465426599336178,-0.036250088619912,-0.0180053659259339,5.65007811891925e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",24445,-0.018838236453285,0.0032375870930029,-0.0251839071555706,-0.0124925657509993,6.00817894428084e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,-0.016823134084632,0.002893478698949,-0.022494352334572,-0.0111519158346919,6.16893128381629e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LXN,Latexin,29117,0.0274275438815799,0.00472201578908118,0.0181723929349808,0.036682694828179,6.37133043242002e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,29478,-0.010716388424676,0.00184898536612979,-0.0143403997422904,-0.00709237710706162,6.86799146219683e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,-0.0357533598592768,0.006174700130659,-0.0478557721153684,-0.0236509476031851,7.11102095473351e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,-0.0238692509631791,0.00412901714618824,-0.031962124569708,-0.0157763773566501,7.52360535698042e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,-0.0122383090540175,0.00212619106129483,-0.0164056435341554,-0.00807097457387964,8.71544852177293e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,-0.0176998776457406,0.00307681046763471,-0.0237304261623046,-0.0116693291291765,8.88781556935212e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,-0.0395673369828724,0.00687983554440228,-0.0530518146499009,-0.026082859315844,8.94940683841575e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,24920,-0.0149350529511843,0.00259846195433499,-0.0200280383816809,-0.0098420675206877,9.15474559817325e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,28774,-0.0293634620007687,0.00511078906356614,-0.0393806085653583,-0.0193463154361791,9.2635470101273e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,-0.0340971268841523,0.00595667670452063,-0.0457722132250127,-0.0224220405432918,1.04962614017477e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,28774,-0.0179356317382825,0.00313489020831549,-0.0240800165465808,-0.0117912469299841,1.06763566236088e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,24623,0.0168938867939667,0.00295268021142527,0.0111066335795732,0.0226811400083603,1.06785484534114e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0123824931248097,0.00216461014531206,-0.0166251290096213,-0.00813985723999804,1.07304993126711e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,0.0187520802243263,0.00328633806513396,0.0123108576166637,0.0251933028319888,1.16722556318503e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,-0.0280210195097449,0.00492006131396732,-0.0376643396851208,-0.0183776993343689,1.24599155991472e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,-0.038462923978625,0.00675990135743655,-0.0517123306392007,-0.0252135173180494,1.2857266804751e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,-0.0208880752351431,0.00367617694892211,-0.0280933820550304,-0.0136827684152558,1.34363351974522e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,29434,-0.0244734335023734,0.00430900326657714,-0.0329190799048646,-0.0160277870998822,1.36278622327334e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,-0.0251789735087782,0.00443296606198585,-0.0338675869902704,-0.0164903600272859,1.36286649629631e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,29283,-0.0153233942581433,0.00269830008472808,-0.0206120624242103,-0.0100347260920763,1.36841560438743e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,-0.0189443692707282,0.00333720639230766,-0.0254852937996512,-0.0124034447418052,1.38835394648573e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,29757,0.0183726820581752,0.00323818909213839,0.0120258314375839,0.0247195326787664,1.40999876562828e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,28650,-0.0121448988551716,0.00214165760308016,-0.0163425477572087,-0.00794724995313449,1.43504913595049e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,24281,-0.0171025488234691,0.00302305304205633,-0.0230277327858995,-0.0111773648610387,1.55434811379078e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,29497,-0.0118087975510057,0.00208939036039833,-0.0159040026573864,-0.00771359244462497,1.60249033087247e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,-0.0144358240163448,0.00255447256206158,-0.0194425902379855,-0.00942905779470405,1.61074486198169e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,-0.0293023114836386,0.00518662271257755,-0.0394680920002906,-0.0191365309669866,1.62345795058751e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,24111,-0.0239917016755627,0.00424711719434448,-0.0323160513764779,-0.0156673519746475,1.63261770094353e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,-0.029060604307288,0.00514627265303377,-0.0391472987072342,-0.0189739099073418,1.64884453798086e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,-0.00812788117837401,0.00144082946208939,-0.0109519069240692,-0.00530385543267881,1.70839685072774e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,-0.0249096026478403,0.00441671256255118,-0.0335663592704406,-0.0162528460252399,1.71754725442821e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,-0.0244752143330214,0.00434073337002334,-0.0329830517382671,-0.0159673769277756,1.73139510872151e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,24111,0.0142602895518609,0.00253133581251286,0.00929887135933567,0.0192217077443861,1.78554005995999e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,-0.0193543309333209,0.00344292364322124,-0.0261024612740345,-0.0126062005926073,1.91037932095877e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,-0.0178125700588716,0.00316868810508752,-0.0240231987448432,-0.0116019413729001,1.91473496433894e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,24229,-0.0212359032964414,0.00378869611718229,-0.0286617476861187,-0.0138100589067641,2.10436916117351e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,-0.029991307333126,0.00535864464727383,-0.0404942508417827,-0.0194883638244693,2.2031938038835e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,-0.0166670949321882,0.00298217158371005,-0.0225121512362599,-0.0108220386281165,2.30553542063102e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,29694,0.0117720508645297,0.0021081651558254,0.00764004715911196,0.0159040545699475,2.37066443167362e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,24951,0.0236568484714583,0.00424230597869943,0.0153419287532074,0.0319717681897091,2.48071558893538e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,-0.0494451108971296,0.00886814718104652,-0.0668266793719808,-0.0320635424222784,2.49311994673367e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,28916,-0.0191460272475802,0.00343495305070431,-0.0258785352269606,-0.0124135192681997,2.51343165575872e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,24867,-0.0108045447042999,0.00193845487320746,-0.0146039162557865,-0.00700517315281325,2.51837927668941e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,24793,-0.0175904864811844,0.00316025994956708,-0.0237845959823359,-0.0113963769800329,2.63120920056838e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,-0.022157842755826,0.00398828664427848,-0.0299748845786118,-0.0143408009330401,2.79358887945436e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,-0.0170032846502865,0.0030611126978863,-0.0230030655381436,-0.0110035037624293,2.80680233294508e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,-0.0152869004940841,0.00275820960289011,-0.0206929913157487,-0.00988080967241948,3.01078428788499e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,24938,-0.0323968570814595,0.00585507139002443,-0.0438727970059074,-0.0209209171570117,3.17731896385873e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,-0.0193606591626832,0.00350001440697187,-0.0262206874003481,-0.0125006309250183,3.20611431004566e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,29301,-0.0258403369598837,0.00467431862752522,-0.0350020014698331,-0.0166786724499343,3.26380825285374e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,-0.0356729979205115,0.00646211846586283,-0.0483387501136026,-0.0230072457274204,3.41839696819051e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,24111,-0.0478625782947714,0.00867318632148177,-0.0648620234848756,-0.0308631331046671,3.45514202310087e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,0.00796218417214659,0.00144329114464263,0.00513333352864704,0.0107910348156461,3.49001724706594e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,24845,0.014535770227276,0.00263560832680012,0.00936997790674779,0.0197015625478043,3.51957545982142e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,-0.0283717578613458,0.00514898337811303,-0.0384637652824473,-0.0182797504402442,3.61459286837751e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,-0.0188011845287778,0.0034138089194866,-0.0254922500109715,-0.0121101190465841,3.6789344007971e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,-0.0186805090076112,0.00339934843710115,-0.0253432319443295,-0.012017786070893,3.93288928143271e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,28867,-0.0230884897061039,0.00420326845998928,-0.0313268958876828,-0.0148500835245249,3.98529908190354e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,-0.0153799228861081,0.0028023840775847,-0.0208725956781742,-0.00988725009404212,4.10125096961663e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,24647,-0.0169630326009054,0.00309667024197921,-0.0230325062751846,-0.0108935589266261,4.34784477342488e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,24016,-0.0139312626010565,0.00254567414721769,-0.0189207839296031,-0.00894174127250977,4.48107292111911e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,-0.0296379070682517,0.00541594707138884,-0.0402531633281739,-0.0190226508083296,4.48570568912973e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,-0.0134825349194426,0.00247176440001799,-0.0183271931434778,-0.00863787669540731,4.95537269063996e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,-0.0157768757179126,0.00289305547290399,-0.0214472644448044,-0.0101064869910208,4.98331928050229e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,-0.0303994759616382,0.0055764054223482,-0.0413292305894407,-0.0194697213338358,5.03718502174213e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,-0.0155586131133927,0.00286034186945698,-0.0211648831775284,-0.00995234304925702,5.39704111594176e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,-0.0149092883693729,0.00274172918500906,-0.0202830775719907,-0.00953549916675513,5.43378517076835e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,29443,-0.0105086753955926,0.00193331905000786,-0.014297980733608,-0.0067193700575772,5.50575619726529e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,-0.0369789062453388,0.00680873878127591,-0.0503240342566396,-0.023633778234038,5.64522611662111e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,-0.0261675469915353,0.00482216261852058,-0.0356189857238357,-0.016716108259235,5.80182008440601e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,-0.0154987458173455,0.00286174596861156,-0.0211077679158241,-0.00988972371886683,6.14815598630518e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.026799956118924,0.00495091400986585,-0.0365037475782611,-0.017096164659587,6.25050644835313e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,-0.019199694121199,0.00355537989353642,-0.0261682387125304,-0.0122311495298676,6.71005217383665e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,29786,-0.029400058926967,0.00545291101564386,-0.040087764517629,-0.018712353336305,7.03535801347362e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,28931,-0.0109160329419784,0.00202666217637229,-0.0148882908076681,-0.0069437750762887,7.25189403745331e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,29163,-0.0285876752464669,0.00530913306936161,-0.0389935760624156,-0.0181817744305181,7.31578467554542e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,-0.033156697279236,0.00616396037604671,-0.0452380596162875,-0.0210753349421844,7.55392196174401e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,-0.0204662546896069,0.00380497294269661,-0.0279240016572922,-0.0130085077219215,7.55498313053215e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,24195,-0.0192562367997262,0.00358676116799946,-0.0262862886890052,-0.0122261849104473,8.00377470089048e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,24966,-0.0275277678605727,0.00512766125545272,-0.03757798392126,-0.0174775517998854,8.01098358774538e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,29757,-0.0113105559386092,0.0021074520773346,-0.015441162010185,-0.00717994986703343,8.06849973659527e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,24793,-0.0307766833799341,0.00573897808243833,-0.0420250804215132,-0.019528286338355,8.26997001496868e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,-0.00910499264044599,0.00169840883452256,-0.0124338739561102,-0.00577611132478177,8.34351663982426e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,-0.0246504279944472,0.00460530041571684,-0.0336768168092522,-0.0156240391796422,8.73489008464341e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,0.026584631413117,0.00497740163756208,0.0168289242034953,0.0363403386227387,9.32152076250078e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,24381,-0.0358167287929281,0.00670643673639652,-0.0489613447962653,-0.0226721127895909,9.34436492031263e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,24938,0.0187329156309035,0.00351863246721552,0.011836395995161,0.0256294352666459,1.02433369221552e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,-0.0263702248562255,0.00495620518538285,-0.0360843870195759,-0.0166560626928751,1.04296655382767e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,-0.00980206847108184,0.00184268124245346,-0.0134137237062906,-0.00619041323587305,1.04972762403131e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,28797,-0.0163466145217969,0.00307839051758925,-0.0223802599362718,-0.010312969107322,1.10366716682809e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,-0.020035489844382,0.00377927782973159,-0.027442874390656,-0.0126281052981081,1.15759876056578e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBN1,Drebrin,24229,-0.0192052560528263,0.00362377985860758,-0.0263078645756971,-0.0121026475299554,1.16953061297085e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,24938,-0.0327919500281195,0.00618873707013004,-0.0449218746855743,-0.0206620253706646,1.17652825232192e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,-0.00780097903448275,0.00147362221060567,-0.0106892785672699,-0.00491267950169564,1.20698059756888e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F3,Tissue factor,29541,0.0101179407453372,0.00191906387662699,0.00635657554714832,0.0138793059435261,1.35648069279233e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,28931,-0.0176373654501837,0.00334545749760851,-0.0241944621454963,-0.011080268754871,1.35888015955903e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,0.011144193213583,0.00211432298686196,0.00700012015933354,0.0152882662678324,1.36959620653906e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,24805,-0.0165912554597239,0.00315094890394364,-0.0227671153114534,-0.0104153956079943,1.40989208724916e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,-0.0102249221350929,0.00194229090455741,-0.0140318123080254,-0.00641803196216035,1.41842706199433e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,29349,-0.0314274792020646,0.00600384522636796,-0.0431950158457458,-0.0196599425583834,1.66517188531616e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,-0.0137538482706575,0.00263127998856297,-0.0189111570482409,-0.00859653949307404,1.73625141198205e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,24111,-0.0141914072936951,0.0027150589527868,-0.0195129228411572,-0.00886989174623294,1.73789037189155e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,-0.021347990402331,0.0040901984590647,-0.0293647793820978,-0.0133312014225642,1.80835582704288e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,-0.0302827691330887,0.00580484597334565,-0.0416602672408462,-0.0189052710253312,1.83495307163353e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,29454,-0.0131573887906709,0.002526762939471,-0.0181098441520341,-0.00820493342930777,1.92987072628895e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,24069,-0.0360426086401792,0.00694420385303581,-0.0496532481921294,-0.022431969088229,2.11643049187967e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLG,Plasminogen,24421,-0.00811936144272926,0.00156454460676596,-0.0111858688719905,-0.00505285401346798,2.12431607713789e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,-0.021117638620989,0.00407088171379495,-0.0290965667800271,-0.0131387104619509,2.14595735900768e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,29478,-0.0246069204375744,0.00474503256449073,-0.0339071842639763,-0.0153066566111726,2.16478049201016e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,-0.0140460736977091,0.00270961944388963,-0.0193569278077328,-0.00873521958768546,2.19137419917824e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,24938,-0.0158402161593309,0.00306564591510422,-0.0218488821529352,-0.00983155016572659,2.39703403186456e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,-0.0315021951895298,0.00609890869829814,-0.0434560562381941,-0.0195483341408654,2.42059759219356e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,29581,-0.00758598615753521,0.00147814170317897,-0.010483143895766,-0.00468882841930442,2.88322596752945e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,28757,-0.0393853319945881,0.00770448099225813,-0.054486114739414,-0.0242845492497622,3.20801777086533e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,-0.013465494940855,0.00264573156815418,-0.0186511288144372,-0.00827986106727285,3.61661309163507e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLU,Clusterin,24966,0.0113865827530135,0.00224016534096713,0.00699585868471798,0.0157773068213091,3.74358055784481e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,-0.0269496943726871,0.00530765563803274,-0.0373526994232313,-0.016546689322143,3.84788278984501e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,24793,-0.0184266302794504,0.00363430163512317,-0.0255498614842918,-0.011303399074609,4.00262280384408e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,-0.0335013678939199,0.00660931783347564,-0.0464556308475322,-0.0205471049403077,4.02743985420437e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,24793,-0.0184014900502382,0.0036303786288547,-0.0255170321627934,-0.011285947937683,4.03311594183204e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,-0.0198566600862522,0.00393285173612198,-0.0275650494890512,-0.0121482706834531,4.47547452739091e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,-0.0261120984252904,0.00518438062497335,-0.0362734844502382,-0.0159507124003426,4.77060024587747e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,-0.0111001091255885,0.0022048934366849,-0.0154217002614909,-0.00677851798968605,4.83019593777647e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,-0.104423930709735,0.0207496854996653,-0.145093314289079,-0.0637545471303912,4.86834111728148e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,28845,-0.0155794261640498,0.00309835566158942,-0.021652203260765,-0.00950664906733452,4.97841018847081e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,-0.0402803332559471,0.00802749570563691,-0.0560142248389954,-0.0245464416728988,5.26290108855176e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,-0.018034970954745,0.00359438840468279,-0.0250799722279232,-0.0109899696815667,5.27107214901679e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,29434,-0.0109993375292044,0.00219248089047255,-0.0152966000745305,-0.00670207498387816,5.28324138435273e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),24484,0.0632566073063343,0.012612117738248,0.0385368565393682,0.0879763580733005,5.32538625426209e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRL,Prolactin,29694,-0.0265452984823129,0.00531660119751532,-0.036965836829443,-0.0161247601351829,5.9813727700758e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,29443,0.0171524605200101,0.00344173271699543,0.010406664394699,0.0238982566453211,6.27430836382649e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,29434,-0.0272757124530152,0.00547709074052012,-0.0380108103044347,-0.0165406146015958,6.39558291896922e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,24101,-0.0298019508590335,0.00599330031241828,-0.0415488194713733,-0.0180550822466936,6.65338547161224e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,24229,-0.0136868615045387,0.00275772819020496,-0.0190920087573405,-0.008281714251737,6.98499676938087e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,24111,-0.02188114904637,0.00441734649155186,-0.0305391481698116,-0.0132231499229283,7.33986198828986e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0195139123836767,0.00394053095406507,-0.0272373530536443,-0.0117904717137092,7.38222054091489e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,29453,-0.0326477443792107,0.00660280674021865,-0.0455892455900392,-0.0197062431683821,7.67492380828724e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,24229,-0.041873989232865,0.00847528885505466,-0.0584855553887721,-0.0252624230769579,7.83553543251162e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,28931,-0.0187785975060137,0.0038012707911599,-0.0262290882566871,-0.0113281067553403,7.85243673514154e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,29581,-0.0115802573787393,0.00234762239009731,-0.0161815972633301,-0.0069789174941486,8.15154950249433e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,-0.0162314228820418,0.00329083575158339,-0.0226814609551452,-0.00978138480893832,8.17874724228879e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,24845,0.0146149795951982,0.002964563486286,0.00880443516207767,0.0204255240283188,8.28051274831873e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,-0.0077169402056034,0.00156603398739471,-0.010786366820897,-0.00464751359030978,8.36565401353666e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,0.0100745888159226,0.00204474825530698,0.00606688223552089,0.0140822953963242,8.40313852540064e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,-0.0345560143216638,0.00702074223439208,-0.0483166691010723,-0.0207953595422554,8.62346558043527e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,29443,-0.00835089428981787,0.00169781422959404,-0.0116786101798222,-0.00502317839981356,8.76284087706785e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,29694,0.00798328960985411,0.00162402773405214,0.00480019525111192,0.0111663839685963,8.89215681527522e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,29478,-0.0297464928932298,0.00607850527747588,-0.0416603632370825,-0.0178326225493771,9.94706137186086e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,-0.0409811477490112,0.00838295584807692,-0.0574117412112419,-0.0245505542867804,1.02073344178001e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,-0.0409453360123688,0.00837700813982334,-0.0573642719664225,-0.024526400058315,1.02491676062371e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,24805,-0.0211041697377416,0.00431787933429464,-0.0295672132329591,-0.0126411262425241,1.02697656862058e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,29121,-0.0196406740835086,0.00402037375168824,-0.0275206066368175,-0.0117607415301996,1.03827120527494e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,-0.0249878979291125,0.0051165218076812,-0.0350162806721677,-0.0149595151860574,1.0473583252052e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,0.0206208989662927,0.00422349238552109,0.0123428538906714,0.0288989440419141,1.05330861951373e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,-0.0110836802911429,0.00227236017633439,-0.0155375062367583,-0.00662985434552746,1.08044110723377e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,-0.030241804011899,0.0062028967562778,-0.0423994816542035,-0.0180841263695945,1.09265300993981e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.0162957230663712,0.00334352311459623,-0.0228490283709798,-0.00974241776176258,1.10044476815147e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFB,Complement factor B,24538,-0.0112871080803653,0.00231851386534756,-0.0158313952564465,-0.00674282090428411,1.13290063497302e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,24445,-0.0100613247547473,0.00206732534516316,-0.0141132824312671,-0.00600936707822748,1.14108343785367e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,29349,-0.00970433101598024,0.00199509346913775,-0.0136147142154902,-0.00579394781647025,1.15575057182341e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,21656,-0.0361200481679243,0.00743424384497648,-0.0506911661040782,-0.0215489302317703,1.19042917855576e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,29497,-0.0111771573479505,0.00230787137245294,-0.0157005852379583,-0.00665372945794275,1.28503059123016e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,0.00873353666845656,0.001804704050441,0.00519631672959221,0.0122707566073209,1.3108214078714e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,24789,-0.0194002682296757,0.00402342051394083,-0.0272861724369997,-0.0115143640223516,1.43087437283584e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,24726,-0.0117427443327557,0.00244694018858437,-0.0165387471023811,-0.00694674156313037,1.60430448668687e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,24867,-0.00866220376885195,0.00180511426308798,-0.0122002277245044,-0.00512417981319951,1.60624675625222e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,24867,-0.015087030466339,0.00314436638873858,-0.0212499885882666,-0.00892407234441136,1.61095117642769e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,24845,-0.0174208053538965,0.00363760844896617,-0.0245505179138702,-0.0102910927939228,1.685116244398e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,-0.0260906716242107,0.00544807469521855,-0.0367688980268391,-0.0154124452215824,1.68629009744493e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,-0.0293965120619791,0.00614399304187403,-0.0414387384240522,-0.017354285699906,1.72159350947775e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,24273,0.0115910347849774,0.00242581299933261,0.00683644130628548,0.0163456282636693,1.77900296328331e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,29218,-0.0111234570358008,0.00232809273901978,-0.0156865188042796,-0.006560395267322,1.77971585405693e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,-0.0322767694381236,0.0067586962201294,-0.0455238140295772,-0.01902972484667,1.80227282479917e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,-0.0231152778502913,0.00484239687847092,-0.0326063757320943,-0.0136241799684883,1.82083714469701e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,-0.0123426344673461,0.00259119892151749,-0.0174213843535203,-0.00726388458117179,1.91363934724613e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,-0.0120006634239906,0.00252367084763513,-0.0169470582853554,-0.00705426856262572,1.99147297096268e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRNN,Cornulin,28580,0.022301512817119,0.0046943435893824,0.0131005993819295,0.0315024262523085,2.03677683799637e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,29349,-0.0139519267876936,0.00294041665292791,-0.0197151434274323,-0.00818871014795488,2.09610843768051e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,24922,-0.0176260325511425,0.00371832427884046,-0.0249139481376698,-0.0103381169646151,2.14563672221795e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,24016,-0.0122254626144486,0.00257932133474839,-0.0172809324305555,-0.00716999279834177,2.15157033795087e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,-0.0194841731098788,0.00411847671537749,-0.0275563874720187,-0.0114119587477389,2.24756607901389e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,29820,0.0097762537060462,0.00206823981004455,0.00572250367835889,0.0138300037337335,2.29073387507596e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,-0.0204429071873123,0.00433700224993504,-0.028943431597185,-0.0119423827774396,2.44739645106574e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,29443,0.0065046873944791,0.001380810387393,0.00379829903518883,0.00921107575376938,2.47902155651614e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,-0.036940741644207,0.00785569191323607,-0.0523378977941497,-0.0215435854942643,2.58291505642797e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,-0.0179434809831825,0.00382905555777237,-0.0254484298764163,-0.0104385320899487,2.79888150596191e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,29434,-0.0183537005748914,0.00391718668043102,-0.0260313864685361,-0.0106760146812466,2.80622783561729e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,-0.0243780620156358,0.00521375865103894,-0.0345970289716721,-0.0141590950595995,2.94462572255723e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,-0.0193588388837197,0.00414420457122376,-0.0274814798433183,-0.0112361979241212,3.00645524928715e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,24966,-0.0107911435460553,0.00231045462203283,-0.0153196346052397,-0.00626265248687099,3.01927221928887e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.0187766881307456,0.0040248640427079,-0.0266654216544531,-0.0108879546070381,3.09708433826752e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,24793,-0.0137762726690613,0.00295848854156675,-0.0195749102105322,-0.0079776351275905,3.23260125819534e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.016456917088898,0.00353702379062317,-0.0233894837185194,-0.00952435045927655,3.29215796885018e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,24867,-0.0225251082842156,0.00486709274727673,-0.032064610068878,-0.0129856064995532,3.71003180844409e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,0.00848914913317748,0.00183738604208538,0.00488787249069014,0.0120904257756648,3.85226741028807e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,24867,-0.00967910285535743,0.00209773680446037,-0.0137906669920998,-0.0055675387186151,3.96831131847812e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,28954,-0.0134376019125956,0.00291365990285383,-0.0191483753221891,-0.00772682850300205,4.00649212074071e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,29400,-0.0284424484172458,0.00616731184659407,-0.0405303796365702,-0.0163545171979215,4.00865624753837e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,-0.0138705733158637,0.00300985631433838,-0.019769891691967,-0.00797125493976051,4.07856422182191e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,29349,0.00490108220707088,0.00106519459834261,0.00281330079431937,0.00698886361982239,4.21993508771634e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,-0.00886450836231964,0.00192817834807055,-0.0126437379245379,-0.00508527880010136,4.29656182006676e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,29820,0.00887207402619497,0.00193023548646536,0.00508881247272287,0.0126553355796671,4.31679632663442e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,-0.014828276118074,0.00322736917243929,-0.021153919696055,-0.00850263254009304,4.35901476757714e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,24111,0.0102250862458168,0.00223056513615758,0.00585317857894793,0.0145969939126857,4.58281231799391e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,-0.0234506247517403,0.00511886421591055,-0.0334835986149249,-0.0134176508885556,4.64180032659931e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,28722,-0.0116400883257317,0.00254098001699726,-0.0166204091590463,-0.00665976749241703,4.64825314920895e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,29787,0.0138227804796881,0.00302805746254226,0.00788778785310525,0.0197577731062709,5.01728802210151e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,24833,-0.0152261956205792,0.00333731230034009,-0.0217673277292458,-0.00868506351191262,5.08111457566596e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,28916,-0.0168410866477829,0.0036932471478534,-0.0240798510575756,-0.00960232223799025,5.13713145488568e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,24381,-0.0142553225820874,0.00312810762663102,-0.0203864135302842,-0.00812423163389058,5.20987245399832e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,-0.027972708374305,0.00615256425219946,-0.0400317343086159,-0.0159136824399941,5.48038437061214e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,24867,-0.0199544971494917,0.0044016834330429,-0.0285817966782558,-0.0113271976207276,5.83183444954847e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,24951,-0.00838653170766261,0.001851804566531,-0.0120160686580634,-0.00475699475726186,5.95821871241658e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,-0.0195573250982457,0.00433972976285795,-0.0280631954334473,-0.0110514547630441,6.61899753768766e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,28984,-0.0107949487910226,0.00239564647852206,-0.0154904158889259,-0.0060994816931194,6.62976396315044e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,24229,0.0084058886154257,0.00186662915233064,0.00474729547685765,0.0120644817539937,6.7235849867976e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,-0.0169032160056436,0.00375993576559781,-0.0242726901062153,-0.00953374190507188,6.96351568441893e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,-0.0100398056584449,0.00223349968195696,-0.0144174650350806,-0.00566214628180925,6.98017790750063e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,-0.0400978941740297,0.00892908416391632,-0.0575988991353057,-0.0225968892127537,7.13066360227255e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,-0.0121401847210709,0.00270847737585443,-0.0174488003777456,-0.00683156906439618,7.41755491358389e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,0.0113896126616108,0.00254261935781127,0.00640607872030076,0.0163731466029209,7.51086489017611e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,24845,-0.0121259829361186,0.00270813076408654,-0.0174339192337282,-0.00681804663850898,7.581544781601e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,29491,-0.0203040910361737,0.00453588962244274,-0.0291944346961615,-0.0114137473761859,7.62251758930093e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,24195,-0.0188415389117995,0.00420942371980916,-0.0270920094026254,-0.0105910684209735,7.63882043466354e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,-0.011709812227111,0.00261766775588799,-0.0168404410286514,-0.0065791834255705,7.73363846903549e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,-0.0147052363821693,0.00329981413567501,-0.0211728720880923,-0.0082376006762463,8.36681975565689e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCT,Secretin,24195,-0.0147251117023366,0.00331394885844603,-0.0212204514648909,-0.00822977193978244,8.89524092098275e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,0.00863538609755594,0.00194798775216241,0.00481733010331762,0.0124534420917943,9.33507820652227e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,28931,-0.0186601190465652,0.00420957416896778,-0.0269108844177421,-0.0104093536753884,9.3367519371621e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,24195,0.0097496607582189,0.00220806031988947,0.00542186253123554,0.0140774589852023,1.01219698554311e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.00800659120744113,0.00181762378646604,0.00444404858596769,0.0115691338289146,1.06164615528806e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,24229,-0.0195812708399339,0.00444815264053012,-0.028299650015373,-0.0108628916644949,1.07660146196292e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,-0.013312175580762,0.00302430942364437,-0.019239822051105,-0.00738452911041906,1.07842546649849e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,29566,0.00848590492638188,0.00193044864379568,0.00470222558454234,0.0122695842682214,1.10739823076939e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,24229,-0.00525935339808415,0.00119941403701585,-0.00761020491063522,-0.00290850188553309,1.16508889903406e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,29725,0.0183870739451698,0.00419849033934984,0.0101580328800441,0.0266161150102955,1.19386310643799e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,29242,0.0152630939646683,0.00348552975587635,0.0084314556431507,0.022094732286186,1.19645475564213e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.014411090979328,0.00329380869866027,0.00795522592995384,0.0208669560287021,1.21811755021839e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C7,Complement component C7,24374,-0.0100146733719087,0.0022939512740616,-0.0145108178690694,-0.00551852887474793,1.27245699730229e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFD,Complement factor D,24966,-0.00602516490884961,0.00138056781453265,-0.00873107782533361,-0.00331925199236561,1.28062589936713e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,29434,0.0130887579734701,0.0030005046413289,0.00720776887646544,0.0189697470704747,1.29207238225067e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,-0.022385055462265,0.0051319995844617,-0.03244377464781,-0.0123263362767201,1.29404589082637e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,24793,-0.012302835703022,0.00282615962422983,-0.0178421085665125,-0.00676356283953158,1.34702432033356e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,0.00741560427536455,0.00170578201143955,0.00407227153294303,0.0107589370177861,1.38262458751967e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.0216896461702655,0.00499677716563507,-0.0314833294149103,-0.0118959629256208,1.42482472505784e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,28797,-0.0245740203787869,0.00566599650189126,-0.0356793735224937,-0.01346866723508,1.44862449051124e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,28443,-0.0109365601406695,0.00252248425624229,-0.0158806292829044,-0.00599249099843457,1.45842225267337e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,28797,-0.022161985943355,0.00511639123076492,-0.0321901127556542,-0.0121338591310558,1.48553281443081e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0149062741981836,0.00345167169913255,-0.0216715507284834,-0.00814099766788384,1.57558022238838e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,-0.0213483173460333,0.00495881206427314,-0.0310675889920086,-0.0116290457000579,1.67548437496398e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,24111,0.0122492341227713,0.00284746162714828,0.00666820933356065,0.0178302589119819,1.70076536805032e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,-0.0175074961251027,0.00408290043499395,-0.0255099809776908,-0.00950501127251455,1.80858655578381e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,-0.0309473848800263,0.00721887988356095,-0.0450963894518058,-0.0167983803082469,1.81796640000986e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,-0.00815084017706613,0.00191666957875169,-0.0119075125514194,-0.00439416780271282,2.11960709080937e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,29434,-0.0115668579772971,0.00272706551299251,-0.0169119063827624,-0.00622180957183178,2.22705396838779e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,-0.0167740298290015,0.00396598537158552,-0.0245473611573091,-0.00900069850069384,2.35098801825584e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,29349,0.00870413278986727,0.00205947238544045,0.00466756691440399,0.0127406986653305,2.38188063867126e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.0229803883511413,0.0054408132917953,-0.0336443824030601,-0.0123163942992225,2.41057139169831e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,29443,0.0120540356967681,0.00285450008892246,0.00645921552248009,0.0176488558710562,2.41990365339598e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,-0.0155587577411414,0.00369806492642494,-0.0228069649969343,-0.00831055048534856,2.59256465854399e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,29434,-0.019237669133295,0.00457780947174511,-0.0282101756979154,-0.0102651625686746,2.64908435025103e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,29478,-0.0224460354129664,0.00535919236309679,-0.0329500524446361,-0.0119420183812967,2.81838450950463e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,29434,-0.0189239254455415,0.00451880002119662,-0.0277807734870868,-0.0100670774039961,2.8246487523625e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,-0.0139200349300333,0.00333238373884471,-0.020451507058169,-0.00738856280189771,2.95987998660018e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,-0.00978406590427561,0.00234599654031006,-0.0143822191232833,-0.00518591268526789,3.04913630741827e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,-0.0119806998648459,0.00287376889213123,-0.0176132868934231,-0.00634811283626872,3.07021632263006e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,29531,0.00822287381914766,0.00197455691752992,0.00435274226078902,0.0120930053775063,3.13038301283899e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.0188873276368511,0.00454709839491835,0.00997501478281113,0.0277996404908911,3.28047134484689e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,-0.0190496119391054,0.00458880871323003,-0.0280436770170363,-0.0100555468611745,3.31683943342058e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,-0.0131609066784226,0.00317626945185234,-0.0193863948040531,-0.00693541855279197,3.43163699354191e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,-0.00667340614730448,0.00161284478557651,-0.00983458192703443,-0.00351223036757453,3.51840900636056e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRTN,Neurturin,28931,-0.0143227968680987,0.00347311241885852,-0.0211300972090614,-0.00751549652713603,3.73537205710141e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,-0.0123239978290341,0.00298868404117987,-0.0181818185497466,-0.00646617710832154,3.74326697654311e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,-0.0266216535709191,0.00646289984354569,-0.0392889372642687,-0.0139543698775695,3.81502560354024e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0171598848020182,0.00417515192178059,0.00897658703532827,0.0253431825687082,3.96739392021752e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,28774,-0.0123424128587723,0.00300656656067184,-0.0182352833176891,-0.00644954239985553,4.05163650275788e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,-0.0114999291835853,0.00280182324145551,-0.0169915027368381,-0.00600835563033249,4.06403203665482e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,24229,-0.00966407462971669,0.00235632277745354,-0.0142824672735256,-0.00504568198590776,4.12110516265471e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,28745,-0.0161814035633736,0.00395386509682915,-0.0239309791531587,-0.00843182797358847,4.27813641056018e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0116981307275727,0.00287186056078396,0.00606928402843609,0.0173269774267092,4.64616870485405e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,-0.0343099664411509,0.00843790044464018,-0.0508482513126457,-0.0177716815696562,4.79156714631415e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,-0.0686931303445448,0.0168956429107071,-0.101808590449531,-0.0355776702395588,4.80297534541935e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,29132,0.0193663999450735,0.00477406043850338,0.0100092414856069,0.0287235584045401,4.99243224784628e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,24922,-0.0279883917906177,0.00690319941490869,-0.0415186626438388,-0.0144581209373967,5.04140060910007e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00741235357901177,0.00182903539524301,0.00382744420433547,0.0109972629536881,5.08098339285468e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,29443,-0.0125194370073476,0.00309341816557119,-0.0185825366118671,-0.00645633740282805,5.19839136618049e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,29632,-0.0174602011081888,0.00431913849586386,-0.025925712560082,-0.00899468965629561,5.30135536037074e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNLY,Granulysin,29443,-0.0146924244036591,0.00366311869641767,-0.0218721370486377,-0.00751271175868047,6.06355208820395e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,-0.0205367507379539,0.0051287720179793,-0.0305891438931933,-0.0104843575827145,6.24015941241049e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,-0.0200901438079313,0.00503861262424739,-0.0299658245514562,-0.0102144630644064,6.70382649117791e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGN,Cingulin,24195,-0.0112366093942006,0.00282230530535499,-0.0167683277926964,-0.00570489099570487,6.87226928993547e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,0.011454989102023,0.0029177121280196,0.00573627333110464,0.0171737048729415,8.66039914437002e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0071635629717653,0.00182697487913692,0.00358269220865694,0.0107444337348737,8.84190213417944e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,-0.017230474893859,0.00439907085733048,-0.0258526537742267,-0.00860829601349125,8.99547672320381e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,-0.0242101806815875,0.00619468483767326,-0.0363517629634271,-0.0120685983997479,9.31911252975756e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,-0.0245422080746021,0.00628546641856368,-0.0368617222549869,-0.0122226938942173,9.46370747350888e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,24111,0.0099447378113758,0.00254741565481037,0.00495180312794748,0.0149376724948041,9.49307307743685e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,24229,0.0118299474054374,0.00303486798556315,0.00588160615373365,0.0177782886571412,9.72473943038799e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,-0.0144100904295986,0.00370133880815295,-0.0216647144935784,-0.00715546636561885,9.91854616813956e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,28604,0.0190910478381229,0.00490603167580138,0.00947522575355216,0.0287068699226935,9.99171380607313e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,-0.0272731935336784,0.00701018380981743,-0.0410131538009205,-0.0135332332664362,0.00010025365787146
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,-0.00744647057775538,0.0019197496817279,-0.0112091799539421,-0.0036837612015687,0.000105167592022733
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,-0.00619796788358527,0.00160153539805284,-0.00933697726376884,-0.0030589585034017,0.000109106026797831
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0165714523832753,0.00428367121558327,0.00817545680073211,0.0249674479658185,0.000109735392419035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,28852,-0.0199212514624955,0.00515117145989758,-0.0300175475238948,-0.00982495540109628,0.000110277459103965
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,-0.01196623883112,0.00310542208297649,-0.0180528661137539,-0.00587961154848607,0.000116816463715272
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,-0.0129296608043411,0.00336765767321591,-0.0195302698438443,-0.00632905176483795,0.000123618477766979
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,-0.0180265772466991,0.00469962005518453,-0.0272378325548608,-0.00881532193853744,0.00012544627703448
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,29713,-0.00567235057815434,0.00149027133287042,-0.00859328239058037,-0.00275141876572832,0.000141370862592066
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,0.00822562687847386,0.00216226048853602,0.00398759632094327,0.0124636574360045,0.000142627636160802
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,-0.00802845155847293,0.00211073185413738,-0.0121654859925822,-0.00389141712436367,0.000142879871829602
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,-0.0103592824017954,0.00272563654513691,-0.0157015300302637,-0.00501703477332704,0.000144650642784133
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,24867,-0.0207952063828488,0.00547614230579492,-0.0315284453022069,-0.0100619674634908,0.00014655818767546
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,24845,-0.00817571631186404,0.00215376574737909,-0.0123970971767271,-0.00395433544700101,0.000147392979495754
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,-0.0101997521247186,0.00268939747543159,-0.0154709711765645,-0.0049285330728727,0.000149453424335617
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,24556,-0.0165163540872854,0.00435529705868001,-0.0250527363222982,-0.00797997185227262,0.000149649028081286
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,0.0128061671783236,0.00337946882427558,0.00618240828274344,0.0194299260739037,0.000151377498990336
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,24833,-0.00838512010727374,0.00221497810466613,-0.0127264771924194,-0.00404376302212812,0.000153671339075944
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,24111,0.0112100205355904,0.00296350000640705,0.00540156052303256,0.0170184805481482,0.000155513540791527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,24343,-0.0154204597520749,0.00407718301884741,-0.0234117384690159,-0.00742918103513402,0.000155860448177968
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,29523,-0.014686712651968,0.00388629296470503,-0.0223038468627899,-0.00706957844114614,0.000157701910126847
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,24111,-0.0160239789568516,0.00424440839836929,-0.0243430194176554,-0.00770493849604778,0.000160188886062858
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,-0.0143174752508721,0.00379943678067149,-0.0217643713409882,-0.00687057916075599,0.000164743250491394
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,-0.00868377329221474,0.00230626938299087,-0.0132040612828768,-0.00416348530155263,0.000166680025010999
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,-0.00731235978264572,0.00194277263430184,-0.0111201941458773,-0.00350452541941412,0.0001676306985297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,24951,0.0383923201704818,0.0102034481890152,0.0183935617200119,0.0583910786209517,0.000168486351095947
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,24016,0.00691997278842378,0.00184082282347931,0.00331196005440434,0.0105279855224432,0.000170879418923946
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,-0.0100525075961669,0.0026747071957773,-0.0152949336998904,-0.00481008149244334,0.00017136325052696
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,-0.00752495524783236,0.00202075628527808,-0.0114856375669774,-0.00356427292868732,0.000196656847589157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,29761,-0.0156882182442153,0.00421752560599914,-0.0239545684319736,-0.00742186805645702,0.000199771992020522
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRELP,Prolargin,29454,-0.00605487205358941,0.0016351355871033,-0.00925973780431188,-0.00285000630286694,0.0002134718335803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,28797,-0.00923076694863007,0.0024990222005292,-0.0141288504616673,-0.00433268343559284,0.000221378484023922
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,0.00896639869913368,0.0024292739874327,0.00420502168376559,0.0137277757145018,0.000223885211341462
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00772961047135162,0.0020960524454362,-0.0118378732644066,-0.00362134767829667,0.000226772936228765
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,-0.007143715698213,0.00194230158907353,-0.0109506268127971,-0.00333680458362889,0.000235597490424863
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,-0.0100725889715063,0.00273956378698302,-0.015442133993993,-0.00470304394901955,0.000236678480897501
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,-0.00674874113139917,0.00184322605960578,-0.0103614642082265,-0.00313601805457184,0.000251399045764647
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",29725,-0.0188218786287815,0.00514500285533326,-0.0289060842252346,-0.00873767303232825,0.000254348961600373
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,24793,-0.010188392897588,0.00278637623324511,-0.0156496903147485,-0.00472709548042764,0.000256208354445527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,29545,-0.00663007243200221,0.00181720115406489,-0.0101917866939694,-0.00306835817003502,0.000264222000866703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,29518,-0.0116071561215798,0.00318214836217261,-0.0178441669114381,-0.00537014533172148,0.000265172553084638
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,-0.0252255688914716,0.00693308310501509,-0.0388144117773012,-0.011636726005642,0.000274857030222881
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIM,Vimentin,28916,-0.0297877125267401,0.00819374418941413,-0.0458474511379918,-0.0137279739154884,0.000278008233451573
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,29434,-0.0132574065983548,0.00365588677891179,-0.020422944685022,-0.00609186851168774,0.000287977208048742
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,-0.012502792217588,0.00344885163135063,-0.0192625414150352,-0.00574304302014074,0.000289309537856184
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,0.00816663030623529,0.00225279179734491,0.00375115838343927,0.0125821022290313,0.000289425178076959
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,0.0161172024092578,0.00445610247345224,0.00738324156129142,0.0248511632572242,0.000298778447078612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MB,Myoglobin,29820,-0.0133300999487703,0.00368784178922479,-0.0205582698556509,-0.00610193004188972,0.000301298536264333
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,24445,0.00878501649262997,0.00243241030331776,0.00401749229812716,0.0135525406871328,0.000304863602487897
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,24445,0.00940918008972806,0.00260804336930339,0.00429741508589342,0.0145209450935627,0.000309474765818668
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,-0.0139738552636219,0.00387502380555079,-0.0215689019225014,-0.00637880860474231,0.000311401667781218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.00753409883795377,0.00208943700905462,0.00343880230020671,0.0116293953757008,0.000311813919546254
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,28931,-0.008641352624517,0.00239818826306094,-0.0133418016201164,-0.00394090362891755,0.000314749400945808
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',24111,-0.0109463509629706,0.0030382547182497,-0.01690133021074,-0.00499137171520115,0.000315390589070731
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,24914,0.00375512538421956,0.0010431613677315,0.00171052910346583,0.00579972166497329,0.000319135424593062
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,28797,-0.0192784555058776,0.0053584934265425,-0.0297811026219009,-0.00877580838985432,0.000321534599128145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,24922,-0.00674509288636252,0.00187510590667582,-0.0104203004634471,-0.0030698853092779,0.000322308863522166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,29327,-0.0149172475216258,0.00416162595851982,-0.0230740344003246,-0.00676046064292692,0.000338303991974359
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,24229,0.00860849397147496,0.0024078643602483,0.00388907982538829,0.0133279081175616,0.000350698317919307
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,-0.0144697324058558,0.00404983717179718,-0.0224074132625783,-0.00653205154913335,0.000353605727221414
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,28797,-0.0185689758684618,0.00522849510822687,-0.0288168262805865,-0.00832112545633718,0.000383660366075173
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,-0.0161626818968609,0.00455408691402183,-0.0250886922483437,-0.00723667154537813,0.000387355629983529
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,0.00758203805462905,0.00213955662087318,0.00338850707771762,0.0117755690315405,0.000395239309247456
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,0.00942532490913589,0.00266060232332906,0.00421054435541094,0.0146401054628608,0.000397022371504913
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,0.00786663699597696,0.00222743968604278,0.00350085521133311,0.0122324187806208,0.000413676933382715
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,-0.0101243182244583,0.00287264400610952,-0.015754700476433,-0.00449393597248367,0.000425117317685429
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,24101,0.00701069056327873,0.00199190082354502,0.00310656494913049,0.010914816177427,0.000432998297642882
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,-0.0358893191959015,0.0101991461926562,-0.0558796457335076,-0.0158989926582954,0.00043408213435447
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,24195,-0.0172421665784419,0.00490705334294864,-0.0268599911306213,-0.0076243420262626,0.000442632614684243
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,29590,-0.0101450064211644,0.00288869683434795,-0.0158068522164864,-0.00448316062584242,0.000445466912377277
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,29478,0.00839219240194237,0.00239377787271426,0.00370038777142241,0.0130839970324623,0.000455852164778446
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,-0.00921690885761266,0.00262898269245455,-0.0143697149348236,-0.00406410278040174,0.000455897449168391
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.00761907376188521,0.00217455387625444,0.00335694816442652,0.0118811993593439,0.000459578391401144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,-0.00964584192946221,0.0027547422302557,-0.0150451367007634,-0.00424654715816103,0.000463410228558752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,24195,-0.0160928809024648,0.00461406292905699,-0.0251364442434165,-0.00704931756151315,0.000487896224623806
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,0.00788567685178907,0.00226243182371578,0.00345131047730614,0.012320043226272,0.000492115846075442
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,0.0081668495964904,0.00234950360766564,0.00356182252546576,0.012771876667515,0.000509868677907485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,24240,-0.00730615040210806,0.00210238204156326,-0.011426819203572,-0.00318548160064406,0.000511408782391663
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,-0.0138429873692984,0.00398397743788026,-0.0216515831475438,-0.00603439159105312,0.00051239052008905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,28847,-0.0217253329672703,0.00626685953555934,-0.0340083776569666,-0.00944228827757402,0.000527653457855536
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,0.0143552063167527,0.0041436111328219,0.00623372849642176,0.0224766841370836,0.000532301333140301
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,24111,-0.01807068142757,0.00521847447496155,-0.0282988913984946,-0.00784247145664533,0.000535456894855777
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,-0.00562735404792636,0.00162672390049669,-0.00881573289289987,-0.00243897520295285,0.000542303500719389
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,24381,-0.0187304769608677,0.00541790235937869,-0.02934956558525,-0.00811138833648551,0.0005468611359098
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,29725,0.0107910369443844,0.00313409220885564,0.00464821621502731,0.0169338576737414,0.000575849023218673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,0.00756985849540212,0.00219974143056015,0.00325836529150423,0.0118813516993,0.000579835517470475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,-0.00539147693312648,0.001570999758422,-0.00847063645963361,-0.00231231740661936,0.000600256507338375
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,-0.0291589142831166,0.00851068344034274,-0.0458398538261884,-0.0124779747400449,0.000613028895260499
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,-0.0135219908921018,0.00395271316690172,-0.0212693086992291,-0.00577467308497439,0.00062505753870426
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,-0.00851024302828121,0.00249253323309256,-0.0133956081651426,-0.0036248778914198,0.000640351016004445
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,-0.0067833721476292,0.00198730631939344,-0.0106784925336403,-0.00288825176161806,0.000642744484029129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,-0.0105205862959331,0.00311279987312795,-0.0166216740472639,-0.00441949854460232,0.00072658255838402
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,-0.0145656791549028,0.00432473576324343,-0.0230421612508599,-0.00608919705894567,0.000758321319807578
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,-0.0157786157487291,0.00468853903277998,-0.0249681522529778,-0.00658907924448031,0.000765411163056465
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,28490,-0.00619286088128753,0.00185026861190003,-0.0098193873606116,-0.00256633440196348,0.000817950297128045
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,0.00640688002182512,0.00191736057145059,0.00264885330178197,0.0101649067418683,0.00083447371526596
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,24229,-0.00512110262174199,0.00153373475947007,-0.00812722275030333,-0.00211498249318066,0.000842148412248166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,29566,-0.0184772104359113,0.00556687169985347,-0.0293882789676241,-0.00756614190419848,0.000904052318598771
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,24149,-0.0159632568465916,0.00481007040860132,-0.0253909948474502,-0.00653551884573299,0.00090566201376807
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F2,Prothrombin,24966,0.00346082309946062,0.00104501192955164,0.0014125997175394,0.00550904648138184,0.000928444729034505
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,-0.0115342956358553,0.00348581690121722,-0.018366496762241,-0.00470209450946949,0.000937894763397853
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,24951,0.00526047392073334,0.00159145962186422,0.00214121306187947,0.0083797347795872,0.000949612681357768
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,-0.0125708559997709,0.00381114041150642,-0.0200406912063235,-0.00510102079321836,0.000973605465003043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,28722,-0.0142251913488515,0.00432676188853422,-0.0227056446503786,-0.00574473804732442,0.00101122762280065
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,-0.0194230313447831,0.00591965682443125,-0.0310255587206684,-0.00782050396889785,0.00103522732014996
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.0169761332854097,0.00517851281393668,-0.0271260184007256,-0.00682624817009377,0.00104597353124079
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,24445,0.00787434832997045,0.00240266573070287,0.00316512349779282,0.0125835731621481,0.00104936956738758
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,24938,0.00770505041521518,0.00235144789677057,0.00309621253754485,0.0123138882928855,0.0010516176427145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,-0.00804792162806682,0.00245750432963487,-0.0128646301141512,-0.00323121314198247,0.00105844335619009
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,-0.0105724421952714,0.00323719729743463,-0.0169173488982433,-0.00422753549229951,0.00109259672863268
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,24016,0.0081006425614584,0.00248052240952724,0.00323881863878501,0.0129624664841318,0.0010934683363505
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,24111,0.0127597573967803,0.00391855683569198,0.00507938599882401,0.0204401287947366,0.00113054632429644
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,28774,-0.00880336532395165,0.00272394787624823,-0.0141423031613982,-0.00346442748650512,0.00123134079215345
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,0.00578813294219627,0.00179888182862758,0.00226232455808621,0.00931394132630633,0.00129426751645941
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,-0.0241233256969169,0.00749836255501763,-0.0388201163047515,-0.00942653508908239,0.00129642974774005
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,0.00381859707931716,0.00118933462223685,0.00148750121973294,0.00614969293890138,0.00132579604270617
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,24845,-0.021890263139647,0.00682886396025168,-0.0352748365017403,-0.00850568977755367,0.00134975263650813
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.0142730970357875,0.00447334247376391,-0.0230408482843647,-0.00550534578721023,0.00142076020355058
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,28774,-0.0151242669925031,0.00474190800793934,-0.0244184066880642,-0.00583012729694198,0.00142676986229846
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,28931,-0.0133353860042088,0.00418190171624528,-0.0215319133680495,-0.00513885864036806,0.00143000592473589
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,-0.019549486515217,0.00614687683347021,-0.0315973651088186,-0.00750160792161538,0.00147260556647327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FN1,Fibronectin,24966,-0.00599942707734503,0.00188803980437675,-0.00969998509392347,-0.00229886906076659,0.00148682693516327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,24381,-0.0251484054560216,0.00791961260337246,-0.0406708461586316,-0.00962596475341156,0.0014978589220593
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,-0.0133446316955204,0.00421109939563575,-0.0215983865109664,-0.00509087688007432,0.00153197421595764
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,29820,0.00527288020897764,0.00167090219616234,0.00199791190449946,0.00854784851345582,0.00160268057007985
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,24793,-0.0137178578221548,0.00435924829535552,-0.0222619844810517,-0.00517373116325801,0.00165240575407858
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,-0.008757904927433,0.00278373474402764,-0.0142140250257272,-0.00330178482913882,0.00165665334659883
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,24101,0.020112097656099,0.00639587887591417,0.00757617505930721,0.0326480202528908,0.00166550211280978
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,24111,0.00891274783538598,0.00283446576062918,0.00335719494455279,0.0144683007262192,0.00166619081988381
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,24195,-0.013390065901612,0.00427351946215166,-0.0217661640474293,-0.00501396775579478,0.00173080179925677
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,-0.0240727863764512,0.0076881816673159,-0.0391416224443903,-0.00900395030851203,0.00174298834811669
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0101579489809931,0.00326653620393441,-0.0165603599407045,-0.00375553802128164,0.00187454175641445
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,24867,-0.0151182500638668,0.0048624137510679,-0.0246485810159599,-0.00558791911177375,0.00187802249856608
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,-0.0139333209249609,0.0044852386930449,-0.0227243887633289,-0.00514225308659289,0.0018954417245611
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,29218,0.00265014958696941,0.000854278490741139,0.000975763745116781,0.00432453542882204,0.00192266050312567
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,0.00616411743195609,0.00199229109182294,0.00225922689198314,0.010069007971929,0.00197711386038211
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,24381,0.0204159235641462,0.00660172022039452,0.00747655193217297,0.0333552951961195,0.00198691912830006
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,24101,0.00937871386277043,0.0030333522161273,0.00343334351916093,0.0153240842063799,0.00199130777683931
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTG,Protogenin,29725,-0.00540962868666258,0.00175011242601973,-0.00883984904166124,-0.00197940833166392,0.00199656124551944
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,24867,-0.00815208101719209,0.00264419766525359,-0.0133347084410891,-0.00296945359329505,0.00205144450389152
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,-0.00878620897194104,0.00285928717047751,-0.014390411826077,-0.00318200611780513,0.00212205287012086
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,23970,0.00886034891941862,0.00288645811276464,0.00320289101839993,0.0145178068204373,0.00214566113162228
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,24845,0.0163257860968319,0.00532807304064627,0.00588276293716523,0.0267688092564986,0.00218554741305188
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,29478,-0.0173453723164313,0.00567328595953244,-0.0284650127971149,-0.00622573183574774,0.00223483504455265
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,29694,-0.0140392413089821,0.0045926884017788,-0.0230409105764685,-0.00503757204149562,0.00223861678779577
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,29820,-0.00564576598556204,0.00185105488671954,-0.00927383356353234,-0.00201769840759174,0.00229022226078099
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,-0.00961720804931528,0.00316266175210318,-0.0158160250834375,-0.00341839101519305,0.00236111558687885
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,0.00797640708445585,0.00262415965059893,0.00283305416928195,0.0131197599996298,0.00237143139899489
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,24016,0.00668891306587478,0.0022007759239826,0.00237539225486889,0.0110024338768807,0.00237349847559902
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,24229,-0.0087759771813382,0.00288791492513297,-0.0144362904345988,-0.00311566392807758,0.00237726166262998
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,-0.00711620878341987,0.00234361799051155,-0.0117097000448225,-0.00252271752201723,0.00239659915687579
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,24101,-0.0094584665541125,0.00311645013679179,-0.0155667088222244,-0.00335022428600058,0.0024078195025541
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,29349,-0.0403095103644213,0.0132851044359168,-0.0663483150588182,-0.0142707056700245,0.00241394775598725
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,-0.0114925278986505,0.00379085898604262,-0.018922611511294,-0.00406244428600692,0.0024344379245418
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,24016,-0.0156399132899385,0.00515967033478635,-0.0257528671461198,-0.00552695943375727,0.00243855858299693
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.00651981592181935,0.00215235275212544,0.00230120452765349,0.0107384273159852,0.00245454020043718
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,-0.0142450707764628,0.00472093898406284,-0.023498111185226,-0.00499203036769964,0.00255192451932043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.0111956132876989,0.00371073244333166,0.00392257769876886,0.018468648876629,0.00255480457597722
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,29639,0.00537486244208365,0.00178791255043612,0.00187055384322885,0.00887917104093845,0.00264737182137299
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,-0.00834194577096694,0.00278418390211561,-0.0137989462191135,-0.00288494532282035,0.00273602913894943
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,24919,0.0231490303456727,0.0077292965869652,0.00799960903522093,0.0382984516561245,0.00274739408955125
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,24195,-0.0103060961927394,0.00344613278823234,-0.0170605164576748,-0.00355167592780401,0.00278686102163823
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00657233631051204,0.00220124017019946,0.0022579055769211,0.010886767044103,0.00283127660326637
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,24349,0.00773931545746477,0.0025977564857756,0.00264771274534459,0.012830918169585,0.00289258423955845
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,-0.0136342333519929,0.00457769576419522,-0.0226065170498155,-0.00466194965417023,0.00290032396495752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,24229,-0.0160515163459499,0.0054296492525184,-0.026693628880886,-0.00540940381101386,0.00311683251261084
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,24229,-0.00616021027417291,0.00209028209739608,-0.0102571631850692,-0.0020632573632766,0.00321105071890214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,-0.0146128688033515,0.00498614757157375,-0.024385718043636,-0.00484001956306691,0.00338519733685311
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,24867,-0.0123424947820676,0.00421433955047907,-0.0206026003010066,-0.00408238926312867,0.00340702570381567
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,28353,0.006481291018992,0.00221741511248831,0.00213515739851493,0.0108274246394691,0.00347057773871591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0175125511130365,0.00600798351443472,-0.0292881988013286,-0.00573690342474449,0.00356151059450485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,28797,0.0167365814632787,0.0057429675826762,0.00548036500123336,0.0279927979253241,0.00356791265420321
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,-0.0130826499267387,0.00450050311840374,-0.02190363603881,-0.00426166381466734,0.00365276665543879
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,0.00535554586858007,0.00185317535390747,0.00172332217492142,0.00898776956223872,0.00385673513003688
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,0.0057750086191185,0.00199855656720061,0.00185783774740531,0.0096921794908317,0.00386084119734444
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,-0.0116494817394183,0.00404137785754702,-0.0195705823402104,-0.00372838113862612,0.00394758730452756
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,24101,0.00715794856203388,0.00248780811784109,0.00228184465106534,0.0120340524730024,0.00401559772027016
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.00573839634382484,0.00200668128602861,-0.00967149166444091,-0.00180530102320877,0.0042441580348761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,29169,0.00645394584769446,0.00225779007591247,0.00202867729890601,0.0108792143964829,0.00425919290024426
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,0.012673956372506,0.00444842792648349,0.00395503763659839,0.0213928751084137,0.00438821081456819
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,-0.00906350746254891,0.00318296951847337,-0.0153021277187567,-0.00282488720634111,0.00440950643839139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_A,,24867,-0.00654694150373224,0.00231126900531889,-0.0110770287541573,-0.00201685425330722,0.00462057042043705
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00592225425136411,0.00209821408881718,-0.0100347538654458,-0.00180975463728244,0.00476853897322025
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,29693,-0.00637641242234425,0.00226117491720279,-0.0108083152600617,-0.00194450958462678,0.00480621577364323
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.00688728510202624,0.00244361285590797,0.00209780390444663,0.0116767662996059,0.00482827151253223
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,-0.0159594904065214,0.0056669595473135,-0.0270667311192558,-0.0048522496937869,0.00486284664852945
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,24307,-0.0166532474264469,0.00593082749188167,-0.028277669310535,-0.00502882554235882,0.00499034585538366
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,0.00928304855484825,0.00331226575993064,0.0027910076653842,0.0157750894443123,0.00507287356774239
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,24101,-0.0219189078916179,0.00784903354586165,-0.0373030136415068,-0.0065348021417291,0.00523337739786383
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,-0.00542250019834097,0.00194284804529414,-0.00923048236711748,-0.00161451802956446,0.00525781919891783
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,29820,-0.00802212544104311,0.00287818328358645,-0.0136633646768726,-0.00238088620521367,0.00531962714057996
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,28931,-0.00763116191977996,0.0027381574659689,-0.012997950553079,-0.00226437328648091,0.0053238138223249
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,29216,-0.0101239523014855,0.00363489408195871,-0.0172483447021246,-0.0029995599008464,0.00535271159432545
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,29137,0.0122312603261321,0.00439823283385121,0.00361072397178371,0.0208517966804804,0.00542350983245251
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,-0.00631812150352805,0.00227494727138548,-0.0107770181554436,-0.0018592248516125,0.00548615726092164
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_DRA,,29322,-0.00704752304864394,0.00253853545490763,-0.0120230525402629,-0.00207199355702498,0.00550305252398035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,29114,-0.0202971950810092,0.00733929932433372,-0.0346822217567033,-0.00591216840531511,0.00568627980317796
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00777783625405965,0.00281426549484621,-0.0132937966239582,-0.00226187588416109,0.00571902830895414
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,-0.0101875909084638,0.00369572523001908,-0.0174312123593012,-0.00294396945762637,0.00584447137447119
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,-0.0115023065089335,0.00418690968819577,-0.0197086494977972,-0.00329596352006982,0.00601418851316341
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,24966,-0.00501800425413003,0.0018267827510477,-0.00859849844618353,-0.00143751006207653,0.00602031434350363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0134654932724284,0.00490419760870256,0.00385326595937142,0.0230777205854854,0.00604174690922281
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0188600170780306,0.00690642836105209,0.00532341749036848,0.0323966166656927,0.00632198549944451
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,29434,-0.0170144743576194,0.00625513354155142,-0.0292745360990602,-0.00475441261617861,0.00653041090002219
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,-0.00868234577971967,0.00320816095056495,-0.014970341242827,-0.00239435031661236,0.00680788157152518
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00808090219792983,0.00298720851435955,0.00222597350978511,0.0139358308860746,0.00683175157934878
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,0.0117384625475622,0.00434708150778725,0.00321818279229918,0.0202587423028252,0.00693235396069676
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,24111,-0.0095982857711227,0.00355843328080566,-0.0165728150015018,-0.0026237565407436,0.00699455880420525
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERVV_1,,24111,0.00878386370325436,0.00326233643381611,0.00238968429297478,0.0151780431135339,0.00709660623345118
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00989271459846236,0.00367789777203943,0.00268403496526507,0.0171013942316596,0.00715482616119291
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.00533795526651683,0.00198530939177257,-0.00922916167439107,-0.00144674885864259,0.00717728860496765
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,24016,-0.0137431415358872,0.00511172016571693,-0.0237621130606923,-0.00372417001108199,0.00718115179815156
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,0.00785194900433333,0.00292071679766706,0.00212734408090589,0.0135765539277608,0.00718525199728887
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARTN,Artemin,28931,-0.00843526082549787,0.00314514864701803,-0.0145997521736532,-0.00227076947734253,0.00732269617579778
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,-0.0194341479322135,0.00725416689489443,-0.0336523150462066,-0.0052159808182204,0.00738839770194729
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.0075280306017914,0.0028122821163461,-0.0130401035498298,-0.00201595765375304,0.00743703172194387
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,24111,0.00644079313971555,0.00241143124647297,0.00171438789662853,0.0111671983828026,0.00756894981305867
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,24229,-0.00862579222277568,0.00323209926137144,-0.0149607067750637,-0.00229087767048766,0.0076175894846232
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,24445,0.00538192008412262,0.00202326381049969,0.00141632301554322,0.00934751715270201,0.0078187257425431
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,0.00722465099941942,0.00271714393994879,0.00189904887711978,0.012550253121719,0.00784448647094368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,24240,-0.013722232743603,0.00516796121214241,-0.0238514367194021,-0.00359302876780389,0.00793013157885373
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,24111,0.00872994173663237,0.00330028434016409,0.00226138442991075,0.015198499043354,0.0081693443784936
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,-0.00898959982006657,0.00343114971983716,-0.0157146532709474,-0.00226454636918574,0.00879766626707515
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,-0.0103763017580884,0.00396064636250876,-0.0181391686286056,-0.00261343488757122,0.00880236527557391
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,29313,-0.0127508081802329,0.00488632151192972,-0.0223279983436151,-0.00317361801685063,0.00907233279963607
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,-0.00672499104013396,0.00258584137294498,-0.0117932401311061,-0.0016567419491618,0.00930909989227683
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.010905160753956,0.00420491859342211,-0.0191468011970633,-0.00266352031084865,0.00950814142334484
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,-0.0211563827856616,0.0081644060485397,-0.0371586186407994,-0.00515414693052377,0.00956714348449811
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,29165,0.00870235690952671,0.00337755616388245,0.0020823468283171,0.0153223669907363,0.00998478011441104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,-0.0074832769301186,0.00290645925374681,-0.0131799370674623,-0.00178661679277485,0.0100373854643936
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,-0.00471366213273685,0.00183357558387206,-0.00830747027712608,-0.00111985398834762,0.0101526995791269
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,24381,-0.00657093999221584,0.00255659237152,-0.011581861040395,-0.00156001894403664,0.0101700248079216
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.00668346981220126,0.00260795807748292,0.00157187198033474,0.0117950676440678,0.0103915233001708
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,29413,-0.0230333597118462,0.00899181270161217,-0.040657312607006,-0.00540940681668631,0.0104242914471334
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,29725,-0.011296312907894,0.00441877890477928,-0.0199571195612614,-0.00263550625452662,0.0105800659218814
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,-0.00855478574902843,0.00334988378983964,-0.0151205579771141,-0.00198901352094274,0.0106627230632433
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.00778947148948664,0.00305173323994953,0.00180807433918556,0.0137708686397877,0.0107019770075867
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,24867,-0.00896460714256823,0.00351568213611314,-0.01585534412935,-0.00207387015578648,0.0107816002998577
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,24615,-0.0115699121556125,0.00453787336532304,-0.0204641439516456,-0.00267568035957933,0.0107896449560973
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,29199,0.0227544569815262,0.00895339471773003,0.00520580333477532,0.040303110628277,0.0110450239677546
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,24407,0.00554036599350036,0.00218389126708248,0.0012599391100187,0.00982079287698201,0.0111893020969018
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,24111,0.00901612842522104,0.00356367900310714,0.00203131757913104,0.016000939271311,0.0114123810217447
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,24867,-0.00542388324108783,0.00214437380121016,-0.00962685589145974,-0.00122091059071592,0.0114333576609591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,0.00444979466434824,0.00176286906651633,0.000994571293976237,0.00790501803472025,0.0116032667190128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,-0.00818882080365078,0.00324561455227941,-0.0145502253261184,-0.00182741628118315,0.0116398018938238
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,24101,0.00879750727617073,0.0034883884379902,0.00196026593770993,0.0156347486146315,0.0116773448998853
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.0254444642776352,0.0101593117876012,-0.0453567153813336,-0.0055322131739369,0.0122674405964365
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,28774,-0.00669404520059107,0.00268591244151133,-0.0119584335859533,-0.00142965681522886,0.0126981861942662
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,-0.00800927496063099,0.00322000931137808,-0.014320493210932,-0.00169805671032994,0.012876661148368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,29478,0.0204151672387325,0.0082123726096402,0.00431891692383769,0.0365114175536273,0.0129277930836167
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,28774,0.00572032286955171,0.00230270493478485,0.0012070211973734,0.01023362454173,0.0129908319164805
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,24793,-0.00925716831327807,0.00372833822000302,-0.016564711224484,-0.00194962540207214,0.0130375739331367
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,24756,-0.0102861219384209,0.00415395787205068,-0.0184278793676403,-0.00214436450920162,0.0132847353293304
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,28916,-0.00846453193247443,0.00342094607249708,-0.0151695862345687,-0.00175947763038015,0.0133545218462588
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.00350842236466694,0.00142415234992582,0.000717083758812338,0.00629976097052154,0.0137638109129564
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,24016,0.00809551297277157,0.00328695033757435,0.00165309031112584,0.0145379356344173,0.0137878320206738
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,0.00579379757989474,0.00235717911988495,0.00117372650492025,0.0104138686548692,0.0139795112340368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,-0.00687468880630943,0.00281307051398861,-0.0123883070137271,-0.00136107059889175,0.0145378328539283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,28931,-0.0105535052289701,0.00432766480020773,-0.0190357282373773,-0.00207128222056295,0.0147496707621194
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,-0.00580686496276164,0.00238444192208996,-0.010480371130058,-0.00113335879546532,0.0148847823795509
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFP,Properdin,24966,-0.00394759305519651,0.00162556830165948,-0.00713370692644909,-0.000761479183943938,0.0151710045065088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,24101,0.00792251290290504,0.00326716999857766,0.00151885970569282,0.0143261661001173,0.0153205231502258
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,24111,-0.019023369925573,0.00784630548761285,-0.0344021286812942,-0.00364461116985185,0.0153367760282581
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,0.00632941372999044,0.00261089798401686,0.0012120536813174,0.0114467737786635,0.0153482247080143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,24111,-0.0154434571102495,0.00638300489650804,-0.0279541467074052,-0.00293276751309372,0.0155507083466857
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,-0.00761988815661213,0.00315165840045119,-0.0137971386214965,-0.00144263769172779,0.0156245979297163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,-0.00717598374001585,0.00296837944914545,-0.0129940074603409,-0.00135796001969076,0.0156357675276379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,24195,-0.0128688097480765,0.00532901737234759,-0.0233136837978777,-0.00242393569827518,0.0157488016418681
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,24101,0.0163397915272221,0.00676636268032122,0.00307772067379251,0.0296018623806517,0.0157488317424179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,0.00866847245449911,0.00359057297848809,0.00163094941666246,0.0157059954923358,0.0157758664591454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,0.00734721236034271,0.00304825570382072,0.0013726311808541,0.0133217935398313,0.0159467992331151
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0290392521338703,0.0120701043270908,0.00538184765277244,0.0526966566149682,0.0161396678405861
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,29566,0.00635613044707421,0.00264658581769697,0.00116882224438815,0.0115434386497603,0.0163281653786408
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,24195,-0.0106692207207053,0.00444857989690566,-0.0193884373186404,-0.00195000412277026,0.0164769615116483
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,24195,-0.00978259131233523,0.00408555506957669,-0.0177902792487055,-0.00177490337596491,0.0166536128274603
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,-0.00883665811760916,0.00369514356774907,-0.0160791395103973,-0.00159417672482099,0.0167907152115264
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,24101,0.00575241604380823,0.00241658520398974,0.00101590904398834,0.0104889230436281,0.0173020394570667
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,-0.00790097909302946,0.0033362109452269,-0.0144399525456742,-0.00136200564038474,0.0178790581708915
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,24195,-0.015240121540113,0.00649080743930275,-0.0279621041211464,-0.00251813895907965,0.0188848321566458
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,29218,0.00922536743057421,0.00394493804823997,0.00149328885602386,0.0169574460051246,0.0193663305307426
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,-0.00882720355062619,0.00378077267583505,-0.0162375179952629,-0.0014168891059895,0.0195639253086657
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,-0.0127333807031178,0.00545659536856549,-0.0234283076255062,-0.00203845378072942,0.0196260638330086
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,29341,-0.0118094545379474,0.00506176436799037,-0.0217305126992085,-0.00188839637668623,0.0196511557233993
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,-0.00944717468930507,0.00405425522411073,-0.0173935149285621,-0.00150083445004805,0.0198044903180153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,24016,-0.0098116353096891,0.00421246795414082,-0.0180680724998051,-0.00155519811957309,0.0198572938219702
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,28872,-0.00917173129921232,0.00395286353991755,-0.0169193438374507,-0.00142411876097393,0.0203329314143328
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,24793,0.0181960743331805,0.00788753311479671,0.00273650942817896,0.033655639238182,0.0210663084183327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,0.0051296720370879,0.00222573494819669,0.00076723153862238,0.00949211253555342,0.0211896978230748
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,24195,0.00469505931969111,0.00204782465025697,0.000681323005187449,0.00870879563419478,0.0218734964558976
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,-0.0109613891219853,0.00478437801412052,-0.0203387700296615,-0.00158400821430909,0.0219660283572832
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.0129108795477755,0.005643309355976,-0.0239717658854885,-0.00184999321006251,0.0221566243749095
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,-0.0108571688952149,0.00476438887683036,-0.0201953710938024,-0.00151896669662736,0.0226850121277767
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.00812093124144071,0.00356541767235036,-0.0151091498792474,-0.001132712603634,0.0227519958883778
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,-0.00593472216741989,0.00260895919748491,-0.0110482821944903,-0.00082116214034946,0.0229297598170227
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,0.00949825849993582,0.0041808080973049,0.00130387462921823,0.0176926423706534,0.0231030546411873
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,-0.013528222995479,0.00596767883710723,-0.0252248735162092,-0.00183157247474879,0.0234041862896569
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C5,Complement C5,24966,-0.00241892402112089,0.00106993913164717,-0.00451600471914935,-0.000321843323092431,0.0237798947483025
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.00506093833517793,0.0022394593287901,0.000671598050749326,0.00945027861960654,0.0238351659721658
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,-0.0075628952053491,0.00334983877811362,-0.0141285792104518,-0.000997211200246408,0.0239739464669494
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,24793,-0.00555741270452367,0.00246588468153153,-0.0103905466803255,-0.000724278728721876,0.0242225139089136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,24445,-0.00696987866298918,0.00309399130945484,-0.0130341016295207,-0.000905655696457697,0.0242860002316584
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,24845,0.00627869766895826,0.00279028374343021,0.000809741531835046,0.0117476538060815,0.0244449417437182
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,-0.0120391256036018,0.00535294145090798,-0.0225308908473815,-0.00154736035982218,0.0245169335524729
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,-0.0135786884102789,0.0060454032175099,-0.0254276787165983,-0.00172969810395945,0.0247054777487688
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,29594,0.00475921512948144,0.00212449020643367,0.000595214324871455,0.00892321593409143,0.0250874085796847
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.0118095735260644,0.00528095719724112,-0.022160249632657,-0.00145889741947178,0.0253441093534958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,24195,-0.00814036555383699,0.00365390548197751,-0.0153020202985129,-0.00097871080916107,0.0258994589542578
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,-0.0152460456106708,0.00686234777853348,-0.0286962472565964,-0.00179584396474515,0.0263129047456756
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,0.00630678760568747,0.00284600737640265,0.00072861314793827,0.0118849620634367,0.0266999109387178
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,29820,-0.0112954236479952,0.00509863209792465,-0.0212887425599275,-0.00130210473606287,0.0267413057084963
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,-0.00687009688582046,0.00310839182006749,-0.0129625448531527,-0.000777648918488185,0.02710217945007
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00587233314007836,0.00265699775898414,0.000664617532469445,0.0110800487476873,0.0271035244399646
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00654995905275452,0.00296369486729401,0.000741117112858264,0.0123588009926508,0.0271097119061403
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0135582277082145,0.00613763990899852,-0.0255880019298516,-0.00152845348657736,0.0271817027898169
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,-0.00753110263909239,0.00341296596721945,-0.0142205159348425,-0.000841689343342262,0.0273503483397829
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,28774,-0.00889513336848572,0.0040443219864229,-0.0168220044618746,-0.000968262275096835,0.0278565151137139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,-0.00545886397979172,0.0024826833277503,-0.0103249233021823,-0.000592804657401121,0.0279030776320297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,29497,0.00513933028154547,0.00233881304802242,0.000555256707421529,0.00972340385566941,0.0279989547672388
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,29218,-0.00540980359981046,0.00246207022075301,-0.0102354612324864,-0.000584145967134553,0.028009847037519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,24195,-0.00520891745546432,0.0023710594025694,-0.00985619388450033,-0.0005616410264283,0.0280389392419824
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,24833,-0.0040042692882859,0.00182383692932934,-0.00757898966977141,-0.000429548906800394,0.0281355868716647
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,0.00588923821700797,0.00268466584978485,0.000627293151429663,0.0111511832825863,0.0282695397383025
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,29478,0.00713430476276941,0.00325454795736928,0.00075539076632561,0.0135132187592132,0.0283798560706755
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,24938,-0.00722458348700333,0.00329886354445214,-0.0136903560341295,-0.000758810939877132,0.0285318808655913
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.00873951888438562,0.0039945317678908,0.000910236619319662,0.0165688011494516,0.028686886479161
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,28751,-0.0133616930302408,0.00610772799170755,-0.0253328398939876,-0.00139054616649401,0.0287016791644868
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,-0.0133458782210581,0.00611775505489256,-0.0253366781286476,-0.00135507831346874,0.0291561764439711
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,-0.00401323984884387,0.00183988096606091,-0.00761940654232326,-0.000407073155364476,0.0291743138607734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,-0.00939277309979392,0.00431273786092502,-0.017845739307207,-0.000939806892380882,0.0294218215491213
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,24445,0.00599753908356844,0.00276117967579613,0.000585626919008026,0.0114094512481288,0.0298582325525211
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,-0.00568157199088104,0.00261629594262659,-0.0108095120384292,-0.000553631943332913,0.0298932640297635
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,28797,-0.00602071838095101,0.00277609276622098,-0.0114618602027441,-0.00057957655915789,0.0301079916855112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,-0.0095946972278444,0.00443164857858577,-0.0182807284418725,-0.000908666013816294,0.0303927605332296
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,24016,0.00723041143412822,0.00334147420076865,0.000681122000621659,0.0137797008676348,0.0304865577939991
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,24240,-0.0131445871196953,0.0060747123698125,-0.0250510233645278,-0.00123815087486282,0.0304878704268467
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,24195,0.00574042982662236,0.00266479966611012,0.000517422481046529,0.0109634371721982,0.0312367398978474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.00575873755657734,0.00267435108986483,-0.0110004656927124,-0.000517009420442278,0.0313030138339912
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,-0.0118700654496173,0.00552018355151251,-0.0226896252105818,-0.00105050568865277,0.03153959082424
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00568210228556011,0.00265189958752703,0.000484379094007124,0.0108798254771131,0.0321509086102963
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,24938,0.0134010083016791,0.0062720085949839,0.00110787145551064,0.0256941451478475,0.0326372018712764
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,29519,-0.00458051766896179,0.0021498398079812,-0.00879420369260494,-0.000366831645318651,0.0331277098878914
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALLD,Palladin,24229,0.00598336713785818,0.00282403946425115,0.000448249787925931,0.0115184844877904,0.0341237440236359
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0206047239168016,0.00972640016727552,-0.0396684682446616,-0.00154097958894157,0.034148308052366
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00356647560544831,0.00168418598459118,-0.00686748013524702,-0.000265471075649593,0.0342166778757931
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.00632260044437936,0.00298617642687587,0.000469694647702641,0.0121755062410561,0.034245177681305
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,0.00505313858931383,0.0023884539226094,0.0003717689009994,0.00973450827762826,0.0343846008151203
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,24903,-0.00535011875096806,0.00254128841112261,-0.0103310440367684,-0.000369193465167741,0.0352771040896875
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCIN,Adseverin,24101,-0.0109431303114329,0.00520338388763973,-0.0211417627312068,-0.000744497891658999,0.0354691611237866
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,0.00588007739955356,0.00280755847170079,0.000377262795020018,0.0113828920040871,0.0362370417409356
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,29434,-0.00507947806357858,0.00243742804662006,-0.00985683703495391,-0.000302119092203255,0.0371733272039088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,24101,0.00699831319774965,0.00336586958284881,0.000401208815365972,0.0135954175801333,0.0376096033584831
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,-0.0113606616225602,0.0054908132718578,-0.0221226556354015,-0.000598667609718918,0.0385537992344998
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,24111,0.0067406665547361,0.00326147156475942,0.000348182287807649,0.0131331508216646,0.038767789635278
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,0.00632916163511038,0.00306438944564635,0.000322958321643528,0.0123353649485772,0.0388967104879054
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,0.0082958197525148,0.00401942199385605,0.00041775264455695,0.0161738868604727,0.0390347434516174
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,-0.014977611793093,0.00732120383797093,-0.029327171315516,-0.000628052270669954,0.0407882860772361
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,-0.00476930436706687,0.00233404833879891,-0.00934403911111273,-0.000194569623021012,0.0410257580153788
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00850168349915248,0.00417472008555895,0.000319232131456938,0.016684134866848,0.0417143064557075
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,24195,0.00498123253555259,0.00244610409644845,0.000186868506513638,0.00977559656459154,0.0417216460529643
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,24195,-0.00598882458205082,0.00294468764787245,-0.0117604123718808,-0.000217236792220808,0.0419854386191624
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,24016,-0.00894112504513454,0.00440146012236832,-0.0175679868849765,-0.000314263205292637,0.0422254534139585
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,29579,-0.0217268761279235,0.0107061864938527,-0.0427110016558748,-0.000742750599972322,0.0424289642354603
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,-0.00749796036814506,0.00370040312014998,-0.014750750483639,-0.000245170252651103,0.0427495020098009
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,24329,0.00437922807331223,0.00216370856327939,0.000138359289284628,0.00862009685733982,0.0429866795849142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,24195,-0.00447443658598055,0.00221276777026876,-0.00881146141570731,-0.000137411756253781,0.0431770632153906
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,-0.00654092642764133,0.00324114848163849,-0.0128935774516528,-0.000188275403629886,0.0435930419283532
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NENF,Neudesin,24793,-0.0156652751629778,0.00776438846993104,-0.0308834765640426,-0.000447073761912933,0.043645776872571
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,24111,0.00770893257300581,0.00382087551576659,0.000220016562103294,0.0151978485839083,0.0436457972322354
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,24845,0.00377904775483006,0.00187322854065344,0.000107519815149317,0.00745057569451081,0.0436647201679344
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,-0.0069696126936466,0.00346082785558171,-0.0137528352905867,-0.000186390096706457,0.0440355796945939
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,24657,-0.00424450654646574,0.00211069109358497,-0.00838146108989227,-0.000107552003039203,0.0443409932805379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,-0.00878183075668823,0.00437206137527624,-0.0173510710522297,-0.000212590461146805,0.0445880824581607
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,24793,-0.00521829851893364,0.00260208623633277,-0.0103183875421459,-0.000118209495721421,0.0449280850786748
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,0.00485299222705294,0.00242201776368,0.000105837410240132,0.00960014704386575,0.0451115199266712
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,-0.0153117332979117,0.00765111068419876,-0.0303079102389413,-0.000315556356882169,0.0453776112524359
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPHS2,Podocin,24229,0.0145679898151655,0.00730740567034727,0.000245474701284824,0.0288905049290461,0.0462077937729252
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,0.00619695466245688,0.00311853525756022,8.46255576388471e-05,0.0123092837672749,0.0469185957792029
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,-0.0129978273601311,0.00654307359057853,-0.025822251597665,-0.000173403122597194,0.0469888877091015
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,24445,0.00493753159983623,0.00250684864702906,2.41082516592699e-05,0.00985095494801319,0.0488935665569435
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,-0.00540711320162517,0.00274539001638799,-0.0107880776337456,-2.61487695047006e-05,0.0489041596616464
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,-0.00561893605976425,0.002859393705954,-0.0112233477234341,-1.45243960944005e-05,0.0494165024036521
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,-0.0116503140629762,0.00593814165138788,-0.0232890716996965,-1.15564262559865e-05,0.0497802088539294
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,0.00575012487593567,0.00293846466937473,-9.26587603879928e-06,0.0115095156279101,0.050377071429376
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,-0.00549299069878321,0.00281083584761091,-0.0110022289601006,1.62475625341708e-05,0.0506849213144322
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,24381,-0.00714404714557431,0.00366731779703654,-0.0143319900277659,4.38957366173109e-05,0.0514227726286008
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTN,Titin,24111,-0.00924529007699426,0.0047465670147145,-0.0185485614258347,5.7981271846164e-05,0.0514523400640775
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,24229,-0.0120154342715932,0.00618191988326855,-0.0241319972427996,0.00010112869961313,0.0519503015786879
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,24111,0.00472249277156331,0.00243079078948522,-4.18571758277093e-05,0.00948684271895434,0.0520543259099039
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,-0.00412450165710639,0.0021237623762356,-0.00828707591452816,3.8072600315386e-05,0.0521380090881693
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,-0.0114739541011571,0.00591956593842901,-0.0230763033404779,0.000128395138163812,0.0525951809520987
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,24445,0.00570336592244027,0.00294502548256859,-6.88840233941676e-05,0.0114756158682747,0.0528045460598704
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,24016,0.00607345523716634,0.00313830161108724,-7.76159205646571e-05,0.0122245263948973,0.0529691271879543
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,24111,0.00704258888020049,0.00366014945075978,-0.000131304043288683,0.0142164818036897,0.0543505496490735
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,29349,0.00379854439115891,0.00197903013118349,-8.03546659607348e-05,0.00767744344827856,0.0549438065186752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,24016,0.00502094435254194,0.00261737630257323,-0.00010911320050159,0.0101510019055855,0.0550833123788739
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,24111,0.00683272717702503,0.00357617724189408,-0.000176580217087366,0.0138420345711374,0.0560648768157556
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,29434,0.00661969865961287,0.00347010818663196,-0.000181713386185782,0.0134211107054115,0.0564481782521877
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,24938,0.00323654378621403,0.00170264739832424,-0.000100645114501482,0.00657373268692953,0.057328071478368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,-0.00916084036195921,0.00482003285968192,-0.0186081047669358,0.000286424043017352,0.0573690873572064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,0.00648451614296897,0.00341916379079111,-0.000217044886981613,0.0131860771729196,0.0579030675764175
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,0.0054326419548798,0.00287227489678993,-0.000197016842828465,0.0110623007525881,0.0585798252042494
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,24445,-0.00959899951094309,0.00508330539714157,-0.0195622780893406,0.000364279067454379,0.0589924055762929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,28830,-0.00646508099121975,0.00343030244433266,-0.0131884737821118,0.000258311799672254,0.0594808020612257
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,-0.00668391666018697,0.00355414479692693,-0.0136500404621638,0.000282207141789824,0.060038667805277
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,-0.005421646510418,0.0028908877051996,-0.0110877864126092,0.000244493391773212,0.0607438828857622
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,-0.00622753867599694,0.00332866580275902,-0.0127517236494046,0.00029664629741073,0.0613715247102012
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,24793,0.00729012999269363,0.00391582504633749,-0.000384887098127844,0.0149651470835151,0.0626558323173352
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,-0.0142519009548297,0.00766390375510667,-0.0292731523148388,0.000769350405179316,0.062952372567526
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,24229,0.00607488440068178,0.00327759781939189,-0.000349207325326321,0.0124989761266899,0.0638291355011659
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,24826,0.00311990874659221,0.00168518086233744,-0.000183045743589183,0.00642286323677359,0.0641268973947036
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,0.0038436081943655,0.00207619417759937,-0.000225732393729256,0.00791294878246026,0.0641420420074178
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,24229,0.00712668847825928,0.003849969564581,-0.000419251868319478,0.014672628824838,0.0641669694939553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,24805,-0.0148089204360175,0.00800444860958691,-0.0304976397108079,0.000879798838772806,0.0643130083152109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,24195,-0.0107979374672357,0.00584889574822471,-0.0222617731337561,0.000665898199284767,0.0648826774917254
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,29157,0.00363205678359981,0.00197907150167687,-0.000246923359686846,0.00751103692688647,0.0664813993532927
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,-0.0133884414133166,0.00729536007598858,-0.0276873471622542,0.000910464335621045,0.0664884053159142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0126903435794369,0.00696401646657101,-0.0263398158539161,0.000959128695042303,0.0684258652293023
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,28931,-0.00409010494884615,0.00224892218102972,-0.00849799242366439,0.000317782525972094,0.0689682174695001
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,24229,0.00564069172484395,0.00310609901815275,-0.000447262350735449,0.0117286458004233,0.0693819472366777
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,24111,-0.00470201516643851,0.00260250407150102,-0.00980292314658051,0.000398892813703495,0.0708172771290221
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,-0.0054741526563824,0.00303983027458138,-0.0114322199945619,0.000483914681797115,0.0717433924924642
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,24445,-0.00528731685062666,0.00293829404708206,-0.0110463731829075,0.000471739481654175,0.0719596656011358
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,-0.00585719754728233,0.00326176919219174,-0.0122502651639781,0.000535870069413475,0.0725508430942599
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,28931,0.00360269709557789,0.00200890410194744,-0.000334754944239086,0.00754014913539487,0.0729251220000541
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,24111,0.00913038705263681,0.00510061416351456,-0.000866816707851721,0.0191275908131253,0.0734573950496738
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,-0.00829437778682906,0.00464040214648136,-0.0173895659939325,0.000800810420274406,0.0738810831729394
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,-0.00478506488846945,0.00268921098542534,-0.0100559184199031,0.000485788642964214,0.075193876774605
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,24938,-0.00591890364544601,0.00334464637563982,-0.0124744105417001,0.000636603250808039,0.0767951876457508
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,24016,0.0059605501702709,0.00337488398293986,-0.000654222436291216,0.012575322776833,0.0773834551572035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,28774,0.00638165143731102,0.00363269199333477,-0.00073842486962514,0.0135017277442472,0.0789748374156857
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,24195,0.0041573921013842,0.00237216854178651,-0.000492058240517365,0.00880684244328577,0.079688467965237
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-0.00504329629286446,0.0028876436009214,-0.0107030777506704,0.000616485164941478,0.0807351783224034
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,0.00434306453075139,0.00249566068688349,-0.000548430415540258,0.00923455947704303,0.081828526720449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,29434,-0.00736769778946462,0.00423921768123906,-0.0156765644446932,0.000941168865763941,0.0822238764163151
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,-0.00942934703552829,0.00549052083097583,-0.0201907678642409,0.00133207379318434,0.0859192665579416
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,-0.00645132683310089,0.00375738573679646,-0.0138158028772219,0.000913149211020163,0.0859969270612282
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0061083760543652,0.00355860114520526,-0.000866482190237107,0.0130832342989675,0.0860810822021101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,0.00456728947384382,0.00266345416279494,-0.000653080685234255,0.0097876596329219,0.0863948331192958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,28774,-0.00573969813091498,0.00337975437816013,-0.0123640167121088,0.000884620450278863,0.0894697153807505
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENG,Endoglin,29820,0.0020518435078024,0.00121004691146785,-0.000319848438674583,0.00442353545427938,0.0899583260671521
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCLN,Nicalin,28931,-0.00621617356766747,0.00367660767660951,-0.0134223246138221,0.000989977478487164,0.0908979805828847
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,-0.0070723191050975,0.00419798093942212,-0.0153003617463649,0.00115572353616986,0.0920603587237898
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,-0.00359687069028439,0.00214389320868251,-0.00779890137930212,0.00060515999873334,0.0934126634598511
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,29123,0.00302756824877118,0.00180796936397522,-0.000516051704620258,0.00657118820216262,0.0940296985218973
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,28931,0.00469979399061598,0.0028133047495903,-0.000814283318581006,0.010213871299813,0.0948194684022165
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.00483492469191616,0.00289693501013505,-0.0105129173117809,0.000843067927948543,0.0951343201804491
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,0.0059529318963272,0.00356980496601238,-0.00104388583705707,0.0129497496297115,0.0954121663209919
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,24445,-0.00271314861885333,0.00162931541274897,-0.00590660682784131,0.000480309590134644,0.0958841413303484
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,0.00856229734681456,0.00515118252725554,-0.0015340204066063,0.0186586151002354,0.0964856185665171
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,24195,-0.00705705966291142,0.00425997354921441,-0.0154066078193717,0.00129248849354883,0.0976139408729157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,0.00619539400129609,0.00374425302220983,-0.00114334192223518,0.0135341299248274,0.0980102385968444
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,0.00468099476208584,0.00283719330543208,-0.000879904116561041,0.0102418936407327,0.0989829475061708
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,28916,-0.00701511191246492,0.00425254014541334,-0.0153500905974751,0.00131986677254523,0.0990297856028919
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,-0.00341739734170432,0.00208026040072405,-0.00749470772712345,0.000659913043714806,0.100442721018228
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,24867,0.00600457377206575,0.003658132981392,-0.00116536687146257,0.0131745144155941,0.100720581588511
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,24845,0.00260943673071868,0.00159379195437141,-0.000514395499849286,0.00573326896128666,0.101590803403929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,-0.0107066569837273,0.00654543095006618,-0.023535701645857,0.00212238767840241,0.101906046143302
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.00341057771498438,0.00210222581652205,-0.00070978488539883,0.00753094031536759,0.104737853412369
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,0.00798211862316288,0.00496792194238075,-0.00175500838390338,0.0177192456302291,0.108126302160983
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,29566,0.00314672958589195,0.00195975607203939,-0.00069439231530525,0.00698785148708915,0.108356217542475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,24867,0.00402466140891558,0.0025081714149238,-0.000891354564335066,0.00894067738216622,0.108590216624854
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,28774,-0.00626862325959965,0.00391057649026936,-0.0139333531805276,0.00139610666132829,0.10894737749943
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,24016,0.00464343690959577,0.00290729420212513,-0.00105485972656948,0.010341733545761,0.110241455214285
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,28797,-0.0116246997638341,0.00727961740646394,-0.0258927498805034,0.00264335035283525,0.110302691703378
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAG,S-arrestin,24101,0.0059651942933347,0.00373977417418559,-0.00136476308806906,0.0132951516747385,0.110710139239347
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,-0.00503132289343756,0.00317257790700252,-0.0112495755911625,0.00118692980428738,0.11277964842811
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,-0.00492269314972015,0.00312730983897671,-0.0110522204341145,0.0012068341346742,0.11547752186009
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,24229,0.00648002405272742,0.00411925633290868,-0.00159371835977359,0.0145537664652284,0.115707497880584
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,24229,-0.00359875158409175,0.00228782219498463,-0.00808288308626163,0.000885379918078121,0.115731146956326
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESPL1,Separin,24016,0.00616858602343377,0.00392384845098766,-0.00152215694050205,0.0138593289873696,0.115946223184
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,-0.00837661061636192,0.00532913086759696,-0.018821707116852,0.00206848588412812,0.115997699877991
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,28774,-0.00359213510314345,0.00228813282818001,-0.00807687544637627,0.000892605240089363,0.116449848858612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,-0.00416989797055566,0.00266207239801246,-0.00938755987066009,0.00104776392954876,0.11726554811572
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,-0.00389225730792446,0.00249204622385575,-0.00877666790668174,0.000992153290832809,0.118330870012529
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,29439,0.00646982439965354,0.00414940670294391,-0.00166301273811653,0.0146026615374236,0.118955844122024
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00387529902160035,0.00249296836058784,-0.00101091896515181,0.00876151700835251,0.120078131645967
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,0.00331172866332607,0.0021305927056752,-0.000864233039797312,0.00748769036644946,0.120109403682384
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,0.0051154685311012,0.00329134190613092,-0.00133556160491541,0.0115664986671178,0.120144777663927
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,28931,-0.0100158194553272,0.00645161638640468,-0.0226609875726804,0.00262934866202594,0.120565249749803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.00296906750118935,0.00191434497596655,-0.00672118365408379,0.000783048651705097,0.120922511098884
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,29565,-0.00420619328172148,0.0027145474416606,-0.00952670626737626,0.0011143197039333,0.121272101412764
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,-0.00288379594342889,0.0018664507103541,-0.00654203933572293,0.000774447448865143,0.122342165418686
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,0.00366537301304796,0.00238092363485413,-0.00100123731126613,0.00833198333736206,0.123699066522254
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,24229,-0.00680315249004161,0.00442000054369026,-0.0154663535556745,0.00186004857559129,0.12377474746758
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,29478,-0.00414258870114105,0.00269786759884086,-0.00943040919486913,0.00114523179258703,0.124670611607316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,-0.00344081436023361,0.00224916420921327,-0.00784917621029162,0.000967547489824404,0.126074575604174
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,24229,0.0061408329674611,0.0040259969432952,-0.0017501210413975,0.0140317869763197,0.127198596680974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,24914,0.00242260153276005,0.00159476543289019,-0.000703138715704716,0.00554834178122482,0.12875107048602
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,-0.00421694507249558,0.00278272272510467,-0.00967108161370073,0.00123719146870957,0.129683185283966
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,24229,-0.0037589974857943,0.00248496310360031,-0.00862952516885091,0.00111153019726231,0.130369564079337
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,28774,-0.00475030188043268,0.00314587938724984,-0.0109162254794424,0.00141562171857702,0.131052462946959
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,0.00145125628948942,0.000961283496053866,-0.000432859362776152,0.003335371941755,0.131131135036457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,29478,-0.00812195021058082,0.00540808847511136,-0.0187218036217991,0.00247790320063744,0.133155522908985
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,-0.00339721556402283,0.00227350836846907,-0.0078532919662222,0.00105886083817653,0.135119989628323
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,28114,-0.00292852473526541,0.00197669050161448,-0.00680283811842979,0.000945788647898979,0.138476817597002
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,0.00690242949248086,0.00466288097732512,-0.00223681722307637,0.0160416762080381,0.138808228987752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,-0.00690149309614076,0.00467616078201493,-0.01606676822889,0.0022637820366085,0.139986826154765
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,28774,-0.00618019228665194,0.00419273699982735,-0.0143979568063135,0.00203757223300966,0.140486246419064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,0.00946738889170568,0.00646523968789974,-0.0032044808965778,0.0221392586799892,0.143110752667972
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,-0.00547652913371431,0.00374378396066843,-0.0128143456966244,0.00186128742919581,0.143526094731274
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,23801,0.00405055509779436,0.00277134042618766,-0.00138127213753345,0.00948238233312218,0.143867632722047
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.00581939434479567,0.00398618699553223,-0.00199353216644749,0.0136323208560388,0.144333362662922
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,24966,-0.00215173294678085,0.00147594999652658,-0.00504459493997295,0.000741129046411244,0.144890883824991
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00289833366488148,0.00199419565288147,-0.00101028981476621,0.00680695714452917,0.146127592674985
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,24016,0.00622179604015467,0.00428505176480522,-0.00217690541886355,0.0146204974991729,0.146521108179509
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,0.00490094112833317,0.00338447587266858,-0.00173263158209726,0.0115345138387636,0.147611877238777
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,24922,0.0107741163623321,0.00747709932998823,-0.00388099832444485,0.025429231049109,0.149611754070454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,0.00334220282746569,0.00232157413803379,-0.00120808248308053,0.00789248813801192,0.149985706329537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,-0.002696638703265,0.00187663034262851,-0.00637483417481687,0.000981556768286878,0.150742531135198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,24101,0.0075324081589404,0.00524724795028044,-0.00275219782360925,0.0178170141414901,0.151158536552396
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,24016,0.0081300549909954,0.00567706133836092,-0.002996985232192,0.0192570952141828,0.152131480275384
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,28774,-0.00301160425625213,0.00210328360060873,-0.00713404011344525,0.00111083160094098,0.152195221757194
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,-0.00578589144223291,0.00404539453592386,-0.0137148647326437,0.00214308184817786,0.152658190842412
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,0.00445398232098096,0.00313772528054682,-0.00169595922889081,0.0106039238708527,0.155767907031358
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,24101,-0.00750291699297497,0.00530698848630866,-0.0179046144261399,0.00289878044019,0.157439275855254
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,29694,0.00312198117990046,0.00220890237595122,-0.00120746747696394,0.00745142983676485,0.157559467487109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,0.00730654109679639,0.00519230433246063,-0.00287037539482644,0.0174834575884192,0.159384966252591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,23902,-0.00435648037623951,0.00310570961363145,-0.0104436712189571,0.00173071046647812,0.160709563788571
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,0.00490258831232042,0.00349675353807393,-0.0019510486223045,0.0117562252469453,0.160916235984777
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,24195,-0.00348406603749979,0.00249563812462305,-0.00837551676176097,0.0014073846867614,0.162708583278838
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,29218,-0.00592583915845824,0.00427933475140218,-0.0143133352712065,0.00246165695429003,0.166137333075856
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEB,Nebulin,24111,-0.00370911782127946,0.00267986584362564,-0.00896165487478571,0.00154341923222679,0.166350308119375
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.00760682973016606,0.00549857242331416,-0.00317037221952969,0.0183840316798618,0.166549190021668
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,24229,-0.00293841987045648,0.00213526943818785,-0.00712354796930466,0.0012467082283917,0.168792442355564
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,-0.00678862849042898,0.00493330040551384,-0.0164578972852361,0.00288064030437815,0.168808804356413
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.00621716600405026,0.00453317966937282,-0.015102198156021,0.00266786614792046,0.170237950951695
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,23970,0.00769637873142871,0.00564445175924082,-0.00336674671668329,0.0187595041795407,0.172728381394093
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,0.00559888435714428,0.00411786951752578,-0.00247213989720624,0.0136699086114948,0.173949252108511
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,-0.00683897373241703,0.00504328415424076,-0.0167238106747289,0.00304586320989486,0.175094139935628
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,-0.00476619416122316,0.00352211616117696,-0.01166954183713,0.00213715351468369,0.175996344856169
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,24445,-0.00816540313061238,0.00605997688639435,-0.0200429578279453,0.00371215156672055,0.177853829583083
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,0.00323901649225506,0.00240733733808942,-0.0014793646904002,0.00795739767491032,0.178484024898073
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,-0.00932081181328897,0.00693821943094518,-0.0229197218979415,0.00427809827136357,0.179154772464165
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,24966,-0.00241138156599761,0.00180033612057085,-0.00594004036231647,0.00111727723032126,0.180450634872869
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.00267232442398143,0.00200299976800645,-0.00659820396927407,0.00125355512131121,0.182161368280652
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,24101,-0.00583423909595114,0.00438546312609678,-0.0144297468231008,0.00276126863119856,0.183412704800675
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,28774,0.00329226141152681,0.00248027785529016,-0.0015690831848419,0.00815360600789552,0.184394856114014
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,24793,0.00542130620445598,0.00408820418769742,-0.00259157400343097,0.0134341864123429,0.184823770897948
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,-0.00807231612199924,0.00611838845890482,-0.0200643575014527,0.00391972525745421,0.187063384363125
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,24229,-0.00458611296655986,0.00349316141473457,-0.0114327093394396,0.00226048340631989,0.189234747555553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,24229,0.0024651886353987,0.0018914479351404,-0.00124204931747649,0.00617242658827389,0.192473108138355
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,24016,0.00622855865136167,0.00478232545122568,-0.00314479923304066,0.015601916535764,0.192788036840645
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,0.00481432253722019,0.00370546612866246,-0.00244839107495824,0.0120770361493986,0.193871051934586
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,24229,0.00305221382930072,0.00236011337308471,-0.00157360838194531,0.00767803604054675,0.195937353481526
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,24016,0.00281616815073949,0.00217771141620723,-0.00145214622502667,0.00708448252650565,0.195962003408352
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,-0.00459079651191606,0.0035616888241833,-0.0115717066073153,0.00239011358348321,0.197429957678172
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.00294702844081503,0.00230971349535797,-0.00158001001008659,0.00747406689171664,0.201990897667732
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,0.00299935060604795,0.00237987048750272,-0.00166519554945738,0.00766389676155328,0.207573389683408
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,0.00406814622004625,0.00323094550575494,-0.00226450697123344,0.0104007994113259,0.207997138150986
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,24445,-0.00533352549782298,0.0042582954209473,-0.0136797845228797,0.00301273352723372,0.210398820867697
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,0.00545478382248497,0.00436576630266234,-0.00310211813073322,0.0140116857757032,0.211514587323363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,-0.00233964519630743,0.00187640604087209,-0.00601740103641673,0.00133811064380187,0.212455225632271
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.00281998809326286,0.00226291251584446,-0.00725529662431801,0.00161532043779229,0.212709796521488
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,24016,0.00386069945594117,0.0031059147862989,-0.00222689352520468,0.00994829243708702,0.213874354700285
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,-0.00674424675589138,0.00544097343540076,-0.0174085546892769,0.0039200611774941,0.215161522614193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,29694,0.0111486891671933,0.00900868572729719,-0.00650833485830918,0.0288057131926958,0.215893159827392
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,24845,-0.00603808037328022,0.00488494906203161,-0.0156125805348622,0.00353641978830173,0.216448697186381
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,28916,0.00333886227614743,0.00270897145182386,-0.00197072176942735,0.0086484463217222,0.217764818311824
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,0.00383063915900007,0.00313128666807189,-0.00230668271042084,0.00996796102842097,0.221211997707147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00558698202681209,0.00456968803163881,-0.0145435705688241,0.00336960651519997,0.221485872898137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,0.00378192341823138,0.00310644633420878,-0.00230671139681783,0.00987055823328059,0.223447216049767
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.00293436187697249,0.00241420412498758,-0.00179747820800317,0.00766620196194815,0.22420153360909
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,24195,-0.0043525199075963,0.00358226969425656,-0.0113737685083391,0.00266872869314656,0.224371329499598
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,-0.00862260923143962,0.00710904250954736,-0.0225563325501524,0.0053111140872732,0.225177020794337
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,-0.00254186174113219,0.00210209331814486,-0.00666196464469612,0.00157824116243173,0.226595921620791
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,24101,0.00774697188514198,0.00644781685070452,-0.00489074914223888,0.0203846929125228,0.229573933410823
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,-0.00372780339113561,0.00310538513118626,-0.00981435824826067,0.00235875146598945,0.229983449336673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,29566,-0.00230462911346882,0.00193602434205199,-0.00609923682389071,0.00148997859695307,0.233901669541827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,0.00596295854204151,0.00506225197458894,-0.00395905532815281,0.0158849724122358,0.238837557024855
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,-0.0072533340507755,0.00617553152639634,-0.0193573758425123,0.00485070774096133,0.240195297624333
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.00281284942718716,0.00240986931594319,-0.00753619328643582,0.0019104944320615,0.243130870224139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,24805,-0.0213475424709362,0.018332445283259,-0.0572791352261237,0.0145840502842514,0.244245685371207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,-0.00475354759157921,0.00408660036531808,-0.0127632843076026,0.00325618912444423,0.244758434462974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,-0.00556746464482081,0.00478855543750033,-0.0149530333023215,0.00381810401267983,0.244976888304918
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,24938,-0.00743978208269533,0.00645333250190554,-0.0200883137864302,0.00520874962103952,0.248979342992766
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00241790384419127,0.00210559276744925,-0.00170905798000925,0.00654486566839179,0.250844111605844
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,0.00441821926760676,0.0038490076706368,-0.00312583576684137,0.0119622743020549,0.251027323810841
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.00327187594132772,0.00285048450521341,-0.00885882557154601,0.00231507368889057,0.251049225824352
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSPN,Claspin,28719,-0.00280013225549372,0.00244174211981916,-0.00758594681033927,0.00198568229935183,0.251483601006391
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,24016,0.00337141222196557,0.00297431320168135,-0.00245824165332987,0.00920106609726102,0.257011682440814
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,29274,0.00228839988471577,0.00202038387613617,-0.00167155251251112,0.00624835228194266,0.257368030465418
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,-0.00140361395270286,0.0012393236970488,-0.0038326883989185,0.00102546049351278,0.257406424022059
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,24111,-0.00380834656662508,0.00336323177179197,-0.0104002808393373,0.00278358770608718,0.257499700053193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,24101,0.00754661700940421,0.00667145400045452,-0.00552943283148664,0.0206226668502951,0.257990494678233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.0039057169749358,0.0034654755091973,-0.0106980489729625,0.0028866150230909,0.259738283200159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,24101,0.00427536275682034,0.00380428884463945,-0.00318104337867299,0.0117317688923137,0.261097598452686
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00147909153349497,0.00131890877443309,-0.00110596966439388,0.00406415273138382,0.262106739875614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,29725,0.00357619446285603,0.00321969943666151,-0.00273441643300054,0.0098868053587126,0.266696554824464
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,24203,-0.00546132512358561,0.00493247293037399,-0.0151289720671186,0.0042063218199474,0.268210494737377
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,-0.00207129832394361,0.00187689263436614,-0.00575000788730124,0.00160741123941402,0.269785036898242
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,-0.00340641266770441,0.00309007039407298,-0.00946295064008745,0.00265012530467864,0.270310052703331
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,23970,-0.00276484075099871,0.00251104953950039,-0.00768649784841948,0.00215681634642206,0.270877353530077
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,24111,-0.002593655497311,0.00236592719449484,-0.00723087279852088,0.00204356180389889,0.27297889519738
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,24111,0.00343372130627956,0.00314888576585879,-0.00273809479480367,0.00960553740736278,0.275523238892535
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEO1,Neogenin,24867,-0.0016899316433639,0.00154991223521976,-0.00472775962439463,0.00134789633766683,0.275573876683673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,-0.00651071084069004,0.00598826861684056,-0.0182477173296975,0.00522629564831746,0.276937975102508
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,24101,-0.00562268795041933,0.00518720156479235,-0.0157896030174123,0.00454422711657368,0.278396039056131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,-0.00898103954890534,0.00829080200892712,-0.0252310114864025,0.00726893238859181,0.278704990858396
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,29349,-0.00159604496755207,0.00147969358773034,-0.00449624439950354,0.0013041544643994,0.280760644860636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00331598599336028,0.00307917115258523,-0.00271918946570676,0.00935116145242733,0.281531565590698
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,0.00272498582893244,0.00253554389339217,-0.00224468020211621,0.0076946518599811,0.282512996128293
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,-0.00421758605358602,0.00392478138884527,-0.0119101575757227,0.00347498546855071,0.282562487623962
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,24240,-0.00536486997859907,0.00499402586890879,-0.0151531606816603,0.00442342072446216,0.282717966011972
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,29676,0.00324709296657883,0.0030474231680332,-0.00272585644276624,0.00922004237592391,0.286648962213356
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00411025871928475,0.00386868506476282,-0.00347236400765038,0.0116928814462199,0.288043383894079
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,0.00488816874554283,0.00460390136649672,-0.00413547793279075,0.0139118154238764,0.288362159997565
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,24229,0.0016443650704117,0.00154874832507061,-0.00139118164672669,0.00467991178755009,0.288365196426395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,-0.00313802160105058,0.00296805062970496,-0.00895540083527231,0.00267935763317115,0.290400350860242
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,28916,-0.00452145851767413,0.00428087749554515,-0.0129119784089426,0.00386906137359437,0.290886137192761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,24229,-0.00495427044019071,0.00470161158427428,-0.0141694291453683,0.00426088826498687,0.292013044353732
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,24240,-0.00133558938338636,0.00127283599283432,-0.00383034792934162,0.0011591691625689,0.294049602269755
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0109022337478871,0.0104096085947284,-0.00950059909778056,0.0313050665935548,0.294960344187103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,24454,0.00185257126524477,0.00177442412950091,-0.00162530002857702,0.00533044255906656,0.296476819586016
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BSND,Barttin,24016,0.00250272755637673,0.00239784816073625,-0.00219705483866633,0.00720250995141979,0.296616689084925
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,-0.00216257346225365,0.00207487619253181,-0.00622933079961599,0.00190418387510869,0.297298745375461
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,-0.00916066408944767,0.00879977411466433,-0.0264082213541898,0.00808689317529443,0.297879058395455
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,-0.00165744258807571,0.00160084990936702,-0.00479510841043507,0.00148022323428365,0.300513207007287
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,24016,0.00506013479550157,0.0048946675680974,-0.00453341363796934,0.0146536832289725,0.301237463987383
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00264609311580794,0.00256526772553387,-0.00238183162623844,0.00767401785785432,0.302313169889575
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,24445,-0.00543720636609593,0.00527774720211342,-0.0157815908822382,0.00490717815004638,0.302919997047404
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00407299855709969,0.00397417430004654,-0.00371638307099152,0.0118623801851909,0.305436421871458
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,24195,-0.00165187314403123,0.00161731929227969,-0.00482181895689943,0.00151807266883697,0.307091810381465
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,0.00182870563878271,0.0017925262518901,-0.00168464581492189,0.0053420570924873,0.30765136127005
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,28931,-0.00549145394651371,0.00538634623818229,-0.016048692573351,0.00506578468032357,0.307967667402482
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00254306345125468,0.00250013823609742,-0.00235720749149625,0.00744333439400562,0.309083137973088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,24016,-0.00564362411709738,0.00555195277324009,-0.016525451552648,0.0052382033184532,0.309396096617898
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,0.00227741649782195,0.00224369667911472,-0.00212022899324292,0.00667506198888681,0.310102308113811
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,-0.00359763242483015,0.00354760448860987,-0.0105509372225055,0.0033556723728452,0.310544584785175
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00185063010677162,0.00182651132541584,-0.00172933209104342,0.00543059230458665,0.31097256221874
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,0.00297696996933463,0.00294604395231148,-0.00279727617719587,0.00875121611586512,0.312267106314156
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,24016,-0.00520919260687961,0.00518951940232198,-0.0153806506354307,0.00496226542167147,0.315489507138745
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,24101,-0.00409397937096726,0.00407948219769428,-0.012089764478448,0.00390180573651353,0.315603871918822
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,24016,0.00361410121554199,0.00362505155239828,-0.00349099982715863,0.0107192022582426,0.318784627590531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,28931,-0.00456296125313398,0.00458160388312033,-0.0135429048640498,0.00441698235778187,0.319292014323385
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FST,Follistatin,29536,0.00353430449183406,0.00355010781941933,-0.00342390683422784,0.010492515817896,0.319477730811311
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,0.00354419945437744,0.00359150555286904,-0.00349515142924588,0.0105835503380008,0.323735102003325
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,-0.00431263638896645,0.00440476060266881,-0.0129459671701973,0.00432069439226442,0.327547389363809
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,24793,-0.00547802627693323,0.00559871499990048,-0.0164515076767382,0.00549545512287171,0.327864576960783
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,0.00281887069786639,0.00288583377462099,-0.00283736350039075,0.00847510489612353,0.328680033929344
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,0.00396488285755286,0.00405943210819434,-0.00399160407450806,0.0119213697896138,0.328723171348768
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,29725,-0.00201989313875112,0.00206844251595662,-0.0060740404700261,0.00203425419252385,0.328810565374092
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,-0.00175941078307983,0.00181047526105756,-0.00530794229475265,0.00178912072859299,0.331162031500531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,0.00325229173893086,0.00334873671648587,-0.00331123222538145,0.00981581570324317,0.331458648379994
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,24016,-0.00359721840239171,0.00375398101498431,-0.010955021191761,0.00376058438697755,0.337950915079521
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,24111,0.00343689831555744,0.0035929560070365,-0.00360529545823409,0.010479092089349,0.338796127446409
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,24445,0.00382201641759689,0.00402056572092235,-0.00405829239541091,0.0117023252306047,0.341808454917433
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,0.00518123762600908,0.00545698126159775,-0.00551444564672251,0.0158769208987407,0.342391370062458
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,24922,-0.00232080806783706,0.00244660451756913,-0.00711615292227256,0.00247453678659844,0.342841815772575
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,0.00332918256481753,0.00351008966998238,-0.00355059318834793,0.010208958317983,0.342904415570058
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,28931,0.00200444824461453,0.002135197116415,-0.00218053810355887,0.00618943459278793,0.347859271733045
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,-0.00352849367316769,0.00376239454925918,-0.0109027869897157,0.0038457996433803,0.348340636427518
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00300477479525141,0.0032273113008611,-0.00933030494493916,0.00332075535443634,0.351839178339491
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,-0.00456977454731446,0.0049298965161327,-0.0142323717189346,0.00509282262430564,0.353960917711391
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,-0.00103143294146097,0.00111411227415738,-0.00321509299880943,0.0011522271158875,0.354563115518426
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,24229,-0.00401285559149576,0.0043395602322041,-0.0125183936466158,0.00449268246362427,0.355123491311198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,24546,-0.00223322394223436,0.00241809021675888,-0.00697268076708177,0.00250623288261304,0.355730445932896
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,24195,-0.00436019050313381,0.00472811278888073,-0.01362729156934,0.00490691056307241,0.356441748690936
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,0.00242777706113217,0.00263582639781734,-0.00273844267858983,0.00759399680085416,0.357023807583756
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,0.00276381499930487,0.00300146365298297,-0.00311905376054176,0.0086466837591515,0.35715233826984
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.00161996268191927,0.00177191820672678,-0.00185299700326522,0.00509292236710375,0.360596998152478
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,28774,-0.00303157596494948,0.00333192787129045,-0.00956215459267877,0.0034990026627798,0.362905860268116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,24059,-0.00547371168160976,0.00602507345456734,-0.0172828556525617,0.00633543228934224,0.363629139992699
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,-0.00314835939594461,0.00348094939318502,-0.00997102020658724,0.00367430141469802,0.365763640526296
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,24195,-0.00174443223976999,0.00193177432678018,-0.00553070992025915,0.00204184544071916,0.366523894458089
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,0.00394190608608226,0.00442433369359132,-0.00472978795335671,0.0126136001255212,0.372959314464856
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.0023168399633691,0.00264652942023721,-0.00750403762703403,0.00287035770029583,0.381349573342948
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,24867,-0.0027953058960535,0.00319519769227773,-0.00905789337291784,0.00346728158081084,0.381666162497106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,24421,-0.00608262894366234,0.00697869079040998,-0.0197608628928659,0.00759560500554122,0.383435043671991
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.00334483350457809,0.00385159489061973,-0.0108939594901928,0.00420429248103657,0.385168585325012
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,0.00263904299491214,0.0030450353470641,-0.00332922628533349,0.00860731227515777,0.386131082439735
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,0.0051030434291972,0.00590370246708877,-0.00646821340629679,0.0166743002646912,0.387387561002738
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.00240521633706343,0.00280024216599296,-0.00789369098240963,0.00308325830828277,0.39038654353007
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,0.00303805278939281,0.00354114876648228,-0.00390259879291247,0.00997870437169809,0.39094042922335
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,24195,-0.00252571339779321,0.00295783699842115,-0.00832307391469867,0.00327164711911224,0.393165788877817
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,28797,-0.00827384517678523,0.00975116152995914,-0.0273861217755051,0.0108384314219347,0.396167506786735
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.00218467200693926,0.0025803323435633,-0.00287277938644481,0.00724212340032333,0.397189774801659
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,24016,0.00243932630335505,0.00289384176334049,-0.00323260355279231,0.00811125615950241,0.399272077000454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,-0.00505978680428242,0.00602610582911816,-0.016870954229354,0.00675138062078917,0.401115939298579
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,24101,0.00292417744986506,0.00349649483173089,-0.00392895242032748,0.00977730732005761,0.402984987762681
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00191918636320035,0.00230799112914331,-0.00260447624992054,0.00644284897632124,0.405677022861948
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,0.00415302332031139,0.0049973570684115,-0.00564179653377516,0.0139478431743979,0.405957039946047
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,28931,-0.00254365451919671,0.00306157801206942,-0.00854434742285277,0.00345703838445934,0.406075856804982
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,0.0032293168582946,0.00391278223405057,-0.00443973632044452,0.0108983700370337,0.409193821630683
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,-0.00189716870160047,0.00230087653302669,-0.00640688670633279,0.00261254930313185,0.409639980233164
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,0.00403472955157071,0.00490369339285441,-0.00557650949842393,0.0136459686015653,0.410633285410978
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,-0.00332456664769664,0.0040637499722412,-0.0112895165932894,0.00464038329789612,0.413305063577932
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,29349,-0.00493383983827955,0.0060396040134236,-0.0167714637045898,0.00690378402803072,0.413983948972052
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,0.00146536166006999,0.0018146457098107,-0.00209134393115898,0.00502206725129897,0.419375022915197
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,0.00234952868141475,0.00291291206861584,-0.0033597789730723,0.00805883633590179,0.419910088771911
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,0.0035654116769629,0.00443122247657484,-0.00511978437712378,0.0122506077310496,0.421051960736516
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,-0.00302132463773514,0.00377293718566891,-0.0104162815216462,0.00437363224617591,0.423260735775773
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,0.00344428060355555,0.00431172643985957,-0.0050067032185692,0.0118952644256803,0.424404374516565
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00277232577429705,0.00348574362790876,-0.00960438328499822,0.00405973173640411,0.426427822890042
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,28916,0.0029626464057893,0.00374537152404862,-0.00437828178134599,0.0103035745929246,0.428941518972608
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00204870948151118,0.00261443964134248,-0.00717301117854244,0.00307559221552008,0.433274825074982
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,28797,-0.00304738586452805,0.00389341066343622,-0.010678470764863,0.00458369903580695,0.433807729346401
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,24381,-0.0046494099745795,0.00594667563748389,-0.0163048942240479,0.00700607427488893,0.434310168432342
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00305750418578692,0.00393512409563173,-0.0107703474132251,0.00465533904165128,0.437179450157532
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,0.00182826163615059,0.00236680547642439,-0.00281067709764122,0.0064672003699424,0.439849865817577
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,28931,0.00255488523298895,0.00331366872480778,-0.0039399054676343,0.00904967593361221,0.440704887426716
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,24101,0.00262481345729748,0.00340760870840099,-0.00405409961116846,0.00930372652576342,0.441141263925098
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,24229,-0.00552143695762394,0.00720199345710453,-0.0196373441335488,0.00859447021830093,0.443294745083886
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,-0.00152084713885772,0.00198630206051882,-0.0054139991774746,0.00237230489975916,0.443881570812102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,0.00197270553878511,0.00259179254012448,-0.00310720783985887,0.00705261891742908,0.446583508341038
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,-0.00341124972717041,0.00448505931108036,-0.0122019659768879,0.00537946652254709,0.446914998848657
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,24111,-0.00257189811169125,0.00338432463016306,-0.00920517438681085,0.00406137816342836,0.447295332381787
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0065791322470228,0.0086789421435232,-0.0104315943542827,0.0235898588483283,0.448423107915452
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,29443,0.00179161594889311,0.00236970877452069,-0.00285301324916744,0.00643624514695365,0.449625869543502
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,28797,-0.00163856414507827,0.002190235930856,-0.00593142656955603,0.00265429827939949,0.454392559008135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,24111,0.00312987780470539,0.00418619400282428,-0.0050750624408302,0.011334818050241,0.454668525051166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,24111,0.00320232405940703,0.00428935110460897,-0.00520480410562655,0.0116094522244406,0.455327179876738
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,29443,-0.00187357061660367,0.00252362990511523,-0.00681988523062951,0.00307274399742218,0.457844278702996
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.00474699137672906,0.00641712765835239,-0.00783057883364162,0.0173245615870997,0.459466327479489
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.00366718176856889,0.00499444884284986,-0.00612193796341683,0.0134563015005546,0.462801245458117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,24793,-0.00140483025083111,0.00191750328924995,-0.00516313669776101,0.00235347619609878,0.463787935357859
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,29461,-0.00964982210944863,0.0131749359578915,-0.0354726965869159,0.0161730523680187,0.463907177403497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,29694,0.00149390165130867,0.00204717454109276,-0.00251856044923314,0.00550636375185047,0.465555929731063
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,-0.0031878358263632,0.00438007734353108,-0.0117727874196841,0.00539711576695772,0.466740890029905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,24101,-0.00494727460144201,0.00684654902531347,-0.0183665106910564,0.00847196148817239,0.469936428985853
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,-0.00284329785927451,0.00393661305251592,-0.0105590594422057,0.00487246372365669,0.470135255012714
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.00207923546298526,0.00288390392325579,-0.0077316871525666,0.00357321622659608,0.470929153119765
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,28334,-0.0024270779555539,0.00336856949578092,-0.0090294741672845,0.00417531825617669,0.471218828404956
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,24229,-0.00293478970692536,0.00407394237148929,-0.0109197167550444,0.00505013734119365,0.47129754561456
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,-0.00214600599503588,0.00298160312350794,-0.00798994811711144,0.00369793612703968,0.471685373045343
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,-0.00202760322275304,0.0028239219793486,-0.00756249030227629,0.00350728385677022,0.472758299642887
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,24445,0.0022653614330248,0.00316348035913633,-0.0039350600708824,0.008465782936932,0.473937785559998
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,24229,-0.00241675777807579,0.00338510936204413,-0.00905157212768228,0.0042180565715307,0.475272478115932
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,24867,-0.00799395277179156,0.0112033473490607,-0.0299525135759506,0.0139646080323675,0.47552299150632
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,24229,-0.00132130601059674,0.00185240757504518,-0.00495202485768529,0.00230941283649181,0.47567245953805
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.00198229744197601,0.0027942365250754,-0.00349440614717176,0.00745900103112379,0.478068480420975
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,-0.00269409952477763,0.00382599729296909,-0.010193054218997,0.00480485516944179,0.481342366770453
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,-0.00269824310723322,0.00384604003596612,-0.0102364815777268,0.00483999536326037,0.482957907307987
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.00220324189729248,0.00315242285544153,-0.00397550689937291,0.00838199069395787,0.484618398084128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,28626,-0.0032736741195105,0.00471834565306397,-0.0125216315995159,0.00597428336049488,0.487801855880525
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,-0.00189215868194245,0.00276431321901559,-0.00731021259121302,0.00352589522732811,0.493669010061752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,24966,0.000935354577661677,0.00136955728881112,-0.00174897770840811,0.00361968686373146,0.494637660406717
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,29820,-0.00152332425001823,0.00223396982315386,-0.00590190510339979,0.00285525660336333,0.495313080857647
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0126875504016153,0.0186637394800798,-0.0492684797825716,0.023893378979341,0.496639627688536
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,24229,0.00132218867922484,0.00200528436253407,-0.00260816867134194,0.00525254602979163,0.509675892115679
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,24016,0.00291727312807742,0.00447836759737226,-0.00586032736277221,0.0116948736189271,0.514785256193625
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,24240,-0.0027891421231276,0.00431568935720667,-0.0112478932632527,0.00566960901699748,0.518104399165931
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,0.0015885492846393,0.00247671436574658,-0.00326581087222399,0.00644290944150259,0.521271844654837
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,0.00232365399520609,0.0036260006992939,-0.00478330737540997,0.00943061536582214,0.521638522540111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,-0.00271758802117655,0.00425219564964974,-0.01105189149449,0.00561671545213693,0.522762460884121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,-0.00379552597356305,0.00594728688657214,-0.0154522082712444,0.00786115632411834,0.523353123148953
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,0.00252775955322721,0.00400932556730199,-0.0053305185586847,0.0103860376651391,0.52839309331106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00219019490891596,0.00347874066189072,-0.00462813678838986,0.00900852660622178,0.528966097437656
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,24195,0.0026271514258015,0.00418842889065075,-0.00558216919987397,0.010836472051477,0.53050764749543
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,-0.0012081564515866,0.00193743757363229,-0.00500553409590588,0.00258922119273268,0.53290514533938
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,24951,-0.00230470863084693,0.00373100825026634,-0.00961748480136895,0.00500806753967509,0.53676729591457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,0.00176617564272687,0.00286399281724727,-0.00384725027907779,0.00737960156453153,0.537449694599091
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,-0.00512685430112917,0.00838520523639145,-0.0215618565644564,0.0113081479621981,0.540929536597686
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,24938,-0.00134945161732643,0.00221498367095328,-0.00569081961239485,0.002991916377742,0.542372430005505
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,0.00178203236916661,0.00293216682272067,-0.00396501460336592,0.00752907934169913,0.543357197221082
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTTG1,Securin,24445,-0.00177588496668004,0.00292965214841888,-0.00751800317758104,0.00396623324422096,0.544403486817417
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,28931,0.00208386093106053,0.00344216668101583,-0.0046627857637305,0.00883050762585156,0.544923169726667
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,24445,-0.00224221846315977,0.00373208809208478,-0.00955711112364595,0.0050726741973264,0.547982358505839
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,-0.00120537581629375,0.00201549072531968,-0.00515573763792032,0.00274498600533283,0.549807451005549
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,28797,-0.00379266670840164,0.00642855037214272,-0.0163926254378014,0.0088072920209981,0.555213845544541
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,24195,0.0028914025223334,0.0049068664043063,-0.00672605563010696,0.0125088606747738,0.555694780534144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,-0.0017117916742256,0.00290650943310496,-0.00740855016311133,0.00398496681466013,0.555899581041224
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,-0.00191769711312692,0.0033350695326054,-0.00845443339703351,0.00461903917077967,0.565290123399035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,0.00200887383707645,0.00355996217551181,-0.0049686520269267,0.0089863997010796,0.572557683641866
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,0.00305547546127229,0.00541542647931716,-0.00755876043818934,0.0136697113607339,0.572611594090945
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,24101,-0.00190517412489093,0.00337903194872268,-0.00852807674438739,0.00471772849460552,0.572880210083898
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.00449893558108408,0.00801164956896656,-0.0202017687362585,0.0112038975740904,0.574428407536311
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,0.00149442379555656,0.00267349342998912,-0.00374562332722211,0.00673447091833523,0.57618196602632
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,-0.00201037800191763,0.00361414089134746,-0.00909409414895864,0.00507333814512339,0.578042853952774
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,24754,-0.00200202695119319,0.00365561386189084,-0.00916703012049923,0.00516297621811285,0.583931551155932
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,27585,-0.00187848078868983,0.00344420648854315,-0.00862912550623439,0.00487216392885474,0.585480742323051
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,29443,-0.000913725231432949,0.00169039955461071,-0.00422690835846994,0.00239945789560404,0.588830137860398
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00214772486419065,0.00400061324308247,-0.00998892682063229,0.005693477092251,0.59137694142334
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.00318607374709377,0.0059379730234449,-0.0148245008730458,0.00845235337885823,0.591577141894277
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,28931,-0.00209714095393826,0.00391075617287277,-0.00976222305276888,0.00556794114489236,0.591790267662056
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,28774,0.00246254154455684,0.00460253996669221,-0.00655843679015989,0.0114835198792736,0.592626550734284
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,0.00352273824722268,0.00661794122770485,-0.00944842655907883,0.0164939030535242,0.594522308578608
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,24229,0.00154926593440268,0.00291297712143589,-0.00416016922361166,0.00725870109241701,0.594834993999541
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,0.00178007180288517,0.00334859412079607,-0.00478317267387512,0.00834331627964547,0.595016395118165
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,-0.00200735029437211,0.00384970109359093,-0.00955276443781033,0.00553806384906612,0.602071914547015
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,-0.00145006964695162,0.00280434260021905,-0.00694658114338095,0.00404644184947771,0.605105016642161
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,29434,0.00201104426274835,0.00393289716976476,-0.00569743418999058,0.00971952271548728,0.609117438981915
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,29599,-0.00402881692182313,0.00788019726492002,-0.0194740035610664,0.0114163697174201,0.609173956602913
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,0.00302434828072361,0.00601393384198788,-0.00876296204957262,0.0148116586110198,0.615045372891883
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,28931,-0.00172226469259465,0.0034253374442061,-0.0084359260832386,0.00499139669804931,0.615107691208462
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,24101,-0.00224694091431959,0.00448642521000567,-0.0110403343259307,0.00654645249729151,0.616494628705631
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.00095361051323285,0.00190500060731885,-0.00278019067711209,0.00468741170357779,0.616669211825365
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,24016,0.00189252519601813,0.00378791987743983,-0.00553179776376393,0.00931684815580019,0.617346384615757
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,24111,-0.00233627431503606,0.0047064185524392,-0.0115608546778169,0.00688830604774477,0.619615532170516
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,0.00269957387934358,0.00547232840764696,-0.00802618979964446,0.0134253375583316,0.621795536884708
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,24101,-0.00131203276813259,0.00266172839769711,-0.00652902042761893,0.00390495489135374,0.622069996365278
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,-0.00254477858409157,0.00521973029554474,-0.0127754499633593,0.00768589279517612,0.625886753934652
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.00125427927745326,0.00259139190973801,-0.00382484886563324,0.00633340742053976,0.628377651324636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,24111,0.0016626622163905,0.00345617181978967,-0.00511143455039726,0.00843675898317826,0.630470779832614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,24922,0.0010052004714835,0.0020912181178995,-0.00309358703959952,0.00510398798256652,0.630750295140332
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,24445,0.00102657601234695,0.00217185252070738,-0.00323025492823952,0.00528340695293341,0.63645072595914
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,-0.00105667563275158,0.00224383137131757,-0.00545458512053403,0.00334123385503087,0.637698071989199
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00155664275652218,0.00331247211252478,-0.0049358025840264,0.00804908809707075,0.638406535335593
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,-0.00026726414386751,0.000574200702076183,-0.00139269751993683,0.000858169232201809,0.641610340282769
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,-0.00118767230081114,0.00256512668032835,-0.00621532059425471,0.00383997599263243,0.643363322956054
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,0.00197546943025267,0.00429543225922266,-0.00644357779782375,0.0103945166583291,0.645592106866627
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.00175845992142766,0.00382383507480535,-0.00925317666804615,0.00573625682519083,0.645614962571163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,28931,0.00106454772041619,0.00232611856176902,-0.00349464466065108,0.00562374010148346,0.647207489532379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,24195,0.001562964747307,0.00341826305935186,-0.00513683084902265,0.00826276034363666,0.647503048004055
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,-0.00150447794897291,0.00330010200140319,-0.00797267787172316,0.00496372197377735,0.648473626199277
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,-0.000751063075985093,0.00165043963250124,-0.00398592475568752,0.00248379860371734,0.649064044038421
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,-0.00157470026968721,0.00349182532121915,-0.00841867789927673,0.00526927735990232,0.652016864996201
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,24229,0.000886999921928033,0.00197593829668794,-0.00298583913958033,0.00475983898343639,0.653507367562002
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,28797,0.00274430851718758,0.00611684553506415,-0.00924470873153815,0.0147333257659133,0.653689214934543
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,24445,-0.00169352141009468,0.00379122727213936,-0.00912432686348784,0.00573728404329847,0.655099414963387
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,-0.00104040123077468,0.00233313064187806,-0.00561333728885567,0.00353253482730631,0.655655423702157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,0.000892255554165361,0.00200829072424107,-0.00304399426534714,0.00482850537367786,0.656839036940895
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,-0.00196760397698658,0.00446625627637357,-0.0107214662786788,0.00678625832470562,0.659543552171765
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,28916,0.00219630872300854,0.00501773996411588,-0.00763846160665859,0.0120310790526757,0.661600691459166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,0.00150405175894465,0.00345555177563529,-0.00526882972130052,0.00827693323918983,0.663380088070955
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,-0.0014676029425685,0.00343613343483373,-0.00820242447484262,0.00526721858970561,0.669303875405561
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,24938,0.00132176211171188,0.00310205465642345,-0.00475826501487809,0.00740178923830185,0.670044150869517
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,24195,0.00142856167942119,0.00335651824760732,-0.00515021408588915,0.00800733744473154,0.670397154117496
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRN1,Neuritin,24867,-0.00105287898542405,0.00252658980566561,-0.00600499500452865,0.00389923703368054,0.676887262295815
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,0.00140758843193749,0.0033796896415539,-0.00521660326550815,0.00803178012938313,0.67705853261414
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,24016,0.00274265465178186,0.00660356798167047,-0.0102003385922923,0.015685647895856,0.677904635725578
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,24867,-0.00108306639621046,0.00264175239574699,-0.00626090109187456,0.00409476829945363,0.681823944644111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLPS,Colipase,29400,-0.00202830786379129,0.0049782896566352,-0.0117857555907963,0.00772913986321371,0.683694676568568
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00158618372344986,0.00389499057604726,-0.00922036525250249,0.00604799780560276,0.683837664961279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.0022497865461069,0.00553137100469258,-0.0130912737153044,0.00859170062309056,0.684208307979037
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,-0.000971540227346455,0.0023920599992897,-0.00565997782595427,0.00371689737126136,0.684634332655047
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,24229,-0.00077639510263765,0.00192648272534458,-0.00455230124431302,0.00299951103903772,0.686943166005481
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,-0.00217612635005438,0.00540874424723557,-0.0127772650746361,0.00842501237452734,0.687441064144388
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,0.00158020133632853,0.00394145782759786,-0.00614505600576327,0.00930545867842034,0.688484075666628
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIT,Vitrin,24922,-0.0010644959274189,0.00265730660521375,-0.00627281687363784,0.00414382501880005,0.688723928108991
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,-0.000824367096716522,0.00206132112672462,-0.00486455650509677,0.00321582231166372,0.689217699369291
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,-0.00140874362671595,0.00363232398575287,-0.00852809863879158,0.00571061138535969,0.698141312909389
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,28931,0.00111437227044931,0.00289223386989405,-0.00455440611454302,0.00678315065544164,0.700019388808498
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.000896428896719991,0.00234703768668026,-0.00370376496917333,0.00549662276261331,0.702508259733352
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,29589,-0.000915812182011125,0.00240156748630503,-0.00562288445516898,0.00379126009114673,0.702954198569656
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,28916,-0.00284275738193197,0.00754454625728448,-0.0176300680462096,0.0119445532823456,0.70632773050926
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,24445,-0.00448397686462064,0.0119203385396047,-0.0278478404022458,0.0188798866730046,0.706799825062055
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,-0.00203807043580505,0.00541826371619294,-0.0126578673195432,0.00858172644793311,0.706809995425744
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.000947100151924913,0.00252343528785724,-0.00399883301227528,0.0058930333161251,0.707424483207008
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.00226784722742486,0.00610185368210796,-0.00969178598950674,0.0142274804443565,0.71014533793278
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,28797,0.00430529015674125,0.0116439168529996,-0.018516786875138,0.0271273671886205,0.711574571617364
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,24016,-0.0016466026479848,0.00449721147211728,-0.0104611371333347,0.00716793183736508,0.714264893357971
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,24229,0.00141398776788061,0.00389329463774811,-0.00621686972210569,0.00904484525786692,0.716469563899883
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,0.00182074706904836,0.00501620642753131,-0.00801101752891301,0.0116525116670097,0.716628302246591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,24111,-0.00165964097551087,0.00461239854888295,-0.0106999421313215,0.00738066018029972,0.71898364571369
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.000851606996251487,0.0023815076919642,-0.00381614807999835,0.00551936207250133,0.720652042320413
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,23913,0.000873750732633455,0.00244747197894539,-0.00392329434609952,0.00567079581136643,0.721093967894634
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,0.00122690551352605,0.003469157022137,-0.00557264224986247,0.00802645327691457,0.723596065806605
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,-0.00117938959395847,0.00334057684885824,-0.00772692021772061,0.00536814102980368,0.724053782289403
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,24922,-0.00122473160170819,0.00347555963620431,-0.00803682848866864,0.00558736528525225,0.724553282130219
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.00164519251696906,0.00468940842347382,-0.0108364330269777,0.00754604799303963,0.725717736678092
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,28931,0.001592158417691,0.00458869271208229,-0.0074016792979903,0.0105859961333723,0.7286131552447
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,28931,-0.0015210023592442,0.00438648564874994,-0.0101185142307941,0.00707650951230567,0.728783642986031
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,-0.000983045095439399,0.00284221195020548,-0.00655378051784214,0.00458769032696334,0.729440948015975
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,-0.00170238805105882,0.00492234243503415,-0.0113501792237258,0.00794540312160812,0.729458510472689
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,24240,0.00148685963717383,0.00443162155881224,-0.00719911861809816,0.0101728378924458,0.737242237646286
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,28774,0.00123200340311075,0.00372134154559634,-0.00606182602625808,0.00852583283247958,0.740598314854533
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,0.000622250915468063,0.00191039613931249,-0.00312212551758442,0.00436662734852055,0.744640268539727
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.00150013597527487,0.00465520314871818,-0.0106243341467625,0.00762406219621277,0.747266621458827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,-0.000513473391083532,0.00159846554393098,-0.00364646585718826,0.00261951907502119,0.748039155303487
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,-0.00126334232961723,0.00394636738840219,-0.00899822241088552,0.00647153775165106,0.74887410938759
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,24229,0.000677036397697237,0.00212376461741235,-0.00348554225243096,0.00483961504782543,0.749887984575616
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,24793,0.000848901685491347,0.00268056515368812,-0.00440500601573738,0.00610280938672007,0.75148334335019
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.000433022721294235,0.00137284184540212,-0.00312379273828239,0.00225774729569391,0.752444897978941
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,0.000447038709111108,0.00143888233286702,-0.00237317066330826,0.00326724808153047,0.756042528589505
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,28931,-0.00103368178291933,0.00338559612443849,-0.00766945018681877,0.00560208662098011,0.760126537762873
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",24793,-0.000929988407459151,0.00306241528084423,-0.00693232235791384,0.00507234554299554,0.761375705470346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.00127377887259059,0.00421879386337461,-0.00954261484480483,0.00699505709962365,0.762708314028142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,24706,0.00153041281499098,0.00508820797355981,-0.00844247481318624,0.0115033004431682,0.763587547304423
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,-0.000886409193932112,0.0029499394118493,-0.00666829044115674,0.00489547205329251,0.763810705003151
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSC1,Hamartin,24229,-0.00159211330347652,0.00530817077435313,-0.0119961280212087,0.00881190141425561,0.764228290450659
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,-0.00132782720070794,0.00451517498385017,-0.0101775701690543,0.00752191576763839,0.768698547602925
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCN,Decorin,28916,0.00047278692166945,0.00160883776495919,-0.00268053509765056,0.00362610894098947,0.768860413472636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,24101,-0.000704028208099591,0.0024579535224295,-0.0055216171120614,0.00411356069586222,0.774552328880289
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,-0.000844816275362168,0.00295169301070117,-0.00663013457633646,0.00494050202561213,0.774716566614197
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,-0.0018206789703126,0.00641115937537618,-0.0143865513460499,0.0107451934054247,0.776423601682085
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,24793,0.000889730947717956,0.00313757372084478,-0.00525991354513781,0.00703937544057372,0.776740059898525
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00131554371894358,0.00465293514974362,-0.0104352966124411,0.00780420917455392,0.777383055473886
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,24111,-0.000795533754401926,0.0028305780892106,-0.00634346680925471,0.00475239930045086,0.778674522215812
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.00075364900229116,0.0027562425679301,-0.00464858643085183,0.00615588443543415,0.78452198166739
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,0.000674788765526904,0.00250334002479201,-0.00423175768306543,0.00558133521411924,0.787504566341928
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,-0.00105019859567913,0.00390968083507929,-0.00871317303243454,0.00661277584107628,0.788227956572618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,-0.00108622175384319,0.00405170100254365,-0.00902755571882874,0.00685511221114236,0.788632091479978
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.00103397456123552,0.00391236954362287,-0.00663426974426532,0.00870221886673635,0.791563387481283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,24016,0.000760557806800806,0.00289936086510722,-0.00492218948880935,0.00644330510241096,0.793077669329962
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,-0.00143735204674547,0.00553148387594965,-0.0122790604436068,0.00940435635011585,0.794982233682827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.00164692115969357,0.0064350796988786,-0.0109658350501085,0.0142596773694956,0.798007733001451
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,-0.000519776797877559,0.00205311335544865,-0.0045438789745569,0.00350432537880179,0.800142438376851
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,-0.000811478251039638,0.00320918640269681,-0.00710148360032538,0.0054785270982461,0.800377684808781
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,24445,-0.00104375600275216,0.00425259357358184,-0.00937883940697257,0.00729132740146826,0.806117924720265
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.000591523990174521,0.00243500871105425,-0.0041810930834918,0.00536414106384084,0.808065729844911
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.000501100546696652,0.00209391531034115,-0.00360297346157199,0.0046051745549653,0.810864768868832
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,24229,0.000637874850947809,0.0026751376410913,-0.00460539492559114,0.00588114462748676,0.811537506335758
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,29392,0.00131183472213085,0.00553535118305477,-0.00953745359665649,0.0121611230409182,0.81266454045252
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,28916,0.000545869685295553,0.00230412150511778,-0.00397020846473529,0.0050619478353264,0.812728203595134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,28931,-0.00231416227907586,0.00998951392255989,-0.0218936095672932,0.0172652850091415,0.81680440298818
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,0.00101735429949502,0.00444191462523163,-0.00768879836595898,0.00972350696494902,0.818843274485483
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,-0.0028696767550098,0.013038491131427,-0.0284251193726066,0.022685765862587,0.825800489444542
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,24938,-0.000793925571955442,0.00365426320551331,-0.00795628145476152,0.00636843031085064,0.828007432096015
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,0.00102524795224595,0.00473689644901607,-0.00825906908782556,0.0103095649923174,0.828647595056968
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,-0.000727564927489531,0.00344346490081815,-0.0074767561330931,0.00602162627811403,0.832663853561836
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,24845,0.00140119707574429,0.00669064549720435,-0.0117124680987762,0.0145148622502648,0.834117188010088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,24195,-0.00087660565650934,0.00425715191730895,-0.00922062341443487,0.00746741210141619,0.83686010236845
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,24101,0.001087363762393,0.0054671519584247,-0.00962825407611942,0.0118029816009054,0.842350197569346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,-0.000557674250678937,0.00283569107074805,-0.00611562874934511,0.00500028024798724,0.844093224183347
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.000687639980589355,0.00352616869820235,-0.00622365066788726,0.00759893062906597,0.845386358458282
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLC,Galectin-10,29426,-0.000907309679294963,0.00466459790297329,-0.0100499215691226,0.00823530221053268,0.845778121083954
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,-0.000426944175979744,0.00223503635327905,-0.00480761542840668,0.00395372707644719,0.848508625549135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.000991013596590546,0.00520164617975198,-0.0111862401089044,0.00920421291572334,0.848903863042243
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,24229,0.000612685605435061,0.00337081678404149,-0.00599411529128627,0.00721948650215639,0.855771213750629
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,24938,-0.00111889028043926,0.00624622788616139,-0.0133614969373156,0.0111237163764371,0.857836645078908
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.000844433890727608,0.00474491352047421,-0.00845559660940184,0.0101444643908571,0.858751051862829
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,-0.000324439450758511,0.00183495287791923,-0.00392094709148021,0.00327206818996319,0.859658241380485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,-0.0007040692129536,0.00431097456907701,-0.00915357936834453,0.00774544094243733,0.870267702633898
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,-0.000700433660557753,0.00429357542876132,-0.00911584150092995,0.00771497417981444,0.870413057375316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.00041053409932097,0.00255857067660133,-0.00460426442681764,0.00542533262545958,0.872524206116007
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,-0.000641811202854019,0.00406172990988475,-0.00860280182622813,0.0073191794205201,0.874446899682391
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,29536,-0.000914935604420151,0.00581903447044485,-0.0123202431664921,0.0104903719576518,0.875063467226746
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.000534415723359402,0.00355698924726297,-0.00643728320127602,0.00750611464799483,0.880573497107895
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,-0.000404774370955931,0.0027693717121302,-0.00583274292673112,0.00502319418481925,0.883795448795908
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,29594,0.000598575721900747,0.00410584399546607,-0.00744887850921275,0.00864602995301424,0.884091100621327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,-0.000583156220100084,0.00408217575482039,-0.00858422069954805,0.00741790825934789,0.886406477793384
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,24229,-0.000467474089352152,0.0033114232836214,-0.00695786372525009,0.00602291554654579,0.887736708742069
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,-0.000487845772434797,0.00355094309298976,-0.00744769423469472,0.00647200268982513,0.890727751899747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,24229,-0.000411439635731181,0.00304106562911431,-0.00637192826879523,0.00554904899733287,0.892380110696636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,0.000514290611829735,0.00384754830345524,-0.00702690406294253,0.00805548528660199,0.893666927326324
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,24016,0.00109204947318129,0.00825565791213654,-0.0150890400346063,0.0172731389809689,0.894764792822282
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,28797,-0.000802119854021312,0.00611532114077967,-0.0127881492899495,0.0111839095819068,0.895645213441579
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,-0.000205611004152079,0.00158073576906662,-0.00330385311152266,0.00289263110321851,0.896509584990286
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,-0.000178236872858768,0.00142768468106492,-0.00297649884774602,0.00262002510202848,0.900648459245251
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,28931,0.000269514358051338,0.00221904909935973,-0.00407982187669374,0.00461885059279642,0.903331588816047
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,28916,0.000227815223596911,0.00192970116827782,-0.00355439906622762,0.00401002951342144,0.906023112212202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,24016,-0.000468259299769796,0.00427666414989204,-0.0088505210335582,0.00791400243401861,0.912813406683017
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,24111,0.000631084611975775,0.0059157494162492,-0.0109637842438727,0.0122259534678242,0.915044748397174
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,-0.000287694764037593,0.00272339962426664,-0.00562555802760021,0.00505016849952503,0.915870370831926
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,23603,0.000518673672307248,0.00494904604398042,-0.00918145657389438,0.0102188039185089,0.91653321299441
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,-0.000497654069530106,0.0048693638913296,-0.0100416072965361,0.0090462991574759,0.918597938477902
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,24381,0.000240117472215822,0.00242557726100129,-0.0045140139593467,0.00499424890377835,0.921143888639641
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,24101,0.000451144931541018,0.00459237891173585,-0.00854991773546124,0.00945220759854328,0.921744331582232
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,29169,-0.000315539278416309,0.00324796556630598,-0.00668155178837603,0.00605047323154341,0.922608083062102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,0.000301605550280861,0.00344611355036368,-0.00645277700843195,0.00705598810899367,0.930258407229993
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.000195795691896759,0.00225647845443551,-0.00461849346259037,0.00422690207879685,0.93085468586316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,29349,-0.000114797632604674,0.00134300887989351,-0.00274709503719596,0.00251749977198661,0.931882015855706
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,0.000292033592699466,0.0034274026494778,-0.00642567560027701,0.00700974278567594,0.932098721587445
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.000217442531613444,0.00258303953048321,-0.00528020001136054,0.00484531494813365,0.93291330060172
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,24195,-0.00037892504744991,0.0046284618035485,-0.00945071018240498,0.00869286008750515,0.934751991806841
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,0.000474230508482112,0.00599948681301534,-0.0112847636450279,0.0122332246619922,0.936997344515068
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,0.000186035764090699,0.00236177320465599,-0.00444303971703504,0.00481511124521643,0.937216481246548
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,24445,0.000324153497578472,0.00420371994027012,-0.00791513758535097,0.00856344458050792,0.938535788751147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,0.00090396965430428,0.0121908072023438,-0.0229900124622895,0.0247979517708981,0.940890238480175
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,24805,-0.000591360949655996,0.0080748458012989,-0.0164180587202018,0.0152353368208899,0.941619743714053
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,24793,-0.00016426033359369,0.00243218203059333,-0.00493133711355662,0.00460281644636924,0.94615538876238
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,0.000230112412911148,0.00346585617541806,-0.00656296569090826,0.00702319051673055,0.947064514751211
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.000279958028120571,0.00445943151518093,-0.00902044379787519,0.00846052774163405,0.949943113265751
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,-0.000295115552448909,0.00491766648997778,-0.00993374187280536,0.00934351076790755,0.9521471318043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,24111,0.000206950307974252,0.00360522025335264,-0.00685928138859692,0.00727318200454543,0.954224682434419
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,-0.000160413482409047,0.0028444793976625,-0.00573559310182754,0.00541476613700945,0.955027869154165
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,-0.000180936178618539,0.00329275398950717,-0.00663473399805259,0.00627286164081551,0.956178828927157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.000337987252268915,0.00616019180951984,-0.01173598869439,0.0124119631989278,0.956245312020412
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,24016,0.000276880192086777,0.00561886191071786,-0.0107360891529202,0.0112898495370938,0.960699024735043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-8.63674982467745e-05,0.00184854110102028,-0.00370950805624652,0.00353677305975298,0.962735197989168
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPGN,Epigen,24793,-0.000157785064881711,0.00339067062542066,-0.0068034994907062,0.00648792936094277,0.962884164601679
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.000114496760478119,0.00250866448098761,-0.0048024856222576,0.00503147914321384,0.963597142663819
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,0.00024014806967879,0.00563322612667249,-0.0108009751385993,0.0112812712779569,0.965996313975811
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,0.000147072446255285,0.00362880073776218,-0.00696537699975858,0.00725952189226915,0.967671550358785
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,24195,-0.000193625438416887,0.00484081744619303,-0.00968162763295523,0.00929437675612146,0.96809465208143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,24111,-0.000134508051120663,0.00338234679398941,-0.0067639077673399,0.00649489166509858,0.968278680885326
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.000161939842593279,0.00409502589042827,-0.00786431090264613,0.00818819058783269,0.96845580658642
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,-0.000138044273594093,0.00448364709075767,-0.00892599257147912,0.00864990402429094,0.975438555754804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,24229,0.00014147116930487,0.00490241935643398,-0.00946727076930574,0.00975021310791548,0.976978544020934
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,0.000102883007178167,0.00377305820693504,-0.00729231107841451,0.00749807709277085,0.978246362845191
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,-6.49335332244601e-05,0.00288423593424233,-0.00571803596433942,0.0055881688978905,0.982038721612228
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,24111,2.26437315242873e-05,0.00302912422221582,-0.00591443974401873,0.0059597272070673,0.994035659568285
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,-2.13617416695263e-05,0.00307096344085308,-0.00604045008574156,0.00599772660240251,0.994449985883267
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,1.92958757946076e-05,0.00626241139712426,-0.0122550304625689,0.0122936222141582,0.997541565753224
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,29725,-1.96992605147034e-06,0.0022295750774173,-0.00437193707778938,0.00436799722568644,0.999295040490745
